2011 CRS Annual Meeting Abstracts

SHORTCUTS

PODIUM PRESENTATION SESSIONS

Bioactive Materials: Clinical Evaluations of Novel Drug Delivery Systems
Bioactive Materials: Medical Devices
Bioactive Materials: Pulmonary Delivery
Consumer & Diversified Products: Delivering Technologies for the Skin, Personal and Homecare
Mini Symposia: Application QbD to Development of Pediatric Formulations and Dosage Forms, part I
Mini Symposia: Bioresponsive Systems
Bioactive Materials: Biomaterials
Bioactive Materials: Intracellular Delivery
Bioactive Materials: Ophthalmic
Consumer & Diversified Products: Microencapsulation in Foods, Flavors and Nutraceuticals
Mini Symposia: Application QbD to Development of Pediatric Formulations and Dosage Forms, part II
Mini-Symposium: Microdevices
Bioactive Materials: Diagnostics
Bioactive Materials: Regenerative Medicine Technologies
Bioactive Materials: Vaccines
Consumer & Diversified Products: Nanoparticles, Nanospheres and Nanopolymers
Mini Symposia: Application QbD to Development of Pediatric Formulations and Dosage Forms, part III
Mini Symposia: Cancer Therapeutics
Bioactive Materials: Functionalised Nanoparticles
Bioactive Materials: Oncology and Tumour Targeting
Bioactive Materials: Transdermal delivery
Consumer & Diversified Products: Characterization of Controlled Release Systems
Mini Symposia: Biological Research Tools
Bioactive Materials: Delivery to the Brain
Bioactive Materials: Pharmaceutical Manufacturing
Bioactive Materials: Protein Delivery
Consumer & Diversified Products: Regulations of Microencapsulated Products
Mini Symposia: Exploiting the Nanoscale to Deliver Poorly Soluble Drugs
Veterinary: New Frontiers in Drug Development: Translational Research and Models for Veterinary and Human Health, Part I
Bioactive Materials: DNA and RNA Delivery
Bioactive Materials: Microspheres
Bioactive Materials: Mucosal Delivery (nasal, vaginal, buccal and rectal)
Bioactive Materials: New Polymer Chemistries
Bioactive Materials: Oral Controlled Release
Consumer & Diversified Products: Advances in Cyclodextrins for CR Applications
Veterinary: New Frontiers in Drug Development: Translational Research and Models for Veterinary and Human Health, Part II

POSTER SESSIONS

Advances in Cyclodextrins for CR Applications: Consumer & Diversified Products
Analytical Methods: Bioactive Materials
Biomaterials: Bioactive Materials
Characterization of Controlled Release Systems: Consumer & Diversified Products
Clinical Evaluations of Novel Drug Delivery Systems: Bioactive Materials
Delivering Technologies for the Skin, Personal and Homecare: Consumer & Diversified Products
Delivery to the Brain: Bioactive Materials
Diagnostics: Bioactive Materials
DNA and RNA Delivery: Bioactive Materials
Functionalised Nanoparticles: Bioactive Materials
Implants: Bioactive Materials
Intracellular Delivery: Bioactive Materials
Medical Devices: Bioactive Materials
Microspheres: Bioactive Materials
Mucosal Delivery (nasal, vaginal, buccal and rectal): Bioactive Materials
Nanomedicines: Bioactive Materials
New Frontiers in Drug Development: Translational Research and Models for Veterinary and Human Health: Veterinary
New Polymer Chemistries: Bioactive Materials
Oncology and Tumour Targeting: Bioactive Materials
Ophthalmic: Bioactive Materials
Oral Controlled Release: Bioactive Materials
Pharmaceutical Manufacturing: Bioactive Materials
Poorly Soluble Drugs: Bioactive Materials
Protein Delivery: Bioactive Materials
Pulmonary Delivery: Bioactive Materials
Regenerative Medicine Technologies: Bioactive Materials
Transdermal delivery: Bioactive Materials
Vaccines: Bioactive Materials

 

PODIUM PRESENTATIONS

Bioactive Materials: Clinical Evaluations of Novel Drug Delivery Systems     [RETURN TO TOP]

1  Invited Speaker: Electroporation for drug and gene delivery; The science behind, current clinical experience and novel perspectives. Presenter: Julie Gehl, University of Copenhagen. Author(s): J. Gehl. VIEW ABSTRACT

2  Invited Speaker: Intradermal Delivery of Therapeutic Drugs and Vaccines Using Stainless Steel Microneedles. Presenter: Ron Pettis, BD Technologies. Author(s): R. J. Pettis. VIEW ABSTRACT

3  High Volume Intradermal Delivery in Humans using a Fully-Integrated Hollow Microneedle Device. Presenter: Kris Hansen, 3M Drug Delivery Systems. Author(s): K. J. Hansen, S. Burton, N. Sullivan, P. Young, D. Wirtanen. VIEW ABSTRACT

4  Clinical Behavior of Nanosuspension Formulations: Are these Systems Best Characterized as Solutions or Suspensions?. Presenter: Marcus Brewster, Janssen Research and Development. Author(s): S. Ouwerkerk-Mahadevan, V. Sinha, A, Van Peer, C. Mackie, G. Meurs, N. Van Cauter, E. Basstanie, T. Arien, G. Verreck, K. Swinney, S. Stokbroekx, F. Vanhoutte, J. Van Gelder, M. E. Brewster. VIEW ABSTRACT

5  Enhanced Drug Delivery and Therapeutic Effect for Lung Cancer Using NO Releasing Agent (ISDN) and SMANCS Administered via the Bronchial Artery: Experiences with Unresectable Advanced Bronchogenic Cancer. Presenter: Hiroshi Maeda, Faculty of Pharmaceutical Sciences, Sojo University. Author(s): H. Maeda, K. Greish, A. Nagamitsu. VIEW ABSTRACT

6  Ultra-Fast Onset of Action of Human Insulin with the BioChaperone System. Presenter: Rémi Soula, ADOCIA. Author(s): R. Soula. VIEW ABSTRACT

 

Bioactive Materials: Medical Devices     [RETURN TO TOP]

7  Invited Speaker: Tackling the Audacious Goal of a Needle-free Expanded Program on Immunization: a Model of Technology Validation and Adoption. Presenter: Michael Royals, Pharmajet. Author(s): M. Royals. VIEW ABSTRACT

8  Microchip Embedded with Diffusion-Channels and Drug-Wells for Sustained Drug Delivery. Presenter: Young Bin Choy, Department of Biomedical Engineering, College of Medicine and Institute of Medical & Biological Engineering, Medical Research Center, Seoul National University, Seoul, 110-799, Republic of Korea. Author(s): Y. Choy, S. Lee, M. Park, C. Park, J. Lee. VIEW ABSTRACT

9  Drug-Eluting Balloon Development by Imprinting Uniform Array of Microparticles. Presenter: Jutarat Kitsongsermthon, Purdue University. Author(s): J. Kitsongsermthon, G. Acharya, K. Park. VIEW ABSTRACT

10  Long term in vivo study of polycaprolactone vascular grafts in the rat model: lessons learned. Presenter: Sarrade Valence, University of Geneva. Author(s): S. de Valence, J. Tille, D. Mugnai, R. Gurny, B. H. Walpoth, M. Moeller. VIEW ABSTRACT

298  Modeling Free Swelling and Swelling Pressure under Confinement in Sugar Sensitive Hydrogels. Presenter: Ronald Siegel, University of Minnesota. Author(s): R. A. Siegel, A. Kim. VIEW ABSTRACT

12  Analysis of Flow Rate Effects Using a Reciprocating Drug Delivery Prototype for the Inner Ear. Presenter: Erin Pararas, Draper Laboratory. Author(s): E. L. Pararas, Z. Chen, J. Fiering, M. J. Mescher, E. S. Kim, M. J. McKenna, S. G. Kujawa, J. T. Borenstein, W. F. Sewell. VIEW ABSTRACT

13  A One-day Programmable Skin-adhered Patch Infusion System Based on a Low-Voltage Electroosmotic Pump. Presenter: Woonsup Shin, Department of Chemical Engineering, University of Texas at Austin. Author(s): W. Shin, S. J. Shin, J. Lee, R. K. Nagarale, A. Heller. VIEW ABSTRACT

 

Bioactive Materials: Pulmonary Delivery     [RETURN TO TOP]

14  Invited Speaker: Pulmonary Delivery of Liposomal Ciprofloxacin. Presenter: Francis Dayton, Aradigm Corporation. Author(s): F. Dayton, D. Cipolla, I. Gonda, P. Bruinenberg. VIEW ABSTRACT

15  Nanostructured Lipid Carriers as Multifunctional Nanomedicine Platform for Pulmonary Co-Delivery of Anticancer Drugs and siRNA. Presenter: Oleh Taratula, Department of Pharmaceutics, Rutgers, The State University of New Jersey, Piscataway, NJ 08554, USA. Author(s): O. Taratula, M. Shah, O. Garbuzenko, T. Minko. VIEW ABSTRACT

16  Pressurized-metered Dose Inhalers for Delivering Genes to the Lungs. Presenter: Sandroda Rocha, Department of Chemical Engineering and Materials Science, Wayne State University, Detroit, MI, 48202. Author(s): D. S. Conti, B. Bharatwaj, D. Brewer, S. da Rocha. VIEW ABSTRACT

17  Prolonged Pulmonary Vasodilation by Inhaled Liposomes of Fasudil in Monocrotaline (MCT) Induced Rat Model of PAH. Presenter: Nilesh Gupta, School of Pharmacy, Texas Tech University Health Sciences Center, Amarillo TX 79106 USA. Author(s): N. Gupta, V. Gupta, F. Ahsan. VIEW ABSTRACT

18  Nanoparticle transit to lymph nodes from lungs. Presenter: Abdul Khadermohammad, Wayne State University. Author(s): A. Mohammad, L. K. Amayreh, J. J. Reineke. VIEW ABSTRACT

19  Antitumor effect of lipopolysaccharide by pulmonary inhalation combined with chemotherapeutic agent. Presenter: Riho Suzuki, Tokyo University of Science. Author(s): R. Suzuki, K. Hirota, Y. Oishi, H. Taniguchi, H. Inagawa, C. Kohchi, G. Soma, H. Terada. VIEW ABSTRACT

20  Dendrimer Nanocarriers for Lung Delivery: Formulation in Portable Inhalersand in vitro Transport Across a Model of the Lung Epithelium. Presenter: Sandroda Rocha, Wayne State University. Author(s): B. Bharatwaj, D. S. Conti, S. R. da Rocha. VIEW ABSTRACT

 

Consumer & Diversified Products: Delivering Technologies for the Skin, Personal and Homecare     [RETURN TO TOP]

21  Invited Speaker: Encapsulating Fundamental Science into Real-World Tools: â Formulating for Efficacyâ -- a Computer Program for the Optimization of Topically Applied Formulations. Presenter: Johann Wiechers, JW Solutions. Author(s): J. W. Wiechers, S. S. Abbott. VIEW ABSTRACT

23  Development and Characterisation of A Nano-Particulate System for the Oral Delivery of Lansoprazole using milled poly (DL-lactide-co-glycolide). Presenter: Anjumn Shabir, aston university. Author(s): A. Shabir, Y. Perrie, A. U. Mohammed. VIEW ABSTRACT

24  Studies on Liposome, Gel and Lipogelosome Formulations Containing Sodium Hyaluronate. Presenter: Gulengul Duman, Assistant Professor. Author(s): G. Duman, I. Aslan, A. Y. Ozer, A. Taralp, I. Inanc. VIEW ABSTRACT

25  Solid Lipid Nanoparticles Based Novel Topical Formulation of Terbinafine Hydrochloride. Presenter: Preeti Wavikar, Student. Author(s): P. R. Wavikar. VIEW ABSTRACT

26  Effect of the hydrogel-forming polymer and the nanocapsules on the skin adhesion of a cutaneous formulation containing capsaicinoids. Presenter: Renata Contri, Universidade Federal do Rio Grande do Sul. Author(s): R. V. Contri, T. Katzer, A. F. Ourique, R. R. Beck, A. R. Polhmann, S. S. Guterres. VIEW ABSTRACT

 

Mini Symposia: Application QbD to Development of Pediatric Formulations and Dosage Forms, part I     [RETURN TO TOP]

27  Invited Speaker: Introduction (Abstract Not Available). Presenter: Arzu Selen, FDA/CDER/ONDQA. Author(s): A. Selen.

28  Invited Speaker: Keynote (How Past Efforts Have Led to Where We are Today and Expectations for the Future (Abstract Not Available). Presenter: Dianne Murphy, FDA. Author(s): D. Murphy.

29  Invited Speaker: Integration and Impact of QbD to Drug Development (Abstract Not Available). Presenter: Helen Winkle, FDA. Author(s): H. Winkle.

30  Invited Speaker: Clinical Experiences/Expectations (Abstract Not Available). Presenter: Gideon Koren, Children's Health Research Institute. Author(s): G. Koren.

 

Mini Symposia: Bioresponsive Systems     [RETURN TO TOP]

31  Invited Speaker: Nanoengineering Particle-Based Medicines and Vaccines. Presenter: Frank Caruso, Melbourne University. Author(s): F. Caruso. VIEW ABSTRACT

32  Invited Speaker: Smart polymeric micelles from PEG-based block copolymers for advanced drug delivery. Presenter: Kazunori Kataoka, University of Tokyo. Author(s): K. Kataoka. VIEW ABSTRACT

33  Invited Speaker: Dynamic siRNA and DNA delivery systems based on bioresponsive polymers. Presenter: Ernst Wagner, Ludwig Maximillians University. Author(s): E. Wagner. VIEW ABSTRACT

34  Invited Speaker: Enzyme-Responsive Molecular Systems. Presenter: Rein Ulijn, Strathclyde University. Author(s): R. V. Ulijn. VIEW ABSTRACT

 

Bioactive Materials: Biomaterials     [RETURN TO TOP]

35  Invited Speaker: Advanced carbon-based nanomaterials: opportunities and challenges in drug delivery. Presenter: Alberto Bianco, CNRS, UPR9021 ICT. Author(s): A. Bianco. VIEW ABSTRACT

36  Invited Speaker: Strategies of Fabricating Peptide Dendrimers for Cancer Diagnosis and Therapy. Presenter: Zhongwei Gu, Sichuan University. Author(s): Z. Gu, K. Luo, B. He, G. Wang, H. Ai. VIEW ABSTRACT

37  PEO-PPO-PEO Block Co-Polymers and Bio-Membrane Interactions: A Structure Based Relationship. Presenter: Martin Redhead, University of Nottingham. Author(s): M. Redhead, G. Mantovani, C. Alexander, C. Bosquillon. VIEW ABSTRACT

38  Controlling liquid crystalline structure for light responsive delivery systems. Presenter: Ben Boyd, Monash Institute of Pharmaceutical Science. Author(s): W. Fong, T. Hanley, B. J. Boyd. VIEW ABSTRACT

39  Polysorbitol-Based Osmotic Active Transporter for Highly Efficient Gene Delivery in Vitro and inVivo. Presenter: Chong-Su Cho, Department of Agricultural Biotechnology and Research Institute for Agriculture and Life Sciences, Seoul National University, Seoul 151-921, Korea. Author(s): M. Islam, R. Arote, C. Yun, Y. Choi, I. Park, J. Shin, M. Cho, C. Cho. VIEW ABSTRACT

40  Smart Nanomedicines Using Hyaluronic Acid Derivatives for the Treatment of Liver Diseases. Presenter: Sei Kwang Hahn, POSTECH. Author(s): S. Hahn, E. Oh, K. Park, K. Kim, J. Yang. VIEW ABSTRACT

 

Bioactive Materials: Intracellular Delivery     [RETURN TO TOP]

41  Invited Speaker: Tools to Unravel the Cellular Entry Mechanisms, Downstream Trafficking and Targetting efficiency of Drug Delivery Systems: Comparative Analysis of siRNA Depletion of Endocytic proteins and Pathways vs Pharmacological Inhibitors. Presenter: Arwyn Jones, Cardiff University. Author(s): A. Jones. VIEW ABSTRACT

42  Efficient Endothelial Uptake of ICAM-1-Targeted Polymer Carriers within a Wide Range of Sizes is Provided by the Sphingomyelin/Ceramide Pathway at Membrane Lipid Raft-Like Domains. Presenter: Daniel Serrano, Department of Cell Biology and Molecular Genetics, University of Maryland, College Park, MD. Author(s): D. Serrano, M. Ansar, R. Chadha, T. Bhowmick, S. Muro. VIEW ABSTRACT

43  Label-FreeRaman Micro-Spectral Imaging of EGFR-Targeted Nanoparticle Internalization and Sub-Cellular Delivery inOvarian Tumor Cells. Presenter: Tatyana Chernenko, Northeastern University. Author(s): T. Chernenko, L. Quintero, M. Diem, M. Amiji. VIEW ABSTRACT

44  Monitoring Disulfide Bond Reduction in the Endocytic Compartments. Presenter: Juhee Lee, University of Michigan. Author(s): J. Lee, Z. F. Walls, C. J. Provoda, J. A. Swanson, K. Lee. VIEW ABSTRACT

45  Triphenylphosphonium (TPP)-Modified Dendrimer Targets Mitochondria. Presenter: Swati Biswas, Northeastern University. Author(s): S. Biswas, V. P. Torchilin. VIEW ABSTRACT

46  Innovative approach to mitochondrial delivery of oligodeoxynucleotide using MITO-Porter, liposome-based carrier for mitochondrial delivery. Presenter: Yuma Yamada, Faculty of Pharmaceutical Sciences, Hokkaido University. Author(s): Y. Yamada, E. Kawamura, Y. Yasuzaki, J. Harashima. VIEW ABSTRACT

47  Intracellular Drug Delivery using Polymer Nano-needles. Presenter: Poornima Kolhar, University of California Santa Barbara. Author(s): P. Kolhar, N. Doshi, S. Mitragotri. VIEW ABSTRACT

 

Bioactive Materials: Ophthalmic     [RETURN TO TOP]

48  Invited Speaker: Drug Delivery to the Back of the Eye for the Treatment of Retinal Diseases: The Suprachoroidal Highway. Presenter: Henry Edelhauser, Emory University. Author(s): H. F. Edelhauser, S. R. Patel, D. E. Berzeovsky, M. R. Prausnitz. VIEW ABSTRACT

49  Antibody diffusion and penetration in AMD treatment -- Does size really matter?. Presenter: Ilva Rupenthal, Department of Ophthalmology, The University of Auckland. Author(s): S. Tait, Y. Chen, I. D. Rupenthal. VIEW ABSTRACT

50  Enhancement of transscleral transport of macromolecules by sonophoresis. Presenter: Ying Chau, The Hong Kong University of Science and Technology. Author(s): Y. Chau. VIEW ABSTRACT

51  Chitosan Coated Planar SU-8/PEGDMA Microdevices for Retinal Drug Delivery. Presenter: Jennifer Wade, University of California San Francisco - Department of Bioengineering and Therapeutic Sciences. Author(s): J. S. Wade, R. D. Lowe, T. A. Desai. VIEW ABSTRACT

52  Eyedrop administration of edaravone-loaded liposomes protected against light-induced retinal damage. Presenter: Kohei Hironaka, Gifu pharmaceutical University. Author(s): K. Hironaka, H. Shimazaki, T. Fujisawa, Y. Tozuka, K. Tsuruma, M. Shimazawa, H. Hara, H. Takeuchi. VIEW ABSTRACT

53  A novel Cyclosporin A micellar ophthalmic formulation as an alternative to systemic administration for corneal graft rejection treatment. Presenter: Claudia Di Tommaso, University of Geneva, University of Lausanne, CH-1211 Geneva 4. Author(s): C. Di Tommaso, J. Bourges, F. Valamelesh, F. Behar-Cohen, G. Trubitsyn, M. Rodriguez-Aller, R. Gurny. VIEW ABSTRACT

54  Formulation and Evaluation of Cationic submicronic emulsion as an Artificial tear system in Moderate dry eye. Presenter: Harita Desai, Research student at Institute of Chemical Technology. Author(s): H. R. Desai. VIEW ABSTRACT

 

Consumer & Diversified Products: Microencapsulation in Foods, Flavors and Nutraceuticals     [RETURN TO TOP]

55  Invited Speaker: Omega-3 Biotechnology: Functional Foods and Pharmaceuticals. Presenter: Colin Barrow, Deakin University. Author(s): C. J. Barrow, J. Kralovec, W. Zhang. VIEW ABSTRACT

56  Encapsulation within sugar alcohol crystals. Presenter: Matthew Sillick, Firmenich, Inc.. Author(s): M. Sillick, C. M. Gregson. VIEW ABSTRACT

57  Easy Prediction of Antioxidant Capacity by using the free radical Tempo. Presenter: Rainer Müller, Free University of Berlin. Author(s): D. Peters, R. H. Müller, C. M. Keck. VIEW ABSTRACT

60  Preparation and Evaluation of Controlled Release Behavior of Nicotine Loaded Ion Exchange Resins for Manufacturing Chewing Gums by Direct Compression. Presenter: Jayachandar Gajendran, Scientist, Phast GmbH / Johannes Gutenberg University, Mainz. Author(s): J. Gajendran, J. Kraemer, P. Langguth. VIEW ABSTRACT

 

Mini Symposia: Application QbD to Development of Pediatric Formulations and Dosage Forms, part II     [RETURN TO TOP]

61  Invited Speaker: Clinical Industry Experience (Abstract Not Available). Presenter: Sam Maldonado, Johnson & Johnson. Author(s): S. Maldonado.

62  Invited Speaker: Manufacturing Challenges/Opportunities (Abstract Not Available). Presenter: Alan Royce, Novartis. Author(s): A. Royce.

63  Invited Speaker: Biopharmaceutics Risk Assessment Road Map (Abstract Not Available). Presenter: Jim Polli, Univ of Maryland. Author(s): J. Polli.

 

Mini-Symposium: Microdevices     [RETURN TO TOP]

64  Invited Speaker: Hierachical Microdevices for Enhanced Drug Delivery. Presenter: Tejal Desai, UCSF. Author(s): T. A. Desai. VIEW ABSTRACT

65  Invited Speaker: Hollow, Solid and Dissolving Microneedles for Targeted Drug Delivery to Skin, Eyes and Cells. Presenter: Mark Prausnitz, Georgia Institute of Technology. Author(s): M. R. Prausnitz. VIEW ABSTRACT

66  Invited Speaker: Microfluidic Chips: From Electrophoresis to digital PCR. Presenter: Luc Bousse, QuantaLife Inc. Author(s): L. Bousse. VIEW ABSTRACT

67  Invited Speaker: Microengineered hydrogels for tissue engineering, drug delivery, and biosensing applications. Presenter: Ali Khademhosseini, Harvard Medical School. Author(s): A. Khademhosseini. VIEW ABSTRACT

 

Bioactive Materials: Diagnostics     [RETURN TO TOP]

68  Invited Speaker: Lab-on-a-Chip for Diagnostic Applications. Presenter: Martin Gijs, Ecole Polytechnique Fédérale de Lausanne. Author(s): M. Gijs. VIEW ABSTRACT

69  Invited Speaker: Magnetic Targeting and Activation for Controlled Delivery and Release. Presenter: Quentin Pankhurst, Royal Institution of Great Britain. Author(s): Q. Pankhurst. VIEW ABSTRACT

70  Low-energy Nano-emulsions: a promising Platform for Small Animal Preclinical Imaging. Presenter: Nicolas Anton, University of Strasbourg. Author(s): N. Anton, X. Li, A. Jakhmola, F. Hallouard, G. Zuber, P. Choquet, A. Constantinesco, T. F. Vandamme. VIEW ABSTRACT

71  Peanut Agglutinin-immobilized Fluorescent Nanospheres with Surface Poly(N-vinylacetamide) Chains as a Safe Candidate of Diagnostic Drugs for Colonoscopy. Presenter: Makoto Kataoka, Setsunan University. Author(s): M. Kataoka, S. Sakuma, H. Higashino, T. Yano, Y. Masaoka, S. Yamashita, K. Hiwatari, H. Tachikawa, R. Kimura, K. Nakamura, H. Kumagai, J. Gore, W. Pham. VIEW ABSTRACT

72  Development and Characterization of Micellar Theranostic Agent for Simultaneous MagneticResonance Imaging and Cancer Therapy. Presenter: Jaydev Upponi, Northeastern University. Author(s): J. R. Upponi, V. P. Torchilin. VIEW ABSTRACT

73  Applying Chemical Penetration Enhancers as a Novel Method for Non-Invasive Detection of Amniotic Fluid. Presenter: Aharon (Roni) Azaguri, Ben Gurion University of the Negev. Author(s): A. Azaguri. VIEW ABSTRACT

 

Bioactive Materials: Regenerative Medicine Technologies     [RETURN TO TOP]

74  Invited Speaker: Antibiotic-Releasing Porous Poly(methyl methacrylate) Space Maintainers for Craniofacial Tissue Engineering. Presenter: Antonios Mikos, Department of Bioengineering, Rice University. Author(s): P. P. Spicer, M. Shi, J. D. Kretlow, A. M. Henslee, S. Young, N. Demian, J. A. Jansen, M. E. Wong, F. K. Kasper, A. G. Mikos. VIEW ABSTRACT

75  Novel Antibiotic-Eluting Wound Dressings: In-Vitro and In-Vivo Study and Engineering Aspects in the Dressing's Design. Presenter: Meital Zilberman, Tel-Aviv University. Author(s): J. J. Elsner, I. Berdicevsky, A. Shefy-Peleg, M. Zilberman. VIEW ABSTRACT

465  Controlled Protein Release from Microparticles as Mechanism to Concentrate Drugs within Scaffolds. Presenter: Roozbeh Qodratnama, University of Nottingham. Author(s): R. Qodratnama, H. Cox, L. White. VIEW ABSTRACT

467  Gentamicin loaded composite polymeric graft for infection-free healing of full thickness wounds. Presenter: Anupama Mittal, National Institute of Pharmaceutical Education and Research. Author(s): A. Mittal, R. Kumar, D. Prasad, N. Kumar. VIEW ABSTRACT

469  Polymer-Drug Conjugates for the treatment of Familial Amyloidotic Polyneuropathy (FAP). Presenter: Inmaculada Conejos-Sánchez, Polymer Therapeutics Lab. Centro de Investigacion Principe Felipe. Author(s): I. Conejos-Sánchez, I. Cardoso, M. J. Saraiva, M. J. Vicent. VIEW ABSTRACT

79  Mechanical Changes of Senescent Mesenchymal Stem Cells. Presenter: Daniel McGrail, Georgia Institute of Technology. Author(s): D. McGrail, D. Ghosh, M. Dawson. VIEW ABSTRACT

77  Optimization of mPEG Grafting on Langerhans Islets Capsule Using Response Surface Mehtod. Presenter: Ebrahim Vasheghani-Farahani, Tarbiat MOdares. Author(s): Ebrahim Vasheghani-Farahani. VIEW ABSTRACT

 

Bioactive Materials: Vaccines     [RETURN TO TOP]

81  Invited Speaker: Vaccine Delivery System for Immunization against StreptococcusPyogenes. Presenter: Istvan Toth, Univ of Queensland. Author(s): I. Toth, P. Simerska, M. Skwarczynski. VIEW ABSTRACT

82  Dramatically Enhanced Potency of Molecular Adjuvants via Intra-lymph Node Controlled Release. Presenter: Christopher Jewell, Massachusetts Institute of Technology. Author(s): C. M. Jewell, D. J. Irvine. VIEW ABSTRACT

83  The potential of chitosan and trimethyl chitosan (TMC) to induce immune protection following intranasal immunization with Japanese Encephalitis (JE) vaccine. Presenter: Worawan Boonyo, Sirindhorn College of Public Health, Phitsanulok. Author(s): W. Boonyo, H. E. Junginger, N. Waranuch, A. Polnok, S. Yoksan, N. Nitatpattana, T. Pitaksuteepong. VIEW ABSTRACT

84  Virosomal Candida albicans rSap2 vaccine for vaginal immunization: Formulation development, toxicity and immunogenicity studies. Presenter: Gaëlle Vacher, Université de Genève. Author(s): G. Vacher, C. Gremion, M. Amacker, C. Moser, R. Gurny, G. Borchard. VIEW ABSTRACT

85  Lipid and Carbohydrate Based Systems to Target and Deliver Peptide Drug Candidates to Specific Cells. Presenter: Pavla Simerska, The University of Queensland, School of Chemistry and Molecular Biosciences, Brisbane, QLD 4072. Author(s): P. Simerska, Z. Ziora, D. Goodwin, I. Toth. VIEW ABSTRACT

86  Preparation, characterisation and entrapment of a non-glycosidic threitol ceramide into liposomes forpresentation to invariant natural killer T cells. Presenter: Yvonne Perrie, Aston University. Author(s): R. Kaur, J. Chen, V. Cerundolo, Y. Garcia-Diaz, L. Cox, G. Besra, Y. Perrie. VIEW ABSTRACT

87  KALA-modified multi-layered nano particles as antigen gene carrier for MHC Class-I mediated antigen presentation in DNA vaccine approach. Presenter: Hidetaka Akita, Hokkaido University. Author(s): H. Akita, S. M. Shaheen, T. Nakamura, S. Takayama, S. Futaki, A. Yamashita, R. Katoono, N. Yui, H. Harashima. VIEW ABSTRACT

 

Consumer & Diversified Products: Nanoparticles, Nanospheres and Nanopolymers     [RETURN TO TOP]

88  Invited Speaker: Nanocoatings with antibacterial activity. Presenter: Simona Margutti, Natural and Medical Sciences Institute at the University of Tuebingen. Author(s): S. Margutti. VIEW ABSTRACT

89  Development of oral nanoparticulate coenzyme Q10 formulations: Nanostructured lipid carriers (NLC) and drug nanocrystals. Presenter: Jana Pardeike, Institute of Pharmaceutical Sciences, Department of Pharmaceutical Technology, Karl-Franzens Universität Graz. Author(s): J. Pardeike, A. Hommoss, A. Zimmer. VIEW ABSTRACT

90  Supersaturated-Self-Emulsifying Nano-Systems for Softgel Capsules. Presenter: Sridhar Gumudavelli, Pharmaceutics International Inc. (Pii). Author(s): S. Gumudavelli, S. Agrawal. VIEW ABSTRACT

532  Upscaling of human serum albumin (HSA) desolvation. Presenter: Matthias Wacker, Goethe University, Institute of Pharmaceutical Technology. Author(s): M. Wacker, V. Vogel. VIEW ABSTRACT

92  Preparation and characterization of alkylpolyglucoside - based solid lipid nanoparticles. Presenter: Rainer Müller, Dr. Author(s): A. B. Kovacevic, R. H. Müller, S. D. Savic, G. M. Vuleta, C. M. Keck. VIEW ABSTRACT

526  Incorporation of Diflucortolone Loaded Lecithin-Chitosan Nanoparticles into Chitosan Gels for Dermal Delivery. Presenter: Ipek Özcan, Dr.. Author(s): I. Özcan, T. Senyigit, E. Korkmaz, M. Özyazici, Ö. Özer. VIEW ABSTRACT

59  Lipid based Nanomedicine of Curcumin. Presenter: Hayat Onyuksel, University of Illinois at Chicago. Author(s): M. Thaqi, H. Onyuksel. VIEW ABSTRACT

 

Mini Symposia: Application QbD to Development of Pediatric Formulations and Dosage Forms, part III     [RETURN TO TOP]

93  Invited Speaker: Collaborative Efforts for Developing Pediatric Formulations and Dosage Forms (Academia, Pharmaceutical Industry and EMA) (Abstract Not Available). Presenter: Catherine Tuleu, Univ of London. Author(s): C. Tuleu.

94  Invited Speaker: EMA Perspective (Abstract Not Available). Presenter: Ann Marie Kaukonen, EMA Paediatric Medicines. Author(s): A. Kaukonen.

95  Invited Speaker: Ethical Considerations (Abstract Not Available). Presenter: Robert Nelson, FDA. Author(s): R. Nelson.

 

Mini Symposia: Cancer Therapeutics     [RETURN TO TOP]

97  Invited Speaker: Optimization of interferon-ϒ cancer gene therapy by regulating transgene expression profile or controlling the tissue distribution of transgene product. Presenter: Yoshinobu Takakura, University of Kyoto. Author(s): Y. Takakura. VIEW ABSTRACT

98  Invited Speaker: Lipid-based nanoparticulate formulations of anticancer drugs: Products designed to achieve optimized combination effects. Presenter: Marcel Bally, BC Cancer Agency. Author(s): M. B. Bally, M. Verreault, J. Kalra, D. Waterhouse, D. T. Yapp. VIEW ABSTRACT

99  Invited Speaker: Phase 1 trial of ALN-VSP02, a novel RNAi therapeutic targeting VEGF and KSP for the treatment of solid tumors with liver involvement. Presenter: Jared Gollob, Alnylam Pharmaceuticals. Author(s): J. A. Gollob, M. Alsina, J. Tabernero, J. R. Infante, P. LoRusso, A. Cervantes, G. I. Shapiro, L. Paz-Ares, R. Falzone, J. Hill, J. Cehelsky, A. White, I. Toudjarska, D. Bumcrot, R. Meyers, G. Hinkle, N. Svrzikapa, D. W. Sah, A. K. Vaishnaw, H. A. VIEW ABSTRACT

100  Invited Speaker: Carrying out Early Phase Clinical Trials in the European Union on Non EU Produced Investigational Medicinal Products: Importation and Qualified Person Certification Challenges. Presenter: Aidan Madden, FivePharma. Author(s): A. Madden. VIEW ABSTRACT

 

Bioactive Materials: Functionalised Nanoparticles     [RETURN TO TOP]

101  Invited Speaker: Rational design of multifunctional polymer therapeutics for cancer theranostics. Presenter: Ronit Satcchi-Fanairo, Tel Aviv University. Author(s): E. Segal, H. Pan, P. Kopecková, J. Kopecek, R. Satcchi-Fanairo. VIEW ABSTRACT

380  The surface structure of the PEGylated liposome in physiological conditions studied using all atom molecular dynamics simulation and Langmuir monolayer studies. Presenter: Alex Bunker, Centre for Drug Research, University of Helsinki. Author(s): A. Bunker, M. Stepniewski, M. Pasenkiewicz-Gierula, T. Róg, R. Danne, A. Orlowski, M. Karttunen, M. Yliperttula, A. Urtti, E. Vuorimaa. VIEW ABSTRACT

104  Design, Synthesis and Biological Evaluation of a Novel Multifunctional Carbon Nanotube Based "Smart" Drug Delivery Platform. Presenter: Sanyog Jain, Centre of Pharmaceutical Nanotechnology, NIPER Mohali. Author(s): M. Das, R. Singh, S. Datir, S. Kumar, S. Jain. VIEW ABSTRACT

105  Multifunctional 2C5-Immunoliposomes Containing pH-sensitive Bonds and PEGylated TAT Peptide for Enhanced Cellular Internalization by Tumor Cells. Presenter: Erez Koren, Northeastern University, Boston, MA. Author(s): E. Koren, A. Apte, V. P. Torchilin. VIEW ABSTRACT

106  Surface-Modified Nanoparticles EnhanceOncolytic Drug Delivery. Presenter: Deepak Thassu, PharmaNova Inc. Author(s): D. Thassu, K. Holt, D. Hermans. VIEW ABSTRACT

107  Nanoparticles Targeting Dendritic Cell Surface Molecules Effectively Block T cell Conjugation and Shift Immune Response. Presenter: Chuda Chittasupho, The University of Kansas. Author(s): C. Chittasupho, L. Shannon, C. Vines, T. Siahaan, C. Berkland. VIEW ABSTRACT

187  Comparison of different polymers as drug carrier. Presenter: Gianfranco Pasut, University of Padua. Author(s): C. Clementi, G. Pasut, R. Botting, F. Greco. VIEW ABSTRACT

 

Bioactive Materials: Oncology and Tumour Targeting     [RETURN TO TOP]

108  Invited Speaker: Lipid Nanoparticle (LNP) Carriers for siRNA Delivery: Structure-Activity Relationship and Mechanism of Action Studies. Presenter: Thomas Madden, AlCana Technologies Inc. Author(s): T. D. Madden, M. J. Hope, M. Tracy, A. Akinc, M. Maier, M. Jayaraman. VIEW ABSTRACT

402  A Peptide Probe-Guided Imaging and Delivery of Liposomal Doxorubicin to Lung Tumor. Presenter: Byung-Heon Lee, Kyungpook National University. Author(s): B. Lee, A. S. Hoffman. VIEW ABSTRACT

110  New potent anticancer nanoassembly from squalenoylation platform: doxorubicin derivative. Presenter: Luigi Cattel, Università degli Studi di Torino Dipartimento di Scienza e Tecnologia del Farmaco. Author(s): A. Ferrero, A. Maksimenko, S. Wack, P. Marque, C. Lerda, B. Stella, F. Dosio, P. Couvreur, L. Cattel. VIEW ABSTRACT

111  Nanovector geometry governs accumulation into the tumor mass. Presenter: Biana Godin, The Methodist Hospital Research Institute. Author(s): B. Godin, C. Chiappini, S. Srinivasan, Q. Li, J. F. Alexander, M. Ferrari, P. Decuzzi, X. Liu. VIEW ABSTRACT

112  Targeting Human Prostate Cancer PC3 with Bombesin-Anti-DTPA Fab Bispecific Complexes and DTPA-polymer-drug conjugates for Molecular Imaging and Therapy. Presenter: Keyur Gada, Northeastern University. Author(s): V. Patil, K. Gada, R. Panwar, A. Varvarigou, S. Majewski, Y. Tekabe, B. Khaw. VIEW ABSTRACT

113  Targeted delivery of a novel D-peptide for anti-glioblastoma molecular therapy. Presenter: Weiyue Lu, School of Pharmacy, Fudan University. Author(s): C. Li, J. Shen, W. Lu. VIEW ABSTRACT

114  Development of a sequential delivery system for the treatment of lung cancer. Presenter: Neha Arya, Department of Biological Sciences and Bioengineering, Indian Institute of Technology Kanpur, Kanpur-208016, INDIA. Author(s): N. Arya, D. S. Katti. VIEW ABSTRACT

 

Bioactive Materials: Transdermal delivery     [RETURN TO TOP]

115  Invited Speaker: Microneedles for Minimally Invasive Drug, DNA and Vaccine Delivery Through the Skin. Presenter: James Birchall, Cardiff University. Author(s): J. C. Birchall. VIEW ABSTRACT

116  Invited Speaker: Vehicle effects to promote dermal bioavailability. Presenter: Jonathan Hadgraft, School of Pharmacy, University of London. Author(s): J. Hadgraft, M. E. Lane. VIEW ABSTRACT

117  Peptides for Use in the Delivery of siRNA into Skin. Presenter: Tracy Hsu, Department of Chemical Engineering, University of California, Santa Barbara. Author(s): T. Hsu, S. Mitragotri. VIEW ABSTRACT

118  In Vitro and in Vivo Permeation of Ketorolac Tromethamine Formulated in Elastic Liposomes. Presenter: Iván Calderón-Lojero, Facultad de Estudios Superiores Cuautitlán UNAM. Author(s): M. Nava-Arzaluz, I. O. Calderón-Lojero, C. Domínguez Delgado, E. Piñon-Segundo, D. Quintanar-Guerrero, A. Ganem-Rondero. VIEW ABSTRACT

119  Co-iontophoresis of Rasagiline and Pramipexole for the treatment of Parkinsonism. Presenter: Dhaval Kalaria, University of Geneva. Author(s): D. R. Kalaria, Y. N. Kalia. VIEW ABSTRACT

120  Transdermal Exenatide Delivery in the Hairless Rat using the PassPort® System. Presenter: Frank Tagliaferri, Altea Therapeutics. Author(s): F. Tagliaferri, A. M. Smith, M. Baudys, C. T. Palazzola, H. S. Branam, S. E. Mills, G. Tolia, R. M. Jennings, F. Mace. VIEW ABSTRACT

 

Consumer & Diversified Products: Characterization of Controlled Release Systems     [RETURN TO TOP]

121  Invited Speaker: Characterization of Nanoparticles and Microparticles Using State-of-the-Art Techniques. Presenter: Nicole Papen-Botterhuis, TNO. Author(s): N. Papen-Botterhuis, M. Wouters, A. Ten Cate, S. Bellmann. VIEW ABSTRACT

122  Surfactant-dependent interaction of nanoparticles with Raw 264.7 and Caco-2 cells. Presenter: Philip Wachsmann, University of Bonn. Author(s): P. Wachsmann, A. Lamprecht. VIEW ABSTRACT

123  Particle Size Analysis by Laser Diffractometry: Influence of Instrumental Setup on Result. Presenter: Rainer Müller, Department of Pharmaceutics, Biopharmaceutics and NutriCosmetics, Freie Universitaet Berlin, Kelchstr. 31, 12169, Berlin, Germany. Author(s): S. Acar-Kübart, R. H. Müller, C. M. Keck. VIEW ABSTRACT

124  Quantitative Whole-Body Autoradiography Following Single Subcutaneous Injection of [1-14C] 2-erucoyl)-DEPC DepoFoam® Formulation in Rats. Presenter: Brigitte Richard, Pacira Pharmaceuticals. Author(s): R. Willis, B. M. Richard, K. Los, B. H. Willis, P. J. Strzemienski, e. G. Solon. VIEW ABSTRACT

125  A Mathematical Model to Predict Hydrophilic Drug Encapsulation inUnilamellar Liposomes. Presenter: Xiaoming Xu, University of Connecticut. Author(s): X. Xu, M. A. Khan, D. J. Burgess. VIEW ABSTRACT

529  Safety Evaluation of a Novel Pharmaceutical Excipient (DEPC) in EXPAREL™, an Extended-Release Liposomal Formulation of Bupivacaine. Presenter: Brigitte Richard, pacira pharmaceuticals. Author(s): B. M. Richard, T. N. Merriman, P. Newton, L. Ott, D. Haan, A. N. Brubaker, P. I. Cole, P. E. Ross, M. C. Rebelatto, L. Swick, K. G. Nelson. VIEW ABSTRACT

 

Mini Symposia: Biological Research Tools     [RETURN TO TOP]

128  Invited Speaker: Principles and Applications of Two-photon Microscopy. Presenter: Alison Gurney, Univ of Manchester. Author(s): A. M. Gurney. VIEW ABSTRACT

129  Invited Speaker: Three Dimensional Perfused Cell Culture -- The Importance of the New Dimension. Presenter: Z. Cui, Univ of Oxford. Author(s): Z. F. Cui, J. Urban, D. Hughes, Z. Li. VIEW ABSTRACT

130  Invited Speaker: Efficacy testing of anticancer drug(s) loaded nanocarriers in tumor bearing animal model. Presenter: Sanyog Jain, NIPER. Author(s): S. Jain. VIEW ABSTRACT

131  Invited Speaker: Design of Appropriate In Vitro and in Vivo Models for BioDiscovery of Novel Targets for Proangiogenic and Secretory Control Therapy for Compromised Wound Healing. Presenter: Abhay Pandit, National University of Ireland. Author(s): S. MacLellan, N. Garret, M. El-Hammadi, M. de la Fuente, A. Lalatsa, M. Lozano, M. Santander Ortega, A. Raza, W. Holmes, B. Condon, I. F. Uchegbu, J. Moger, A. Schatzlein. VIEW ABSTRACT

 

Bioactive Materials: Delivery to the Brain     [RETURN TO TOP]

132  Invited Speaker: The Blood-Brain Barrier and Drug Transfer to the Brain. Presenter: David Begley, King's College. Author(s): D. J. Begley. VIEW ABSTRACT

133  Invited Speaker: MRI-guided local Blood-Brain barrier disruption using focused ultrasound. Presenter: Kullervo Hynynen, University of Toronto. Author(s): K. Hynynen. VIEW ABSTRACT

134  In Vivo Evaluation of Antinociceptive and Side-Effect Profiles of Novel Lipid Conjugated Endomorphine-1 Analogues. Presenter: Pegah Varamini, School of Chemistry and Molecular Biosciences, The University of Queensland. Author(s): P. Varamini, F. M. Mansfeld, B. Wyse, M. Smith, I. Toth. VIEW ABSTRACT

135  BP02 Peptides Facilitating Transportation of Liposomal Delivery System across the Blood-Brain Barrier. Presenter: Yi-Ju Ko, Industrial Technology Research Institute. Author(s): Y. Ko, S. Cheng, L. Chang, H. Liang, M. Lu. VIEW ABSTRACT

136  ICAM-1-Targeted NanocarriersProvide Efficient Targeting, Transport Across the BBB, and Uniform Distribution and Effects of Therapeutic Enzymes in the Brain. Presenter: Tridib Bhowmick, Institute for Bioscience & Biotechnology Research, University of Maryland, College Park, MD. Author(s): T. K. Bhowmick, J. Hsu, R. Dhami, S. R. Burks, J. P. Kao, E. H. Schuchman, S. Muro. VIEW ABSTRACT

137  Ultrasmall Polymeric Nanoparticles Improve Distribution Volume during Convection-Enhanced Delivery. Presenter: Jiangbing Zhou, Department of Biomedical Engineering, Yale University. Author(s): J. Zhou, T. R. Patel, W. Sheen, J. M. Piepmeier, W. Saltzman. VIEW ABSTRACT

 

Bioactive Materials: Pharmaceutical Manufacturing     [RETURN TO TOP]

138  Invited Speaker: Quality by Design and Pediatric Dosage Form Development. Presenter: Alan Royce, Novartis. Author(s): A. E. Royce. VIEW ABSTRACT

139  Invited Speaker: Clinical Trial Manufacturing - Managing Expectations. Presenter: Mike Hudson, SurModics Pharmaceuticals Inc. Author(s): M. Hudson.

140  Taste Masking of Bitter APIs by Using Hot-Melt Extrusion (HME). Presenter: Dennis Douroumis, University of Greenwich, School of Science. Author(s): D. Douroumis, M. Maniruzzaman, J. S. Boateng. VIEW ABSTRACT

141  UV Imaging - a Technology Platform for Formulation Development. A Closer Look at Drug Release and Dissolution Processes. Presenter: Jesper Østergaard, Department of Pharmaceutics and Analytical Chemistry, Faculty of Pharmaceutical Sciences, University of Copenhagen. Author(s): J. Østergaard. VIEW ABSTRACT

142  Detection of low levels of amorphous materials using H/D exchange, FT-Raman and FT-Infrared spectroscopy. Presenter: Christopher Stapleton, University of Nottingham. Author(s): C. S. Stapleton, F. W. Harun, P. T. Whiteside, A. Parker, S. Y. Luk, J. J. Titman, M. W. George. VIEW ABSTRACT

143  Investigation of Piracetam Cocrystals Formation During Different Grinding Procedures by Raman Spectroscopy. Presenter: Soenke Rehder, University of Hamburg, Institute of Pharmacy. Author(s): S. Rehder, M. Klukkert, C. J. Strachan, A. Sakmann, T. Rades, C. S. Leopold. VIEW ABSTRACT

 

Bioactive Materials: Protein Delivery     [RETURN TO TOP]

144  Invited Speaker: Self-Microencapsulation of large Molecules without Organic Solvents. Presenter: Steven Schwendeman, University of Michigan. Author(s): S. P. Schwendeman, S. E. Reinhold, A. M. Sophocleous, K. H. Desai, K. F. Olsen. VIEW ABSTRACT

145  Single-File Diffusion of Protein Drugs through Cylindrical Nanochannels. Presenter: Jeong-A Yang, POSTECH. Author(s): J. Yang, S. Yang, G. Jeon, J. Kim, S. Hahn. VIEW ABSTRACT

146  Photocrosslinked poly(ester anhydride)s in drug delivery: modification of in vivo peptide release by oligomer chemistry and visualization of surface erosion controlled release. Presenter: Juha MÖnkäre, School of Pharmacy, University of Eastern Finland. Author(s): J. MÖnkäre, R. A. Hakala, M. Kovalainen, J. Pajander, K. Herzig, H. Korhonen, J. V. Seppälä, K. Järvinen. VIEW ABSTRACT

147  A new method for high selective TGase-mediated PEGylation of salmon calcitonin and human growth hormone. Presenter: Gianfranco Pasut, University of Padua. Author(s): A. Mero, O. Schiavon, M. Schiavon, F. Veronese, G. Pasut. VIEW ABSTRACT

148  Effect of Recombinant Human Hyaluronidase (rHuPH20) in Facilitating a Subcutaneous Administration of Immunoglobulin in a Porcine Model. Presenter: David Kang, Halozyme Therapeutics, Inc.. Author(s): D. W. Kang, G. Y. Fu, J. M. Anderson, M. L. Zepeda. VIEW ABSTRACT

149  Enhanced In Vivo Delivery of Three Distinct Therapeutic Enzymes for Lysosomal Storage Disorders by ICAM-1-Targeted Nanocarriers. Presenter: Janet Hsu, Fischell Department of Bioengineering, University of Maryland, College Park, MD. Author(s): J. Hsu, D. Serrano, T. Bhowmick, S. Muro. VIEW ABSTRACT

150  Bioadhesive Double-Walled Nanospheres as an Oral Insulin Delivery Platform. Presenter: Daniel Cho, Brown University. Author(s): D. Y. Cho, C. Tian, K. M. Estrellas, Y. Liu, J. J. Reineke, S. Furtado, E. Mathiowitz. VIEW ABSTRACT

 

Consumer & Diversified Products: Regulations of Microencapsulated Products     [RETURN TO TOP]

202  Invited Speaker: U.S. Regulation of Microencapsulated Products: OTC Drugs, Dietary Supplements & Cosmetics. Presenter: Norma Skolnik, EAS Consulting Group. Author(s): N. Skolnik. VIEW ABSTRACT

199  Invited Speaker: Cosmetic Products -- Current Affairs. Presenter: Wen Schroeder, SEKI Cosmeticals LLC. Author(s): J. Crowther. VIEW ABSTRACT

201  Invited Speaker: Physico-Chemical Characterization of Nanomaterials in the Pharmaceutical Industry. Presenter: Sudesh Kamath, US FDA. Author(s): S. Kamath, A. Rasheed, R. Fahmy. VIEW ABSTRACT

 

Mini Symposia: Exploiting the Nanoscale to Deliver Poorly Soluble Drugs     [RETURN TO TOP]

156  Invited Speaker: 20 years lipid nanoparticles (SLN, NLC) for the delivery of poorly soluble drugs. Presenter: Rainer Muller, Freie Univ of Berlin. Author(s): R. H. Muller. VIEW ABSTRACT

157  Invited Speaker: Liposome Formulations of Sparingly Soluble Compounds. Presenter: Dody Reimer, Northern Lipids. Author(s): D. L. Reimer. VIEW ABSTRACT

158  Invited Speaker: Nanosizing: The Value and Benefits When Formulation in the NanoScale Range. Presenter: Elaine Liversidge, Elan Drug Technologies. Author(s): E. M. Liversidge. VIEW ABSTRACT

159  Invited Speaker: Abstract Not Available (Anette Mullertz). Presenter: Anette Mullertz, Univ of Copenhagen. Author(s): A. Mullertz.

 

Veterinary: New Frontiers in Drug Development: Translational Research and Models for Veterinary and Human Health, Part I     [RETURN TO TOP]

160  Gel-and-Water-in-Oil injectable emulsions: a new technology to encapsulate and deliver high amounts of hydrophilic drugs. Presenter: Gerard Trouve, SEPPIC. Author(s): G. Trouve. VIEW ABSTRACT

161  A novel single-dose subcutaneous controlled-release amoxicillin degradable implant for veterinary medicine use. Presenter: Eran Lavy, School of Veterinary Medicine, Hebrew University of Jerusalem. Author(s): E. Lavy, E. Horwitz, N. Avni-Magen, A. Hoffman, L. Kagan, D. Daryi, M. Friedman. VIEW ABSTRACT

162  Invited Speaker: Genetics of Complex Traits in the Domestic Dog. Presenter: Elaine Ostrander, NHGRI/NIH. Author(s): E. A. Ostrander, H. G. Parker, B. VonHoldt, J. Schoenebeck, A. Boyko, L. Li, N. B. Sutter, C. D. Bustamante, R. K. Wayne. VIEW ABSTRACT

163  Invited Speaker: Of Mice & Men (and Dogs & Cats!): Development of a Xenogeneic DNA Vaccine Program for Spontaneous Cancers in Client Owned Pets. Presenter: Philip Bergman, BrightHeart Veterinary Centers. Author(s): P. J. Bergman. VIEW ABSTRACT

 

Bioactive Materials: DNA and RNA Delivery     [RETURN TO TOP]

164  Invited Speaker: Microfluidics-mediated Synthesis of DNA/RNA Polyplexes. Presenter: Kam Leong, Duke University. Author(s): K. Leong, M. Ho, C. Grigsby, F. Zhao. VIEW ABSTRACT

165  The Effect of Carrier Structure on Morphology and Gene Delivery Efficiency of Polymer/DNA Micellar Nanoparticles. Presenter: Yong Ren, Johns Hopkins University. Author(s): Y. Ren, X. Jiang, D. Pan, R. Patil, P. Wang, J. Williford, H. Mao. VIEW ABSTRACT

166  Ethylamino Glycol Chitosan-Based Self-Assembling Nanoparticles: A Promising Gene Delivery System for the Treatment of Solid Tumours. Presenter: Natrah Arifin, University of London. Author(s): N. Arifin, A. G. Schatzlein, I. F. Uchegbu. VIEW ABSTRACT

167  Quantitative Monitoring of Polyplexes and PolyplexMicelles in Bloodstream Using Intravital Real-time Confocal Laser Scanning Microscopy. Presenter: Takahiro Nomoto, Graduate School of Engineering, The University of Tokyo. Author(s): T. Nomoto, Y. Matsumoto, K. Miyata, M. Oba, S. Fukushima, N. Nishiyama, K. Kataoka. VIEW ABSTRACT

168  Delivery of Chemically-Modified Oligonucleotides for Controlled Alternative mRNA Splicing. Presenter: Christopher Cheng, Yale University. Author(s): C. J. Cheng, M. Saltzman. VIEW ABSTRACT

169  Cationic Lipid-Polymer Nanoparticles for siRNA Delivery and Gene Silencing. Presenter: Xianzhu Yang, University of Science and Technology of China. Author(s): X. Yang. VIEW ABSTRACT

170  Treatment of Ischemic Myocardium with Genetically Engineered Stem Cells. Presenter: Malavosklish Bikram, University of Houston. Author(s): M. Bikram, M. Nounou, S. Saifuddin, C. Wijaya, D. Li, Y. Zheng, G. Silva, B. McConnell. VIEW ABSTRACT

 

Bioactive Materials: Microspheres     [RETURN TO TOP]

171  Invited Speaker: Cell-specific Delivery of Nucleic Acid Drugs with a Combination of Glycosylated Bubble Lipoplexes and Ultrasound Exposure. Presenter: Mitsuru Hashida, Kyoto University. Author(s): M. Hashida. VIEW ABSTRACT

172  Enzymatically-Degradable Microgels for Pulmonary Disease-Responsive Release of Biologics. Presenter: Prinda Wanakule, University of Texas at Austin. Author(s): P. Wanakule, A. Bergeron, K. Roy. VIEW ABSTRACT

173  Drug Tissue Penetration and Coverage from Doxorubicin Eluting Radiopaque Embolization Beads. Presenter: Matthew Dreher, National Institutes of Health. Author(s): M. R. Dreher, K. Sharma, D. Woods, G. Reddy, D. Donahue, E. Levy, J. Karanian, O. A. Chiesa, W. Pritchard, Y. Tang, A. L. Lewis, B. Wood. VIEW ABSTRACT

174  Synthesis of Colloidal Chitosans for Protein Delivery. Presenter: Thierry Delair, University of Lyon. Author(s): T. Delair. VIEW ABSTRACT

175  Particles from Gas Saturated Solutions (PGSS): Processing Modifications for the achievement of Novel Properties. Presenter: Elizabeth Ahmed, Univeristy of Nottingham. Author(s): E. Ahmed. VIEW ABSTRACT

176  Production and Evaluation of Hybrid Drug Delivery Particles (Nanoparticles-in-Microparticles) Prepared by a Double Emulsion Method. Presenter: Yan Lee, Research Fellow. Author(s): Y. S. Lee. VIEW ABSTRACT

177  Fabrication of Homogeneous Nano/microparticles Using Hydrogel Template Method. Presenter: Ying Lu, Purdue University, Industrial and Physical Pharmacy. Author(s): Y. Lu, G. Acharya, K. Park. VIEW ABSTRACT

 

Bioactive Materials: Mucosal Delivery (nasal, vaginal, buccal and rectal)     [RETURN TO TOP]

178  Invited Speaker: New horizons in mucosal delivery. Presenter: Sevda Senel, Hacettepe University. Author(s): S. Senel. VIEW ABSTRACT

179  Investigations of Intestinal Epithelial Compensatory Responses to Permeation Enhancement caused by Sodium Caprate (C10). Presenter: Sam Maher, UCD School of Veterinary Medicine and UCD Conway Institute, Dublin, Ireland. Author(s): S. Maher, E. G. Walsh, B. Bahar, A. W. Baird, D. J. Brayden. VIEW ABSTRACT

180  Development of a novel claudin binder using baculoviral display for its application in mucosal absorption of drugs. Presenter: Koji Matsuhisa, Graduate School of Pharmaceutical Sciences, Osaka University. Author(s): K. Matsuhisa, A. Takahashi, Y. Kakamu, M. Kodaka, A. Watari, M. Kondoh, K. Yagi. VIEW ABSTRACT

632  Polymer Nanoparticles with siRNA for Treatment of HSV-2 Infection. Presenter: Jill Steinbach, Yale University. Author(s): J. M. Steinbach, C. Weller, W. Saltzman. VIEW ABSTRACT

183  Steroid Loaded Biodegradable Polymer Nanoparticles that Rapidly Penetrate Human Cystic Fibrosis Sputum and Control Inflammation in a Mucus Hyper-secreting Mouse Model. Presenter: Nicholas Boylan, Johns Hopkins University. Author(s): N. Boylan, Q. Xu, B. Miao, J. Suk, P. Adstamongkonkul, S. Wang, M. Boyle, J. Hanes. VIEW ABSTRACT

184  Long-Term, Time-Independent Release of the Antiretroviral Agent Tenofovir in Daily Milligram Quantities from an Intravaginal Ring. Presenter: Todd Johnson, University of Utah. Author(s): T. J. Johnson, T. H. Albright, M. R. Clark, D. R. Friend, P. F. Kiser. VIEW ABSTRACT

628  Mucus Penetrating Nanoparticles: In Vivo Evaluation. Presenter: Laura Ensign, Center for Nanomedicine, Johns Hopkins School of Medicine. Author(s): L. M. Ensign, B. C. Tang, Y. Wang, M. D. Porosoff, R. A. Cone, J. S. Hanes. VIEW ABSTRACT

 

Bioactive Materials: New Polymer Chemistries     [RETURN TO TOP]

185  Invited Speaker: An autocatalytic drug delivery vehicle for treating cancer. Presenter: Niren Murthy, Georgia Inst of Technology. Author(s): N. Murthy. VIEW ABSTRACT

186  Novel approach for the synthesis of sugar-labeled amphiphilic copolymers for targeted drug delivery systems: combination of "clip" and "click" chemistries. Presenter: Christine Jerome, CERM, University of Liège. Author(s): C. Jerome. VIEW ABSTRACT

640  VEGF Release From Liquid Injectable Polymers Based On 5-Ethylene Ketal ε- Caprolactone. Presenter: Oladunni Babasola, Queen's University. Author(s): O. Babasola, B. G. Amsden. VIEW ABSTRACT

188  Nanotherapy of Renal Ischemia-reperfusion Injury by pH-Sensitive Redox Nanoparticle. Presenter: Toru Yoshitomi, University of Tsukuba. Author(s): T. Yoshitomi, A. Hirayama, Y. Nagasaki. VIEW ABSTRACT

189  Synthesis and Characterization of Dihydroxyacetone and Lactic Acid Poly(carbonate-ester)s. Presenter: Jennifer Weiser, Cornell University. Author(s): J. R. Weiser, P. N. Zawaneh, D. A. Putnam. VIEW ABSTRACT

190  Self-assembled Nanocomplexes Based on Synthetic Tannins. Presenter: Mai-Thi Nguyen-Kim, MIT. Author(s): O. Z. Fisher, M. Nguyen-Kim, R. S. Langer, D. G. Anderson. VIEW ABSTRACT

191  PEG Nanocarrier-Based Degradable Hydrogels for Maintaining Vaginal pH. Presenter: Sujata Sundara Rajan, Department of Pharmaceutics, Rutgers University. Author(s): S. Sundara Rajan, Y. Singh, K. S. Noll, M. L. Chikindas, P. J. Sinko. VIEW ABSTRACT

 

Bioactive Materials: Oral Controlled Release     [RETURN TO TOP]

192  Invited Speaker: Controlled release matrix tablets - Opportunities, limitations and challenges. Presenter: Christian Seiler, MSD. Author(s): C. Seiler, R. Elkes, M. S. Beauchamp, S. R. Pygall, K. Bradley, A. Djemai, D. A. Thompson, S. Fitzpatrick. VIEW ABSTRACT

193  Enhanced Oral Anticancer Efficacy and Reduced Cardiotoxicity of Doxorubicin Loaded PLGA Nanoparticles in DMBA Induced Breast Cancer Model. Presenter: Amit Jain, Centre for Pharmaceutical Nanotechnology, National Institute of Pharmaceutical Education and Research (NIPER), S.A.S. Nagar (Mohali), Punjab. Author(s): A. K. Jain, N. K. Swarnakar, C. Godugu, R. P. Singh, S. Jain. VIEW ABSTRACT

686  Enhanced Oral Delivery of a Poorly Bioavailable Ultra Low Molecular Weight Heparin (Glycosaminoglycan C3) for Alzheimer's Disease Utilizing GIPET Technology. Presenter: Alan Cullen, Merrion Pharmaceuticals, plc. Author(s): A. Cullen, T. W. Leonard, J. S. Fox, A. Walsh, U. Cornelli, J. Murphy. VIEW ABSTRACT

195  Biodistribution of ICAM-1 Targeting Nanocarriers in the Gastrointestinal Tract in Mice. Presenter: Viraj Mane, University of Maryland. Author(s): V. P. Mane, R. Ghaffarian, T. Bhowmick, S. Muro. VIEW ABSTRACT

196  Mapping Quantitatively Regional Drug Absorption in Canines with IntelliCap System. Presenter: Dieter Becker, Novartis Pharma AG, Basel. Author(s): D. Becker, H. Schütz, A. Beyerbach, H. Zou, J. Shimizu, V. Iordanov. VIEW ABSTRACT

197  Inorganic Nanostructures for Enteric Delivery. Presenter: David Bassett, McGill University. Author(s): D. C. Bassett, M. G. Cerruti, Y. L. Zhang, J. E. Barralet. VIEW ABSTRACT

198  Taste Masking of Ibuprofen Granules Using a Novel Reverse Enteric Film Coating. Presenter: Yidan Lan, BASF Corp.. Author(s): A. Prasad, N. Langley, Y. Lan. VIEW ABSTRACT

 

Consumer & Diversified Products: Advances in Cyclodextrins for CR Applications     [RETURN TO TOP]

151  Invited Speaker: The Role of Cyclodextrins in Innovative Formulations. Presenter: Helmut Viernstein, Univ of Vienna. Author(s): H. Viernstein. VIEW ABSTRACT

152  Cationic ß-Cyclodextrin-Based Supramolecular Hybrid Nanoparticles for Gene and Anti-Cancer Drug Co-Delivery and Living Cell Imaging. Presenter: Jun Li, National Univ of Singapore. Author(s): Y. Wu, J. Li. VIEW ABSTRACT

 

Veterinary: New Frontiers in Drug Development: Translational Research and Models for Veterinary and Human Health, Part II     [RETURN TO TOP]

203  Invited Speaker: Genotypic and pharmacologic profiling of canine tumor-derived primary cell cultures. Presenter: Nick Duesbery, Van Andel Research Institute. Author(s): Y. Ding, A. Blanski, N. Duesbery. VIEW ABSTRACT

204  Invited Speaker: Models for Target Diseases with RNAi Therapy -- Self-assembly siRNA Delivery Strategies. Presenter: Ian Blagbrough, Univ of Bath. Author(s): I. S. Blagbrough, A. A. Metwally, H. M. Ghonaim. VIEW ABSTRACT

205  Invited Speaker: Nanocarriers for siRNA brain delivery to silence neurodegenerative diseases in pets and humans: Potential and Limitations. Presenter: S. Prakash, McGill Univ. Author(s): M. Malhotra, C. Tomaro-Duchesneau, S. Saha, R. Chemali, S. Prakash. VIEW ABSTRACT

206  Invited Speaker: US FDA: Development of In Silico PBPK Models to Support Population Predictions for Canine and Human Oral Drug Delivery Systems. Presenter: Leposava Antonovic, FDA. Author(s): L. Antonovic. VIEW ABSTRACT


POSTER PRESENTATIONS

Advances in Cyclodextrins for CR Applications: Consumer & Diversified Products     [RETURN TO TOP]

155  Ibuprofen-Cyclodextrin Polymer Complex: In Vitro Characterization, In Vivo Bioavailability and Ulcerogenic Assessment of Oral And Rectal Formulations. Presenter: Abdelazim Zaghloul, Department of Pharmaceutics, Faculty of Pharmacy, Kuwait University, Kuwait. Author(s): A. A. Zaghloul, F. I. Abd-Allah. VIEW ABSTRACT

 842 Commercial-scale production of pyclodextrin pomplexes. Presenter: Jeffrey Tate, NanoSonic Products Inc. VIEW ABSTRACT 

Analytical Methods: Bioactive Materials     [RETURN TO TOP]

327  Development and Validation of a Reversed-Phase High Performance Liquid Chromatographic (RP-HPLC) Method for the Analysis of Flucloxacillin in Alginate-Wax microspheres. Presenter: Peter Ikamati, Aston University. Author(s): P. M. Ikamati, D. J. Kirby, Y. Perrie, R. B. Walker. VIEW ABSTRACT

 

Biomaterials: Bioactive Materials     [RETURN TO TOP]

207  A Computer Simulation Model of In-vitro Polymer Degradation of PLA/PLGA Based Drug Delivery Systems. Presenter: Shaoxin Feng, Allergan Inc.. Author(s): S. Feng, K. Wu, J. Shiah, S. W. Smith. VIEW ABSTRACT

208  Anticancer Treatment of NOD-SCID Mice bearing MCF-7 Human Xenograft with Folate-targeted Sopramolecular Vesicular Aggregates: New Frontier for in Vivo Veritas. Presenter: fChristian Celia, Department of Pharmacobiological Sciences, Faculty of Pharmacy, University â Magna Græcia❠of Catanzaro and Fondazione per la Ricerca e la Cura dei Tumori â Tommaso Campanellaâ. Author(s): D. Paolino, M. Licciardi, C. Celia, G. Giammona, M. Fresta, G. Cavallaro. VIEW ABSTRACT

209  Bacterial Nanocellulose (BNC) - A Natural Hydrogel as Drug Delivery System. Presenter: Dagmar Fischer, Friedrich-Schiller-University Jena. Author(s): A. Müller, N. Hessler, Z. Ni, S. Moritz, D. Kralisch, D. Fischer. VIEW ABSTRACT

210  Bile Salts Modulate Permeability of Liposome Membranes. Presenter: Ian Tucker, School of Pharmacy, University of Otago. Author(s): I. G. Tucker, Y. Lin, Z. Hu, P. J. Fawcett. VIEW ABSTRACT

212  Characterizing Polymeric Excipients in Drug Formulation by LC-IR Hyphenated Technology. Presenter: Ming Zhou, Spectra Analysis Instruments, Inc.. Author(s): M. Zhou, W. Carson, S. Bourne, T. Kearney. VIEW ABSTRACT

213  Compatibility between Diclofenac Sodium and Hyaluronic Acid and Release of Diclofenac Sodium from Hyaluronic Acid-containing Preparations towards the Treatment of Osteoarthritis. Presenter: Corinne Eenschooten, Novozymes Biopharma DK A/S, Bagsvaerd, DK-2880, Denmark. Author(s): C. Eenschooten, O. Moeller Dall, B. Kaufmann, F. Longin, R. Gurny, K. Schwach-Abdellaoui. VIEW ABSTRACT

214  Controlled BMP-2 delivery to Mesenchymal Stem Cell from PLLA scaffold. Presenter: Hye Jin Chung, Ewha Womans University. Author(s): H. Chung, S. Lee, I. Shim, S. Lee, M. Lee, A. Choi. VIEW ABSTRACT

215  Cytotoxicity Evaluation of Usnic Acid-loaded Xylan/Eudragit(TM) S-100 Microparticles: Comparative Studies Between Spray-dried and Cross-linked Microparticles. Presenter: Acarilia Silva, Laboratório de Sistemas Dispersos (LASID), Universidade Federal do Rio Grande do Norte (UFRN). Author(s): A. E. Silva, M. C. Gomes, H. R. Marcelino, A. E. Silva, L. F. Agnez-Lima, N. S. Magalhães, E. S. Egito. VIEW ABSTRACT

217  Determination of the PKa of the Indoloquinoline Antimalarial Compound Cryptolepine Hydrochloride by Spectrophotometry. Presenter: Noble Kuntworbe, School of Pharmacy, FMHS, University of Auckland. Author(s): N. Kuntworbe, N. Martini, M. Brimble, R. G. Alany, R. Al-Kassas. VIEW ABSTRACT

218  Effect of fungal mycelia in Corneal Epithelial Wound Healing. Presenter: Ling-Chun Chen, Taipei Medical University. Author(s): L. Chen, H. Ho, S. Lui, C. Su, M. Sheu, R. Chen. VIEW ABSTRACT

219  Enzymatically degradable peptidic dendrimer for delivery of 2-Methoxyestradiol. Presenter: Rohit Kolhatkar, University of Illinois Chicago. Author(s): R. Shankar, U. Wenzel, R. Kolhatkar. VIEW ABSTRACT

220  Evaluating the link between self-assembled mesophase structure and drug release. Presenter: Ben Boyd, Monash Institute of Pharmaceutical Science. Author(s): S. Phan, W. Fong, N. Kirby, B. J. Boyd. VIEW ABSTRACT

221  Hydrogel Microwell Array for In Vitro Hair Follicle Regeneration. Presenter: Lifeng Kang, Department of Pharmacy, National University of Singapore. Author(s): J. Pan, T. Hiew, L. Kang. VIEW ABSTRACT

222  In Vitro Immunocompatibility and Toxicity Evaluation of Self-Assembling Peptide EAK16-II and Anticancer Drug Pirarubicin. Presenter: Sheva Naahidi, University of Waterloo. Author(s): S. Naahidi, M. Jafari, M. Logan, J. Rhee, P. Chen. VIEW ABSTRACT

223  Light Responsive Nanostructured Matrices for Pulsatile Drug Delivery: Photochromics. Presenter: Wye Khay Fong, Monash Institute of Pharmaceutical Science. Author(s): W. Fong, T. Hanley, B. Boyd. VIEW ABSTRACT

224  Mesoporous silica nanoparticles as an anticancer drug delivery system. Presenter: Dennis Douroumis, University of Greenwich, School of Science. Author(s): D. Douroumis, A. A. Lafarga, I. Onyesom, D. A. Lamprou, A. J. Urquhart. VIEW ABSTRACT

226  Modified Heparin Reduces HIT as a Function of the Chain Length of Chemical Moieties Conjugated to Native Heparin. Presenter: Brijeshkumar Patel, School of Pharmacy, Texas Tech University Health Science Center. Author(s): B. I. Patel, H. Wang, F. Ahsan. VIEW ABSTRACT

227 Multiphase hydrogel loaded Dual drug delivery carriers containing antibiotic and debriding enzyme loaded PLGA Microspheres: An effective approach for complete wound healing. Presenter: Deependra Singh, UNIVERSITY INSTITUTE OF PHARMACY,PT. RAVISHANKAR SHUKLA UN IVERSITY,RAIPUR. VIEW ABSTRACT

229  pH/temperature Sensitive Thermogelling Chitosan-g-(PA-PEG) Aqueous Solutions. Presenter: Byeongmoon Jeong, Ewha Womans University. Author(s): J. Jang, H. Moon, M. Park, B. Jeong. VIEW ABSTRACT

231  Preformulation study of tacrolimus prodrugs for increasing solubility. Presenter: Young-Guk Na, Chungnam National University. Author(s): Y. Na, C. Keum, C. Hwang, J. Baek, S. Shin, C. Cho. VIEW ABSTRACT

233  Risperidone loaded PCL-PEO-PCL nanospheres: in vitro release results. Presenter: Laura Herrera, Centro de Investigación en Química Instituto Nacional de Tecnología Industrial. Author(s): L. C. Herrera, L. G. Hermida, G. A. Abraham, F. Buffa, G. O. Ybarra, P. E. Lloret. VIEW ABSTRACT

234  Silk Road to Drug Delivery. Presenter: Tatyana Dyakonov Dyakonov, Banner Pharmacaps Inc. Author(s): T. A. Dyakonov, C. Yang, G. Saujanya, D. D. Bush, S. Majuru, A. Fatmi. VIEW ABSTRACT

235  Single Step Fabrication of Wet Spun Binary Phase Composite Microfibers. Presenter: Danya Decoteau, Brown University. Author(s): D. M. Decoteau, D. Cho, L. Zhang, R. Stefani, R. Patel, E. Mathiowitz. VIEW ABSTRACT

236  "Sponge-like" dressings based on biopolymers for the delivery of platelet lysate to skin chronic wounds. Presenter: Andrea Gazzaniga, University of Milan. Author(s): S. Rossi, A. Faccendini, M. Bonferoni, F. Ferrari, G. Sandri, M. Mori, C. Del Fante, A. Gazzaniga, C. M. Caramella. VIEW ABSTRACT

237  Sponge-like poly(hydroxybutyrate) metal implant coatings: morphology and water absorption capacity. Presenter: Anna Bergstrand, Chalmers University of Technology. Author(s): A. Bergstrand, J. Cramby, A. Larsson. VIEW ABSTRACT

238  Stability of styrene-co-maleic acid telomeric micelles encapsulated - zinc protoporphyrin (SZP). Presenter: Gahininath Bharate, Laboratory of Microbiology and Oncology, Faculty of Pharmaceutical Sciences, Department of Nanoscience and Applied Chemistry, Graduate School of Engineering, Sojo University, Japan. Author(s): G. Y. Bharate, H. Nakamura, J. Fang, H. Maeda. VIEW ABSTRACT

243  The Effect of Plasticizer on Sillver Sulfadiazine (AGSD) Release from Chitosan Membrane: In Vitro Study. Presenter: Azadehsadat Hashemi Doulabi, Amirkabir University of Technology. Author(s): E. Babaie, H. Mirzadeh, H. Keshvari, A. Hashemi Doulabi. VIEW ABSTRACT

244  The Role of PLGA Molecular Weight Blends on the Phase Inversion, Drug Release, and Erosion of In Situ Forming Implants. Presenter: Luis Solorio, Case Western Reserve University. Author(s): L. Solorio, A. Olear, A. Beiswenger, J. Hamilton, R. B. Patel, A. A. Exner. VIEW ABSTRACT

246  Therapeutic Backpacks for Macrophages. Presenter: Nishit Doshi, University of California Santa Barbara. Author(s): N. Doshi, A. Swiston, J. Gilbert, M. Alcaraz, R. Cohen, M. Rubner, S. Mitragotri. VIEW ABSTRACT

248  UV Imaging of Piroxicam Release from Pluronic Hydrogels. Presenter: Fengbin Ye, University of Copenhagen. Author(s): F. Ye, A. Yaghmur, H. Jensen, S. W. Larsen, C. Larsen, J. østergaard. VIEW ABSTRACT

 

Characterization of Controlled Release Systems: Consumer & Diversified Products     [RETURN TO TOP]

525  A Novel Drug Delivery System for Poorly Soluble Drugs: Polymeric Micelles. Presenter: Yildiz Erginer, TC. Author(s): Y. Erginer, E. Kahraman, A. Karagoz, S. Dincer. VIEW ABSTRACT

527  Micronization of acetaminophen by RESS. Presenter: Farid dorkoosh, Tehran University of Medical Sciences, Tehran, 11365-8639, Iran .. Author(s): J. Karimi Sabet, c. ghotbi, F. dorkoosh. VIEW ABSTRACT

528  Optimization of binary lipid matrix for lipid nanoparticle formulation. Presenter: Sateesh Kandavilli, Manager, Derma R&D, Dr. Reddy's Laboratories Ltd., Hyderabad, India. Author(s): S. Kandavilli, S. S. Jena, V. Nalamothu, M. A. Mistry. VIEW ABSTRACT

530  Sedimentation Characteristics of Liposome Formulations For use as Reference Standards in the ELIspot Assay. Presenter: Sagida Bibi, Aston University. Author(s): S. Bibi, D. Bryan, B. Walker, E. Lattmann, Y. Perrie. VIEW ABSTRACT

531  Taste masking and solubility enhancement for Ibuprofen with EUDRAGIT® E PO by spray drying. Presenter: Firouz Asgarzadeh, Evonik Degussa Corporation. Author(s): T. Ishii, T. Morita, F. Asgarzadeh. VIEW ABSTRACT

533  Worm like Micelles from Poly(ethylene oxide)-block-poly(îµ-caprolactone) block Copolymer for the Delivery of Agrochemicals to Plant. Presenter: Abdullah Mahmud, Department of Chemical and Biomolecular Engineering, University of Pennsylvania, Philadelphia, USA; Complex Assemblies of soft matter, CNRS/Upenn/Rhodia-UMI 3254, Bristol, USA. Author(s): A. A. Mahmud, T. Harada, R. Murphy, D. E. Discher. VIEW ABSTRACT

 

Clinical Evaluations of Novel Drug Delivery Systems: Bioactive Materials     [RETURN TO TOP]

249  A Scintigraphic Comparison of Gastrointestinal Transit of a Novel Ibuprofen Solution versus a Marketed Suspension Formulation. Presenter: Gillian Eccleston, Strathclyde Institute of Pharmacy and Biomedical Sciences. Author(s): A. C. Boyter, K. A. Sime, V. E. Ronaldson, L. Hodges, J. Winter, J. Rouse, G. M. Eccleston. VIEW ABSTRACT

250  Correlating Formulation Behaviour with Physiological Effects for a Time-Delayed Sleep Tablet. Presenter: Alex Mullen, Drug Delivery International. Author(s): A. Mullen, S. Eccleston, L. Hodges, V. Ronaldson, K. Sime, D. Pecek, H. Stevens. VIEW ABSTRACT

251  Designed Olanzapine Orally Dispersible Tablet (ODT) and Its Pharmacokinetics Evaluation in the Phase of Schizophrenia. Presenter: Hyunjo Kim, Korean drug Co.. Author(s): H. Kim. VIEW ABSTRACT

 

Delivering Technologies for the Skin, Personal and Homecare: Consumer & Diversified Products     [RETURN TO TOP]

326  Easy and efficacious "Cosmetization" of Textiles. Presenter: Jamileh Lakkis, Lipotec Group. Author(s): J. Viladot, A. Fernandez-Botello, J. Lakkis, R. Delgado. VIEW ABSTRACT

 

Delivery to the Brain: Bioactive Materials     [RETURN TO TOP]

535  A Novel Method for Detecting t-PA leakage Risks of Thrombolytic Therapy using a Polymeric Micelle of a MR Contrast Agent. Presenter: Reiko Endoh, The Jikei University School of Medicine. Author(s): R. Endoh, K. Shiraishi, Z. Wang, I. Aoki, M. Yokoyama. VIEW ABSTRACT

536  Angiopep-2 grafted nanoparticle for Brain Tumor Targeting Delivery. Presenter: Zhonggao Gao, Chinese Academy of Medical Sciences. Author(s): Z. Gao, Q. Yi. VIEW ABSTRACT

537  Ascorbate-Decorated Gold Nanoparticles For Brain Targeting. Presenter: Stefano Salmaso, Department of Pharmaceutical Sciences, University of Padua -- Via F. Marzolo 5, 35131 Padova, Italy. Author(s): S. Bersani, F. Mancin, P. Scrimin, E. Fabris, P. Caliceti, S. Salmaso. VIEW ABSTRACT

538  Calyx[4]resorcine as novel potential delivery systems of medicinal substances. Presenter: Irina Semina, Professor. Author(s): I. Semina. VIEW ABSTRACT

539  Folate conjugated dual drug loaded solid lipid nanoparticles for tumor targeting. Presenter: Ramakrishna Sistla, Pharmacology Division, Indian Institute of Chemical Technology, Uppal Road, Tarnaka, Hyderabad 500 607. Author(s): R. Sistla, V. Venishetty. VIEW ABSTRACT

542  Transferrin Mediated Drug Delivery to Brain. Presenter: Divya Chandra, Rensselaer Polytechnic Institute. Author(s): D. Chandra, P. Karande. VIEW ABSTRACT

 

Diagnostics: Bioactive Materials     [RETURN TO TOP]

331  ApoFlamma™, Fluorescent Probes for Apoptosis Detection. Presenter: Namho Kim, BioActs. Author(s): N. Kim, J. Park, Y. Kim, J. Na, D. Kim, K. Cha, I. Kim, B. Lee. VIEW ABSTRACT

333  Tumour Targeting, Delivery and Detection with Quantum Dots. Presenter: Shirin Ghaderi, University College London. Author(s): S. Ghaderi, A. Seifalian, M. Loizidou, M. Winselt, S. Yang, B. Ramesh. VIEW ABSTRACT

 

DNA and RNA Delivery: Bioactive Materials     [RETURN TO TOP]

543  A Non-viral Dual Targeting Carrier for siRNA delivery. Presenter: Ae-June Wang, Andros Pharmaceuticals Co., Ltd.. Author(s): A. Wang, Y. Yu, L. Wen. VIEW ABSTRACT

544  Albumin Enhances Cellular Uptake of Targeted multifunctional EHCO/siRNA nanoparticles. Presenter: China Kummitha, Case Western Reserve University. Author(s): C. M. Kummitha, A. S. Malamas, Z. Lu. VIEW ABSTRACT

545  Antisense ODNs delivery into mammalian cells using high-pressurized lipoplexes. Presenter: Tsuyoshi Kimura, Tokyo Medical and Dental University. Author(s): T. Kimura, A. Sano, K. Nam, Y. Sasaki, K. Akiyoshi, A. Kishida. VIEW ABSTRACT

546  Application of facial amphipathic bile acid-modified polyethyleneimine as nucleic acid carrier in cell and gene therapy of cardiovascular diseases. Presenter: Sun Hwa Kim, SIRIC, Yonsei University Health System. Author(s): S. Kim, D. Kim, H. Moon, M. Lee, J. Jeong. VIEW ABSTRACT

547  Biodegradable Block Copolymers of Poly(ethylene glycol) and Cationic Polycarbonate for Efficient Gene Delivery. Presenter: Zhan-Yuin Ong, 1) Institute of Bioengineering and Nanotechnology 2) Department of Pharmacy, National University of Singapore. Author(s): Z. Ong, C. Yang, P. Ee, J. L. Hedrick, Y. Yang. VIEW ABSTRACT

548  Biophysical Evaluation of the siRNA Delivery Mechanism of Cholesterol-Conjugated Ionizable Amino Lipids: Lipid Polymorphism, Ionization, and Membrane Interactions. Presenter: Jingtao Zhang, Merck & Co., Inc.. Author(s): J. Zhang, H. Fan, L. S. Crocker. VIEW ABSTRACT

549  Bioreducible cationic nonviral vectors for targeted gene delivery. Presenter: Sejin Son, POSTECH. Author(s): S. Son, W. Kim. VIEW ABSTRACT

550  Charaterization of PEG-Cleavable Polyaspartamide Derivative Block Catiomers Bearing Stearoyl Moieties and its VEGF siRNA Delivery toward Pancreatic Tumor. Presenter: Hyun Jin Kim, Department of Materials Engineering, Graduate School of Engineering, The University of Tokyo. Author(s): H. Kim, F. Pittella, H. Cabral, T. Nomoto, Y. Matsumoto, K. Miyata, N. Nishiyama, K. Kataoka. VIEW ABSTRACT

552  Coating of Polyphosphoramidate/DNA Nanoparticles with Hyaluronic AcidIncreasesTheir Colloidal Stability andIn VivoTransfection Efficiency. Presenter: Deng Pan, Department of Biomedical Engineering, Johns Hopkins University. Author(s): D. Pan, X. Jiang, Y. Ren, H. Mao. VIEW ABSTRACT

554  Conjugation of PAMAM dendrimer with GABA and L-Arginine and application to gene delivery in vitro. Presenter: Sangjae Son, Graduate School of Analytical Science and Technology, Chungnam National University. Author(s): S. Son. VIEW ABSTRACT

555  Controlled release of cell-permeable gene complex from poly(L-lactide) scaffold for enhanced stem cell tissue engineering. Presenter: Mira Jung, Ewha Womans University. Author(s): M. Jung, J. Do, J. Shin, C. Bang, S. Lee. VIEW ABSTRACT

556  Dectin-1 targeting delivery of TNF-a antisense ODNs complexed with ß-1,3-glucan protects micefrom LPS-induced hepatitis. Presenter: Shinichi Mochizuki, The University of Kitakyushu. Author(s): S. Mochizuki, K. Sakurai. VIEW ABSTRACT

557  Delivery of microRNA mimics to cardiomyoctyes using ultrasound responsive microbubbles. Presenter: Helena Kelly, Royal College of Surgeons in Ireland. Author(s): H. M. Kelly, S. Gill, G. P. Duffy, S. Logeswaran. VIEW ABSTRACT

560  Development of polymeric systems for the delivery of small interfering RNA. Presenter: Simona Margutti, Natural and Medical Sciences Institute at the University of Tuebingen. Author(s): S. Hossfeld, H. Hartmann, S. Margutti, B. Schloßhauer, R. Krastev. VIEW ABSTRACT

562  Dual-sensitive Polymer/siRNA Nanoparticles with Enhanced Gene Knockdown Efficiency. Presenter: Juan Wu, Johns Hopkins University. Author(s): J. Wu, X. Jiang, D. Pan, M. T. Crow, H. Mao. VIEW ABSTRACT

563  Effect of Formulation Parameters on siRNA Delivery using Anionic Lipoplexes. Presenter: Mamta Kapoor, Department of Pharmaceutics, University of Connecticut. Author(s): M. Kapoor, D. J. Burgess. VIEW ABSTRACT

564  Effect of PEG molecular weight on transfection of sterically stabilized cross-linked polyplexes in vitro and in vivo. Presenter: Bader Aljaeid, School of Pharmacy, University Park, University of Nottingham. Author(s): B. M. Aljaeid, P. Ferruti, E. Ranucci, S. Stolnik, M. C. garnett. VIEW ABSTRACT

565  Efficient siRNA delivery by cationic polyaspartamide derivatives with optimized charge density. Presenter: Tomoya Suma, Graduate School of Engineering, The University of Tokyo. Author(s): T. Suma, K. Miyata, T. Ishii, H. Uchida, S. Uchida, N. Nishiyama, K. Kataoka. VIEW ABSTRACT

566  Efficient siRNA delivery using siRNA-grafted polymer-based polyion complexes. Presenter: Hiroyasu Takemoto, Graduate School of Engineering, The University of Tokyo. Author(s): H. Takemoto, K. Miyata, N. Nishiyama, K. Kataoka. VIEW ABSTRACT

568  Engineering DNA Nanoparticle Shape and Its Effect on Gene Delivery Efficiency and Biodistribution. Presenter: Xuan Jiang, Johns Hopkins University. Author(s): X. Jiang, D. Pan, Y. Ren, J. Wu, H. Mao. VIEW ABSTRACT

569  Enhanced tumor transfection after systemic injection of lipoplex coated with anionic polymers. Presenter: Haruka Yamasaku, Institute of Medicinal Chemistry, Hoshi University. Author(s): H. Yamasaku, Y. Hattori, Y. Maitani. VIEW ABSTRACT

571  Formulation and Characterization of Novel cross-linked sterically stabilized polyplexes for Nucleic Acid delivery. Presenter: Bader Aljaeid, School Of Pharmacy, University Park, University Of Nottingham. Author(s): B. M. aljaeid, P. Ferruti, E. Ranucci, S. Stolnik, M. C. Garnett. VIEW ABSTRACT

573  Hybrid Polymer-Silica Nanotubes for Efficient Gene Delivery and Dual-Imaging. Presenter: Ran Namgung, Pohang University of Science and Technology. Author(s): R. Namgung, K. Singha, I. Park, S. J. Son, W. J. Kim. VIEW ABSTRACT

574  In vitro transfection efficay of polyethylenimine- and poly (ãÿ-amino esters) - DNA complexes predicted by time resolved fluorescence. Presenter: Marjo Yliperttula, Division of Biopharmaceutics and Pharmacokinetics, Faculty of Pharmacy, University of Helsinki. Author(s): M. L. Yliperttula, E. Vuorimaa, T. Ketola, H. Lemmetyinen, M. Hanzlikova, A. Urtti, J. J. Green, D. G. Anderson, R. Langer. VIEW ABSTRACT

575  Inhibiting the Proliferative Effects of Hypoxia in Glioblastoma by Efficient siRNA Delivery. Presenter: Anthony Malamas, Case Western Reserve University. Author(s): A. S. Malamas, C. M. Kummitha, Z. Lu. VIEW ABSTRACT

577  Langmuir Study on Liposome Building Blocks. Presenter: Behfar Moghaddam, Aston University. Author(s): B. Moghaddam, Q. Zheng, Y. Perrie. VIEW ABSTRACT

578  Novel application of Dimethylaminoethyl Methacrylate Copolymer for siRNA delivery. Presenter: Ratnesh Jain, Department of Drug Delivery (DDEL), Helmholtz-Institute for Pharmaceutical Research Saarland (HIPS), Helmholtz Centre for Infection Research (HZI), 66123, Saarbrücken. Author(s): R. Jain, P. Dandekar, B. Loretz, M. Koch, C. Lehr. VIEW ABSTRACT

579  Overcoming Tumor Drug Resistance by Poly (beta-amino esters) Mediated RNA Delivery. Presenter: Qi Yin, Shanghai Institute of Materia Medica, Chinese Academy of Sciences. Author(s): Q. Yin. VIEW ABSTRACT

580  Particulate Delivery of Vascular Endothelial Growth Factor Plasmid from Biodegradable Polycaprolactone/Polyethylenimine Electrospun Nanofibers for the treatment of Myocardial Infarction. Presenter: In-Kyu Park, Department of Biomedical Science, Chonnam National University Medical School. Author(s): H. Che, M. Muthiah, I. Park, Y. Ahn, S. Son, W. Kim, C. Cho. VIEW ABSTRACT

581  P-Glycoprotein Silencing with siRNA delivered by DOPE-modified PEI Overcomes Doxorubicin Resistance in Breast Cancer Cells. Presenter: Gemma Navarro, Northeastern University. Author(s): G. Navarro, R. R. Sawant, S. Biswas, S. Essex, C. Tros de ILarduya, V. P. Torchilin. VIEW ABSTRACT

582  pH-Sensitive Gemini Surfactant-Lipid Composite Nanoparticles as Novel Constructs for Topical Gene Therapy. Presenter: Mahmoud Elsabahy, School of Pharmacy, University of Waterloo. Author(s): M. Elsabahy, M. Donkuru, I. Badea, R. Verrall, M. Foldvari. VIEW ABSTRACT

583  PMF calculation of binding energy of dendrimers demonstrates the effect of dendrimer generation on interaction with DNA. Presenter: Alex Bunker, Centre for Drug Research, University of Helsinki. Author(s): A. Bunker, B. Nandy, P. Maiti. VIEW ABSTRACT

584  Polymer-lipid Conjugate: A Versatile Platform for Enhanced Gene Delivery and siRNA-mediated Silencing. Presenter: Gemma Navarro, Northeastern University. Author(s): R. R. Sawant, G. Navarro, S. Biswas, V. P. Torchilin. VIEW ABSTRACT

585  Reverse-phase evaporation technique for liposomal encapsulation of oligonucleotide therapeutics. Presenter: Young Tag Ko, Sangji University. Author(s): Y. Ko. VIEW ABSTRACT

586  siRNA Delivered by Phospholipid-Modified PEIs. Implications for Transfection. Presenter: Gemma Navarro, Northeastern University. Author(s): G. Navarro, R. R. Sawant, S. Biswas, S. Essex, C. Tros de Ilarduya, V. P. Torchilin. VIEW ABSTRACT

587  siRNA Delivery with eLiposomes. Presenter: William Pitt, Brigham Young University. Author(s): W. G. Pitt, J. Lattin, M. Javadi, J. Hartley, T. Pandey, C. Tracy, B. Willardson. VIEW ABSTRACT

588  Supramolecular Polyrotaxanes for siRNA delivery. Presenter: Prajakta Dandekar, Department of Drug Delivery (DDEL), Helmholtz-Institute for Pharmaceutical Research Saarland (HIPS), Helmholtz Centre for Infection Research (HZI), 66123, Saarbrücken. Author(s): P. Dandekar, R. Jain, B. Loretz, M. Keil, M. Schnabel, T. Albuzat, M. Koch, C. Alexander, G. Wenz, C. Lehr. VIEW ABSTRACT

589  Synthesis and Characterization of PAMAM Dendrimers with Enhanced Buffering Capacity and Transfection Efficiency. Presenter: Gwang Sig Yu, Dept. of Biochemistry, College of Natural Science, Chungnam National University. Author(s): G. Yu, Y. Bae, H. Choi, B. Kong, I. S. Choi, J. Choi. VIEW ABSTRACT

590  Synthesis of PLL-PPP conjugates as gene carrier binding to protein based physical hydrogels. Presenter: XiaoNan Wen, Tokyo Medical and Dental Univerisy. Author(s): X. Wen, T. Kimura, K. Nam, S. C. Heilshorn, A. Kishida. VIEW ABSTRACT

591  Synthesis of surface modified polydiacethylene liposomes and their application for gene carrier. Presenter: Kang hyuck Yim, Department of Biochemistry, Chung-nam National University. Author(s): K. Yim. VIEW ABSTRACT

592  Target Specific Systemic Delivery of TGF-ß siRNA/(PEI-SS)-g-HA Complexfor the Treatment of Liver Cirrhosis. Presenter: Kitae Park, Interdisciplinary school of Bioengineering and Bioscience, POSTECH. Author(s): K. Park, S. Hong, W. Hur, M. Lee, J. Yang, S. Kim, S. Yoon, S. Hahn. VIEW ABSTRACT

595  Therapeutic Gene Delivery and Transfection in Human Pancreatic Cancer Cells using Epidermal Growth Factor Receptor-Targeted Gelatin Nanoparticles. Presenter: Jing Xu, Northeastern University. Author(s): J. Xu, M. Amiji. VIEW ABSTRACT

596  Tumor-directed Akt siRNA as a dual anticancer and anti-angiogenic therapy. Presenter: Paula Ofek, Tel Aviv University. Author(s): P. Ofek, W. Fischer, M. Calderon, R. Haag, R. Satchi-Fainaro. VIEW ABSTRACT

 

Functionalised Nanoparticles: Bioactive Materials     [RETURN TO TOP]

103  Study on the drug release behavior and imaging function of Cu2O hollow spheres. Presenter: Pei Shiuan Pan, National Yang Ming University. Author(s): P. Pan, T. Liu. VIEW ABSTRACT

334  A Reversibly Crosslinked Micelle for Intravenous Delivery of Paclitaxel. Presenter: Sungwon Kim, Purdue University. Author(s): S. Lee, S. Kim, K. Park, J. Cheng. VIEW ABSTRACT

336  Au-Nanoparticles Coated with DNA Containing Films for Localized Delivery Systems. Presenter: Jenifer Blacklock, National Institute of Standards and Technology. Author(s): J. Blacklock, X. Yan, H. Moehwald. VIEW ABSTRACT

337  Avidin-Nucleic-Acid Nano-Assemblies as multivalent, tunable and biocompatible drug delivery tools. Presenter: Margherita Morpurgo, University of Padova, Pharmaceutical Sciences Dept, via Marzolo 5, Padova. Author(s): D. Silvestri, G. Zuccolotto, M. Pignatto, M. Rondina, N. Realdon, A. Rosato, M. Morpurgo. VIEW ABSTRACT

338  Biodegradable Cationic Bis(PLGA-phe-PEG)-qDETA Nanoparticles for Local Hydrophobic Drug Delivery. Presenter: Chih-Kuang Wang, Department of Medicinal and Applied Chemistry, Kaohsiung Medical University. Author(s): C. Wang, Y. Fu, C. Wang, S. Jian, M. Ho. VIEW ABSTRACT

339  Biodegradable Magnetic Nanoparticles Formulated with a Rapidly Activatable Paclitaxel Prodrug Efficiently Inhibit Proliferation of Aortic Smooth Muscle Cells. Presenter: Michael Chorny, Department of Pediatrics, The Childrens Hospital of Philadelphia. Author(s): M. Chorny, R. Adamo, I. Fishbein, R. J. Levy, I. Alferiev. VIEW ABSTRACT

340  Characterization of novel spermine-dextran magnetic nanocarriers as magnetic resonance imaging probe for labeling embryonic stem cells. Presenter: Ebrahim Vasheghani-Farahani, Tarbiat Modares University. Author(s): E. Vasheghani-Farahani, M. Mohammad-Taheri, H. Hosseinkhani, s. Shojaosadati, M. soleimani. VIEW ABSTRACT

341  Chlamydial Infection Induces Folic Acid Receptor Overexpression in Host Cells: Implications for Targeted Antibiotic Delivery. Presenter: Jayanth Panyam, University of Minnesota. Author(s): J. Panyam, U. S. Toti, M. Hali, K. Sekhon, S. M. Wykes, H. Gerard, A. P. Hudson, J. A. Whittum-Hudson. VIEW ABSTRACT

342  Controlled Release of Single Stranded DNA Triggered by Photothermal Effect. Presenter: Shuji Yamashita, Department of Applied Chemistry, Faculty of Engineering, Kyushu University. Author(s): s. Yamashita, H. Fukushima, Y. Akiyama, Y. Niidome, T. Mori, Y. Katayama, T. Niidome. VIEW ABSTRACT

343  Controlled Release System Mediated by Retro Diels-Alder Reaction on Gold Nanorods. Presenter: Takuro Niidome, Kyushu University. Author(s): T. Niidome, S. Yamashita, H. Fukushima, Y. Niidome, T. Mori, Y. Katayama. VIEW ABSTRACT

344  Design of polymeric drug conjugate for photodynamic therapy. Presenter: So Young Park, Division of Biotechnology, The Catholic University of Korea. Author(s): S. Park, N. Yoo, W. Lee, E. Lee. VIEW ABSTRACT

345  Development and in vitro characterization of new chitosan nanobubbles as potential theranostic agents. Presenter: Roberta Cavalli, Università degli Stusi di Torino. Author(s): R. Cavalli, A. Bisazza, A. Maiocchi, E. Terreno, E. Torres, S. Aime. VIEW ABSTRACT

346  Development of amorphous fenofibrate nanostructure system. Presenter: Wonkyung Cho, Chungnam National University. Author(s): W. Cho, S. Hwang. VIEW ABSTRACT

347  Development of an Oral Nanosuspension for a Novel CNS Drug Candidate: Overcoming Poor Dose Linearity to Assess Toxicity. Presenter: Marcus Brewster, Janssen Research and Development. Author(s): C. Mackie, A. Lampo, B. Medaer, V. Sinha, G. Meurs, T. Arien, G. Verreck, F. Vanhoutte, K. Swinney, S. Stokbroekx, J. Van Gelder, M. E. Brewster. VIEW ABSTRACT

349  Development, Optimization and Characterization of Folate Receptor Targeted Nanoparticle Drug Delivery System for Cancer Therapeutics. Presenter: Vibhuti Kabra, Acropolis Institute of Pharmaceutical Education and Research (AIPER), Indore, India. Author(s): V. Kabra, V. Agrahari, M. Nagar, P. Trivedi. VIEW ABSTRACT

350  Doxorubicin Nanorods: temperature-sensitive loading methods. Presenter: Hai-Quan Mao, Johns Hopkins Univ. Author(s): H. Yoo, J. Choi, H. Kim, Y. Son, S. Yoon, E. Cho, H. Mao. VIEW ABSTRACT

351  Doxorubicin-Tethered Responsive Gold Nanoparticles Facilitate Intracellular Drug Delivery for Overcoming Multidrug Resistance in Cancer Cells. Presenter: Tianmeng Sun, Hefei National Laboratory for Physical Sciences at Microscale and School of Life Sciences, University of Science and Technology of China. Author(s): T. Sun, F. Wang, Y. Wang, S. Dou, M. Xiong, J. Wang. VIEW ABSTRACT

352  Encapsulation and sustained release of hydrophobic anticancer drugs using PEGylated dendritic poly(L-lysine) derivatives. Presenter: Kazuto Watanabe, Department of Applied Chemistry, Faculty of Engineering, Kyushu University. Author(s): K. Watanabe, K. Takahashi, T. Mori, Y. Katayama, T. Niidome. VIEW ABSTRACT

354  Evaluation of Steric Stabilisers for Cubic Lyotropic Liquid Crystalline Drug Delivery Systems. Presenter: Ben Boyd, Monash Institute of Pharmaceutical Sciences. Author(s): J. Chong, X. Mulet, L. Waddington, C. J. Drummond, B. J. Boyd. VIEW ABSTRACT    

355  Fabrication and characterization of nanoparticles for controlled release of docetaxel using poly(lactic-co-glycolic) acid. Presenter: Young-Guk Na, Chungnam National University. Author(s): Y. Noh, Y. Na, C. Keum, C. Hwang, J. Baek, S. Shin, C. Cho. VIEW ABSTRACT

357  Influence of p-Aminobenzoic Acid Grafted on Triblock Polyester-Polyether Copolymer and Nanoparticles. Presenter: Jiraphong Suksiriworapong, Department of Pharmacy, Faculty of Pharmacy, Mahidol University. Author(s): J. Suksiriworapong, K. Sripha, J. Kreuter, V. B. Junyaprasert. VIEW ABSTRACT

358  Mesoporous Organosilicate Particles as Chemotherapeutic Drug Carriers. Presenter: Isabelle Lagadic, Northern Kentucky University. Author(s): I. Lagadic, E. Knue, S. Johnson, A. McCallum, R. Shah. VIEW ABSTRACT

359  Molecular dynamics simulation demonstrates reason for failure of AETP targeting ligand on PEGylated liposome. Presenter: Aniket Magarkar, University of Helsinki. Author(s): A. S. Magarkar, A. Bunker, M. Stepniewski, T. Rog, S. Hakola, M. Bergman, J. Lehtinen, A. Urtti. VIEW ABSTRACT

360  MRI-Tracking of Targeted Drug Delivery to Tumors Using a Self-Assembled Multifunctional Nanoparticle. Presenter: Mark Ernsting, Ontario Institute for Cancer Research. Author(s): M. J. Ernsting, W. Tang, S. Li. VIEW ABSTRACT

362  Nanocomplexes of a RGD peptide-functionalized biopolymer for the promotion of cell migration. Presenter: Annasara Hansson, University of Geneva. Author(s): A. Hansson, O. Jordan, G. Borchard, P. Rousselle, F. Falson. VIEW ABSTRACT

363  Nanotechnology for the Delivery of Vaccines: The use and characterisation of anionic liposome systems in drug delivery and vaccine formulation. Presenter: Alexander Wilkinson, School of Life and Health Sciences, Aston University, Aston Triangle, Birmingham, B4 7ET. Author(s): A. Wilkinson, M. Henriksen-Lacey, A. R. Mohammed, Y. Perrie. VIEW ABSTRACT

364  Nevirapine Nanosuspensions : Biodistribution studies and targeting to HIV reservoirs. Presenter: Bharti Goswami, S.N.D.T.Women's University. Author(s): B. Goswami. VIEW ABSTRACT

365  Optimizing of PEG-Modification, Their Dose and Aspect Ratio of Gold Nanorods for Cancer Therapy. Presenter: Yasuyuki Akiyama, Department of Applied Chemistry, Faculty of Engineering, Kyushu University. Author(s): Y. Akiyama, T. Mori, Y. Katayama, T. Niidome. VIEW ABSTRACT

366  Organization at the Bionano Interface -- Relevance of the protein corona to nanoparticle interactions with the living matter. Presenter: Francesca Baldelli Bombelli, Center of BioNano Interactions, UCD, Dublin. Author(s): F. Baldelli Bombelli, M. P. Monopoli, K. A. Dawson. VIEW ABSTRACT

367  PBPK Modeling and Property-Biodistribution Relationships of PLGAmPEG Nanoparticles. Presenter: Mingguang Li, Wayne State University. Author(s): M. Li, Z. Panagi, K. Avgoustakis, J. Shi, J. Reineke. VIEW ABSTRACT

368  Polysaccharide-based nanoparticles of pullulan/folate-photosensitizer conjugates for photodynamic therapy. Presenter: Kun Na, Department of Biotechnology, The Catholic University of Korea. Author(s): K. Na, B. Bae. VIEW ABSTRACT

369  Preparation and Characterization of a Nanoparticulate Carrier Targeting Helicobacter pylori Based on Molecular Imprinting Technology. Presenter: Jun Pan, School of Pharmacy, Fudan University. Author(s): J. Pan. VIEW ABSTRACT

370  Protein-Coated Biodegradable Poly(butyl-2-cyanoacrylate) Nanoparticles with Stealth Surface Properties. Presenter: Ruth Schmid, SINTEF Materials and Chemistry. Author(s): R. Schmid, S. Kubowicz, P. M. Stenstad, H. Johnsen. VIEW ABSTRACT

371  Quinic acid Conjugated Nanoparticles for Drug Delivery to Tumors. Presenter: Zohreh Amoozgar, Department of Industrial and Physical Pharmacy, College of Pharmacy; Purdue University. Author(s): Z. Amoozgar, J. Park, Y. Yeo. VIEW ABSTRACT

372  Releasing drug from eLiposome. Presenter: Marjan Javadi, BYU. Author(s): M. Javadi, w. G. Pitt, J. Lattin, J. M. Hartley. VIEW ABSTRACT

373  Reversible Attachment of Specific Ligands to Liposomes: Synthesis and In vitro Characterization. Presenter: Swati Biswas, Northeastern University. Author(s): S. Biswas, R. R. Sawant, N. S. Dodwadkar, V. P. Torchilin. VIEW ABSTRACT

374  Spatial Inhibition of Peritoneal Macrophages Is Required for Endometriosis Therapy. Presenter: Gershon Golomb, Institute for Drug Research, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Israel. Author(s): E. Haber, N. Koroukhov, M. Schachter, G. Golomb. VIEW ABSTRACT

375  Steroidal Antiestrogen-targeted Multifunctional Gold Nanoparticles for Breast Cancer Therapy and Imaging. Presenter: Kinh Luan Dao, Northeastern University. Author(s): K. D. Dao, R. R. Sawant, V. P. Torchilin, R. N. Hanson. VIEW ABSTRACT

378  The influence of composition, size, and shape of nanocarriers on their accumulation and retention in lungs after pulmonary or intravenous delivery. Presenter: Olga Garbuzenko, Rutgers State University. Author(s): O. Garbuzenko, O. Taratula, T. Minko. VIEW ABSTRACT

379  The Novel Nanopharmaceutical CRLX288 Significantly Improves the Therapeutic Window of its Parent Drug Docetaxel. Presenter: Patrick Lim Soo, Cerulean Pharma Inc.. Author(s): P. Lim Soo, P. Ng, J. Podobinski, R. Case, P. Shum, B. Swerdya-Krawiec, K. Boyle, S. R. Kabir, D. Lazarus, S. Eliasof, S. Svenson. VIEW ABSTRACT

 

Implants: Bioactive Materials     [RETURN TO TOP]

252  In Situ Forming Implant of Antipsychotic Drugs:Burst Release Control Method by Taking Advantage of Solvents Capacity and Intermolecular Force. Presenter: Lexi Wang, College Of Life Science, Jilin University, Changchun, Jilin Province, 130012, China. Author(s): L. Wang, X. Zhao, X. Liiu, D. Wang, F. Sun, Y. Li. VIEW ABSTRACT

253  Leuprolide Sorption to PLGA-COOH Provides Controlled In Vitro-In Vivo Peptide Release: A New and Facile Approach to Prepare Low-Cost Injectable Depots. Presenter: Kashappa-Goud Desai, University of Michigan. Author(s): K. H. Desai, A. M. Sophocleous, M. J. Mazzara, L. Tong, J. Cheng, K. F. Olsen, S. P. Schwendeman. VIEW ABSTRACT

254  Zero Order and Long Term Release of Butamben with A Novel Drug Delivery System: Possible Use for Management of Chronic Pain. Presenter: Ashish Rastogi, The University Of Texas At Austin / The Us Army Institute Of Surgical Research. Author(s): A. Rastogi, P. D. Bowman, S. Stavchansky. VIEW ABSTRACT

 

Intracellular Delivery: Bioactive Materials     [RETURN TO TOP]

255  Alendronate liposomes as a potential antitumor therapy:Activation of gamma delta T cells and inhibition of tumor growth. Presenter: Gershon Golomb, Institute for Drug Research, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Israel. Author(s): D. Gutman, G. Golomb. VIEW ABSTRACT

257  Antitumor Effect of Sirolimus -- Loaded Liposomes Against Human Breast Cancer Cells. Presenter: Dennis Douroumis, Univesity of Greenwich, School of Science. Author(s): D. Douroumis, I. Onyesom, D. A. Lamprou, A. J. Urquhart. VIEW ABSTRACT

258  Bioreducible and Biodegradable Polymersome for Dual-Drug delivery. Presenter: Thavasyappan Thambi, Kyung Hee University. Author(s): T. Thambi, H. Yoon. VIEW ABSTRACT

259  Catalase Loaded PLGA based Nanocarriers for Intracellular Delivery. Presenter: Poonam Saraf, University of the Pacific. Author(s): P. S. Saraf, A. Raj, X. Li, B. Jasti. VIEW ABSTRACT

260  Celastrol-Encapsulated Hydroxy-Terminus Poly(amidoamine) Dendrimers Inhibit Lipopolysaccharide-Mediated Inflammatory Signaling in Microglia. Presenter: Dusica Maysinger, Department of Pharmacology and Therapeutics, McGill University, Montreal, Quebec, Canada. Author(s): S. Boridy, G. M. Soliman, D. Maysinger. VIEW ABSTRACT

261  Cellular Uptake of Pegylated Nanoparticles by Hair Cells of Inner Ear. Presenter: Ibrahim Youm, University of Missouri Kansas City. Author(s): I. Youm, B. C. Youan. VIEW ABSTRACT

263  Development of an Artificial Melanosome Utilizing a Lipid-Polymer Hybrid Microparticle. Presenter: Lauren Quattrochi, Brown University. Author(s): L. E. Quattrochi, D. Cho, K. Estrellas, N. Wicks, E. Mathiowitz, E. Oancea. VIEW ABSTRACT

264  Double-Targeted pH-Responsive Polymer-Doxorubicin Conjugate for Enhanced Cancer Therapy. Presenter: Jin-Zhi Du, University of Science and Technology of China. Author(s): J. Du. VIEW ABSTRACT

266  Drug Delivery Using Laser-Activated Carbon Nanoparticles. Presenter: Aritra Sengupta, Georgia Institute of Technology. Author(s): A. Sengupta, S. C. Kelly, M. R. Prausnitz, N. N. Thadhani. VIEW ABSTRACT

267  Dual Responsive Nanoscale Hydrogels for Intracellular Delivery of small interfering RNA. Presenter: William Liechty, The University of Texas at Austin. Author(s): W. B. Liechty, R. L. Scheuerle, N. A. Peppas. VIEW ABSTRACT

270  Label-free Imaging of Panc-1 Human Pancreatic Tumor Spheroids by Raman Micro-spectroscopy. Presenter: Evgenia Zuser, Northeastern University. Author(s): E. Zuser, T. Chernenko, R. Shah, M. M. Amiji, M. Diem. VIEW ABSTRACT

271  Liposomal delivery system of adenosine modulates inflammation. Presenter: Gershon Golomb, Institute for Drug Research, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Israel. Author(s): D. Gutman, N. Koroukhov, G. Golomb. VIEW ABSTRACT

272  Liposome Targeting to Mitochondria Using Novel PEG-PE Based Polymer with Terminal Triphenylphosphonium Group. Presenter: Swati Biswas, Northeastern University. Author(s): S. Biswas, R. R. Sawant, N. S. Dodwadkar, V. P. Torchilin. VIEW ABSTRACT

275  Novel Oligo-guanidyl Derivatives As Cell Penetrating Tools For Intracellular Delivery Of Therapeutic Supramolecular Systems. Presenter: Stefano Salmaso, Department of Pharmaceutical Sciences, University of Padua, Padova, Italy. Author(s): S. Bersani, S. Salmaso, A. Scomparin, F. Mastrotto, P. Caliceti. VIEW ABSTRACT

277  On-Demand Theranostic Systems In Situ Assembled by Host-Guest Interaction. Presenter: Hyuntae Jung, POSTECH. Author(s): H. Jung, K. Park, J. Yang, E. Oh, D. Lee, K. Park, S. Ryu, S. Hahn, K. Kim. VIEW ABSTRACT

278  Reversal of Multidrug Resistance by Paclitaxel Loaded Liposomes Containing Non-inonic Surfactant. Presenter: Yu Gao, Shanghai Institute of Materia Medica, Chinese Academy of Sciences. Author(s): Y. Gao, Y. Li. VIEW ABSTRACT

279  Screening and optimization of ligands for lysosomal targeting of liposomes. Presenter: Alexander Koshkaryev, Northeastern University. Author(s): I. Meerovich, S. V. Patil, A. Koshkaryev, V. Torchilin. VIEW ABSTRACT

280  Shell-cleavable PLGA-Curcumin Conjugate Micelles. Presenter: Lenah Amayreh, Wayne State University. Author(s): Q. Zhao, S. Desai, A. K. Mohammad, L. K. Amayreh, J. J. Reineke. VIEW ABSTRACT

281  Subcellular delivery of DACHPt by polymeric micelles overcomes oxaliplatin resistance in Human Colon Carcinoma. Presenter: Mami Murakami, Department of Bioengineering, Graduate School of Engineering, The University of Tokyo. Author(s): M. Murakami, H. Cabral, Y. Matsumoto, S. Wu, T. Yamori, N. Nishiyama, K. Kataoka. VIEW ABSTRACT

283  Synthesis and in vitro Characterization of HPMA Copolymer-Dual Drug Conjugates for Targeting Her2-Overexpressing Tumors. Presenter: Jun Lee, Graduate student. Author(s): J. Lee, G. Sabnis, A. Nan. VIEW ABSTRACT

284  Targeted Delivery of Antibiotics to Intracellular Chlamydial Infections using PLGA Nanoparticles. Presenter: Jayanth Panyam, University of Minnesota. Author(s): J. Panyam, U. S. Toti, M. Hali, S. M. Wykes, A. P. Hudson, J. A. Whittum-Hudson. VIEW ABSTRACT

285  Transferrin-modified Lysosomotropic Liposomes for Delivery of Pro-apoptotic Compoundsinto Cancer Cells. Presenter: Alexander Koshkaryev, Northeastern University. Author(s): A. Koshkaryev, A. Piroyan, V. P. Torchilin. VIEW ABSTRACT

 

Medical Devices: Bioactive Materials     [RETURN TO TOP]

286  A Novel Drug Delivery Platform for Sustained Combination Therapy. Presenter: Deborah Schachter, Advanced Technology & Regenerative Medicine, LLC. Author(s): D. M. Schachter, G. Campbell, I. Chun, A. Creasey, M. John, B. Lowenhaupt, T. Matalenas, J. Zhang, L. Baert, K. Amssoms, R. De Vries. VIEW ABSTRACT

288  Controlled Release of Drugs from Multi-Component Biomaterials: drug release and mechanical properties studies. Presenter: Michael Alexandre, CERM, University of Liege. Author(s): M. Alexandre, A. Zalfen, R. Riva, C. Jerome. VIEW ABSTRACT

289  Development of Micro-fluidic Drug Delivery Units for Programmed Delivery of Multiple Drugs. Presenter: Da-som Yang, Yonsei University. Author(s): D. Yang, C. Choi, W. Ryu. VIEW ABSTRACT

290  Drug-Eluting Bioresorbable Stent Coatings: Structure - Release Profile Effects. Presenter: Meital Zilberman, Tel-Aviv University. Author(s): Y. Kloog, A. Kraitzer, M. Zilberman. VIEW ABSTRACT

291  Electron Microscopy and Confocal Raman Microscopy of Controlled Release Implants. Presenter: Mary Miller, MVA Scientific Consultants. Author(s): M. A. Miller, M. Z. Zhou, T. B. Vander Wood. VIEW ABSTRACT

292  Esophageal Stent Coated with Biocompatible Polymeric Nanofibersfor Sustained Delivery of an Anticancer Agent. Presenter: Chun Gwon Park, Interdisciplinary Program in Bioengineering, College of Engineering, Seoul National University, Seoul, Republic of Korea. Author(s): C. Park, M. Kim, M. Park, J. Lee, S. Lee, J. Park, Y. Choy. VIEW ABSTRACT

293  Glucose Diffusive Characteristics of PLGA Microsphere/PVA Hydrogel Composite Coating for Implantable Biosensor. Presenter: Yan Wang, University of Connecticut. Author(s): Y. Wang. VIEW ABSTRACT

294  Implantable Closed-Loop Insulin Delivery Device: Studies on the In Vitro Stability of Insulin and In Vivo Stability of the Device. Presenter: Xiao Yu Wu, University of Toronto. Author(s): C. Gordijo, M. Chu, K. Koulajian, C. Koo, A. Giacca, X. Wu. VIEW ABSTRACT

295  In Vitro Dissolution Testing for the Examination of Drug Release from Steroid-Eluting Pacing Leads. Presenter: Beatrice Semmling, Institute of Pharmacy, University of Greifswald. Author(s): B. Semmling, A. Seidlitz, S. Nagel, E. Trip, C. Schnittker, N. Grabow, K. Sternberg, W. Weitschies. VIEW ABSTRACT

296  Influence of Coating Thickness and Fractional Model Substance Content on Release from Drug-Eluting Stents. Presenter: Anne Seidlitz, Biopharmaceutics and Pharmaceutical Technology, EMA University of Greifswald. Author(s): A. Seidlitz, S. Nagel, B. Semmling, N. Grabow, K. Sternberg, W. Weitschies. VIEW ABSTRACT

297  Injectable Biodegradable micro-fluidic drug delivery system for local pain management: pH-controlled system for enhanced delivery of bupivacaine HCl. Presenter: WonHyoung Ryu, Yonsei University. Author(s): K. Lee, S. Yang, W. Ryu. VIEW ABSTRACT

299  The Importance of Medium Selection for in vitro Drug Elution Testing from Drug-eluting Devices. Presenter: Andrew Loxley, Particle Sciences Inc. Author(s): A. Loxley, J. McConnell, O. Okoh, L. Goldman, N. Kichline. VIEW ABSTRACT

841  The Impact of Sex-Based Differences in Atherosclerotic Plaque on Drug Release from Drug Eluting Stents (DES). Presenter: Ji Guo, Food and Drug Administration. Author(s): J. Guo, D. M. Saylor, D. V. Patwardhan. VIEW ABSTRACT

 

Microspheres: Bioactive Materials     [RETURN TO TOP]

597  A Comparison of New Methods for Single Nano-Particle Sizing. Presenter: Larry Unger, Particle Sizing Systems. Author(s): L. R. Unger. VIEW ABSTRACT

598  A Method to Control the Inner Structure of Protein Loaded Microspheres. Presenter: Michail Kastellorizios, University of Connecticut. Author(s): M. Kastellorizios, D. J. Burgess. VIEW ABSTRACT

599  An Enteric Suspension Formulation for the Treatment of Paediatric Asthma. Presenter: Mark Saunders, Kuecept Ltd. Author(s): M. Saunders. VIEW ABSTRACT

600  CapsMorphTM:Technology for oral delivery of poorly solubles - 3 year stability of an amorphous oral formulation -. Presenter: Christoph Dunmann, R&D Scientist. Author(s): C. Dunmann, M. Grabo, R. Müller. VIEW ABSTRACT

601  Controlled Release of Betamethasone to Differentiating Human Mesenchymal Stem Cells. Presenter: Tracy Richey, Oakwood Laboratories. Author(s): T. Richey, J. Welter, K. Penick. VIEW ABSTRACT

603  Controlling morphology and size of double-walled microspheres from coaxial electrospraying. Presenter: Qingxing Xu, University of Illinois at Urbana-Champaign. Author(s): Q. Xu, B. Wong, D. W. Pack, C. Wang. VIEW ABSTRACT

605  Drying of PLGA single droplet in an Ultrasonic levitator. Presenter: Belal Al Zaitone, Dr.-Ing.. Author(s): B. Al Zaitone, A. Lamprecht. VIEW ABSTRACT

606  Effect of Labrafil® addition on antituberculosis efficacy of rifabutin-loaded PLGA nanoparticles. Presenter: Olga Maksimenko, Nanosystem Ltd.. Author(s): O. Maksimenko, A. Bud'ko, I. Lyubimov, L. Vanchugova, E. Shipulo, J. Kreuter. VIEW ABSTRACT

607  Encapsulation of doxorubicin and chitosan-p53 nanoparticles in monodispersed double-walled microspheres. Presenter: Qingxing Xu, University of Illinois at Urbana-Champaign. Author(s): Q. Xu, C. Wang, D. W. Pack. VIEW ABSTRACT

608  Evaluation of Pharmacokinetics and Biodistribution Properties of Zidovudine Contained in Solidified Reverse Micellar Microparticles in Immunocompromised Rats. Presenter: Anthony Attama, Department of Pharmaceutics, University of Nigeria, Nsukka 410001, Enugu State, Nigeria. Author(s): A. A. Attama. VIEW ABSTRACT

609  Formulation, characterization and stability assessment of novel solid lipid microspheres for the delivery of ketoconazole to paediatric patients. Presenter: Roderick Walker, Rhodes University. Author(s): R. B. Walker. VIEW ABSTRACT

610  Influence of Hydrophobicity and Process Factors in the Production of Chitosan Microparticles for the Delivery of Opioid Antagonists. Presenter: Teresa Calejo, University of Oslo. Author(s): T. Calejo, A. Kjøniksen, A. Maleki, B. Nyström, A. Sande. VIEW ABSTRACT

611  Intravenous formulation of rifabutin based on PLGA nanoparticles: in-vivo performance. Presenter: Svetlana Gelperina, Nanosystem Ltd.. Author(s): I. Lyubimov, O. Maksimenko, A. Bud'ko, I. Treschalin, E. Pereverzeva, E. Shipulo, L. Vanchugova, J. Kreuter, S. Gelperina. VIEW ABSTRACT

612  Iron oxide-encapsulated polymeric substrates for 3D tumor cell culture. Presenter: Ung Yeol Lee, The Catholic University of Korea. Author(s): U. Lee, D. Lee, S. Park, N. Yoo, E. Lee. VIEW ABSTRACT

613  Local Delivery of Doxorubicin and PEGylated TRAIL loaded PLGA microspheres for Effective and Long-Term Combination Tumor Therapy. Presenter: Kang Choon Lee, College of Pharmacy, SungKyunKwan Univ.. Author(s): K. Lee, H. Jiang, T. Kim. VIEW ABSTRACT

615  Multidrug Resistance Reversal by Co-delivery of Tariquidar (XR9576) and Paclitaxel with Long-circulating Liposomes. Presenter: Niravkumar Patel, Northeastern University. Author(s): N. R. Patel. VIEW ABSTRACT

618  Preparation of Biodegradable poly D, L-lactide-co-glycolide (PLGA) microspheres for tolterodine derivative. Presenter: Lesheng Teng, Jilin University and Ohio State University. Author(s): L. Teng, C. Jiang, X. Shi, R. Zhang, Y. Li. VIEW ABSTRACT

620  Production of pH Sensitive Microparticles to Deliver Lactase Orally. Presenter: Mark Saunders, Kuecept. Author(s): A. L. Parry, S. Gaisford, S. Somavarapu, A. Basit, M. Saunders. VIEW ABSTRACT

621  Stromal Derived Factor-1 Alpha (SDF-1a)-Loaded PLGA Microspheres for Stem Cell Recruitment. Presenter: Daisy Cross, University of Minnesota. Author(s): D. P. Cross, C. Wang. VIEW ABSTRACT

622  The influence of pH value on the dissolution profile of metoprolol tartrate from chitosan microparticles. Presenter: Lacramioara Ochiuz, The University of Medicine and Pharmacy Gr. T. Popa Iasi. Author(s): L. Ochiuz, G. Popa, A. M. Tomoioaga, I. Stoleriu, A. Stefanache, I. Cojocaru, I. Popovici. VIEW ABSTRACT

623  The use of Thermosensitive PNIPAAM Microgels for Sustained Release of the Opioid Antagonist Naltrexone. Presenter: Anna-Lena Kjøniksen, University of Oslo. Author(s): A. Kjøniksen, T. Calejo, K. Zhu, A. Maleki, N. Al-Manasir, B. Nyström, A. Sande. VIEW ABSTRACT

624  USP Apparatus 4: Discriminatory In Vitro Drug Release Test for Implantable Dexamethasone Loaded PLGA Microspheres/PVA Hydrogel Composite Coating. Presenter: Jie Shen, University of Connecticut. Author(s): J. Shen, D. J. Burgess. VIEW ABSTRACT

 

Mucosal Delivery (nasal, vaginal, buccal and rectal): Bioactive Materials     [RETURN TO TOP]

630  Optimization and in vitro antifungal evaluation of mucoadhesive hydrogel films of Econazole Nitrate. Presenter: Balaram Gajra, Charotar Univ of Science & Technology. Author(s): B. Gajra, S. S. Pandya, G. Vidyasagar, H. A. Rabari, R. R. Dedania, N. N. Upadhyay. VIEW ABSTRACT

631  PharmacokineticModel for Sublingual Drug Delivery. Presenter: Navdeep Kaur, University of the Pacific. Author(s): N. Kaur, X. Gao, B. Jasti, X. Li. VIEW ABSTRACT

633  Rheological and Mechanical Properties of a Binary Polymeric Gel for Treatment of Canker Sores. Presenter: Zimei Wu, School of Pharmacy, University of Auckland. Author(s): A. Cheng, D. Mihec, K. Yapa, D. Yu, Z. Wu. VIEW ABSTRACT

634  Study on the influence of formulation variables on flow and compressibility properties of powders for development of bioadhesive vaginal tablets with 5 - Fluorouracil. Presenter: Ileana Cojocaru, University of Medicine and Pharmacy Gr. T. Popa, Iasi. Author(s): I. Cojocaru, L. Ochiuz, G. Popa, L. Palade, M. Moscalu, I. Popovici. VIEW ABSTRACT

 

Nanomedicines: Bioactive Materials     [RETURN TO TOP]

383  A Novel Comb-like Copolymer HA-g-PCL as a Micelle Carrier for Targeting Delivery. Presenter: Tse-min Teng, Industrial Technology Research Institute. Author(s): T. Teng. VIEW ABSTRACT

384  A Pharmacokinetic Study in Dog Comparing Glucocorticosteroid Compound X as a NanoCrystal Colloidal Dispersion® Formulation and as a Micronised Suspension Administered Orally at Two Different Levels (1 mg and 10 mg). Presenter: Bryan Kennedy, Elan Drug Technologies. Author(s): B. D. Kennedy, D. S. Manser, A. M. Wilson. VIEW ABSTRACT

385  Development and application of liposomes prepared from bixin. Presenter: Irene Kikuchi, University of Sao Paulo. Author(s): I. S. Kikuchi, R. O. Takamoto, M. S. Matuo, T. A. Pinto. VIEW ABSTRACT

386  Development of Hyaluronidase-Sensitive Nano-Microbicide for Prevention of HIV Transmission. Presenter: Vivek Agrahari, University of Missouri Kansas City. Author(s): V. Agrahari, B. C. Youan. VIEW ABSTRACT

387  Effect of inner core character of polymeric micelles on ABC phenomenon. Presenter: Kouichi Shiraishi, The Jikei University. Author(s): K. Shiraishi, H. Ma, K. Kawano, Y. Maitani, M. Yokoyama. VIEW ABSTRACT

390  Insulin Nanoparticles for Oral Drug Delivery Prepared by Glycofurol-Nanoprecipitation. Presenter: Angela Viehof, University of Bonn. Author(s): A. Viehof, A. Lamprecht. VIEW ABSTRACT

392  Nanostructured Lipidic Carriers for Controlled Delivery of Methotrexate: Effect of Formulation Parameters on the Physicochemical Properties, In Vitro Drug Release and Cell Viability. Presenter: Ghada Abdelbary, Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Cairo University. Author(s): G. Abdelbary, M. Haider. VIEW ABSTRACT

393  Orally Administered Polymeric Nanoparticles with Enhanced Pulmonary Uptake for Tuberculosis. Presenter: Praveen Date, Institute of Chemical Technology. Author(s): P. V. Date, A. Samad, P. V. Devarajan. VIEW ABSTRACT

395  PEGylated Paclitaxel Liposomes: Development, In vitro cytotoxicity in BT-549 cells and in vivo evaluation. Presenter: Nayanabhirama Udupa, MCOPS, Manipal Univeristy, Manipal-576104. Author(s): A. Garu, N. Udupa, P. Deshpande, G. Shavi, R. Averineni, S. Meka. VIEW ABSTRACT

397  Solid Lipid Nanoparticles: Pre-Formulation and Physical Characterization. Presenter: Mine özyazici, Associate Prof.. Author(s): M. özyazici, S. Rençber, E. Gökçe. VIEW ABSTRACT

399  Tolerance Induction for Liposome-Induced Anaphylactoid Reactions in Pigs. Presenter: Janos Szebeni, Seroscience Ltd. Author(s): J. Szebeni, R. Urbanics, P. Bedocs, L. Rosivall, M. Toth, Y. Barenholz. VIEW ABSTRACT

400  Understanding and Utilizing Passive Targeting Routes of Nanoparticles. Presenter: Joshua Reineke, Wayne State University. Author(s): M. Li, A. Mohammad, L. Amayreh, J. Reineke. VIEW ABSTRACT

401  VB12-mediated nanoparticle delivery across intestinal epithelial cells. Presenter: Robyn Fowler, University of Nottingham. Author(s): R. C. Fowler. VIEW ABSTRACT

 

New Frontiers in Drug Development: Translational Research and Models for Veterinary and Human Health: Veterinary     [RETURN TO TOP]

837  Bioadhesive spontaneous plug forming teat dips. Presenter: Sandhya Pranatharthiharan, Institute of Chemical Technology, Nathalal Parekh Marg, Matunga, Maharashtra, India. Author(s): S. Pranatharthiharan, P. V. Devarajan, A. Samad. VIEW ABSTRACT

838  Bio-Distribution and Clinical Efficacy of Buparvaquone Solid Lipid Nanoparticles in Bovine Theileriosis. Presenter: Padma Devarajan, Institute of Chemical Technology. Author(s): S. S. Ugile, M. P. Soni, C. N. Galdhar, R. V. Gaikwad, P. V. Devarajan, A. Samad. VIEW ABSTRACT

839  Development andCharacterizationof an Oleaginous Gel Based Active Teat Sealant for Prevention of Bovine Mastitis. Presenter: Zimei Wu, School of Pharmacy, University of Auckland. Author(s): Z. Wu, I. G. Tucker, W. Leech, F. Alawi. VIEW ABSTRACT

840  Effects of paliperidone prodrugs on MK-801-induced locomotion and stereotypy. Presenter: Fengying Sun, College of Life Science, Jilin University. Author(s): F. Sun, C. Sui, X. Liu, Y. Li. VIEW ABSTRACT

 

New Polymer Chemistries: Bioactive Materials     [RETURN TO TOP]

635  Advancements in Celluloid film Coating â Spectrablend II. Presenter: Beverly Schad, Sensient. Author(s): B. A. Schad, E. Van Ness. VIEW ABSTRACT

636  Characterization of polymeric micelles from solid solutions with a polyvinyl caprolactam-polyvinyl acetate-polyethylene glycol graft copolymer and itraconazole. Presenter: Karl Kolter, BASF SE, R&D Pharma Ingredients. Author(s): D. Djuric, V. Boyko, M. Karl, K. Kolter. VIEW ABSTRACT

638  Preparation of injectable hyaluronan-based hydrogel for controlled protein delivery to the eye. Presenter: Yu Yu, The Hong Kong University of Science and Technology. Author(s): Y. Yu, Y. Chau. VIEW ABSTRACT

639  Soluble Antigen Arrays that Target ICAM-1/LFA-1 Suppress Experimental Autoimmune Encephalomyelitis. Presenter: Cory Berkland, The University of Kansas. Author(s): J. Sestak, T. Siahaan, C. Berkland. VIEW ABSTRACT

 

Oncology and Tumour Targeting: Bioactive Materials     [RETURN TO TOP]

109  Optimization of Vincristrine-Topotecan Combination â Paving the Way for Improved Chemotherapy Regimens by Nanoliposomes. Presenter: Daniel Zucker, Department of Biochemistry, IMRIC, The Hebrew University-Hadassah Medical School. Author(s): D. Zucker, Y. Barenholz. VIEW ABSTRACT

403  A single molecule force spectroscopy approach to characterise the interactions between a lys(urea)glu moiety and the prostate specific membrane antigen receptor. Presenter: Andrew Parker, Molecular Profiles. Author(s): A. Parker, S. Rigby-Singleton, N. Patel, S. Allen, K. McDonnell. VIEW ABSTRACT

404  An Active Targeting SN38-Polymeric Micelle Formulation Decorated by Herceptin. Presenter: Li-Wen Chang, Industrial Technology Research Institute. Author(s): L. Chang, Y. Ko, C. Hsueh, Y. Hsu, P. Li, W. Yu. VIEW ABSTRACT

405  Augmentation of EPR effect by heme oxygenase-1 (HO-1). Presenter: Jun Fang, Laboratory of Microbiology & Oncology, Faculty of Pharmaceutical Sciences, Sojo University. Author(s): J. Fang, H. Qin, H. Nakamura, H. Maeda. VIEW ABSTRACT

406  Carbon nanostructures: next generation of cancer therapeutics?. Presenter: Neha Arya, Department of Biological Sciences and Bioengineering, Indian Institute of Technology Kanpur, INDIA. Author(s): N. Arya, K. S. Vasu, A. K. Sood, D. S. Katti. VIEW ABSTRACT

407  Carboxylesterase-Triggered Hydrolysis of Ester-Containing PEGylating Agents. Presenter: Melissa Howard, Department of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky. Author(s): M. D. Howard, X. Lu, T. D. Dziubla, M. Jay. VIEW ABSTRACT

408  Controlled delivery system to elicit anti-cancerous properties of the HIV protease inhibitor Nelfinavir. Presenter: Ekaterina Perets, Ben-Gurion University. Author(s): E. Perets, J. Kost, A. Rudich. VIEW ABSTRACT

410  Development of Multifunctional Hybrid Nanocrystals for Cancer Therapy and Diagnosis. Presenter: Tonglei Li, University of Kentucky. Author(s): C. Hollis, R. Zhao, H. Zhang, L. Sun, B. Knutson, T. Li. VIEW ABSTRACT

411  Doxorubicin-Loaded Nanopolymersomes. Presenter: Neeraj Kumar, Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research (NIPER), Punjab INDIA. Author(s): N. Kumar, W. Y. Ayen. VIEW ABSTRACT

412  EGF receptor targeting, replicase-based plasmid DNA eliminates breast tumors in mice. Presenter: B. Leticia Rodriguez, The University of Texas, Division of Pharmaceutics. Author(s): B. Rodriguez, K. Kiguchi, X. Li, J. DiGiovanni, Z. Cui. VIEW ABSTRACT

413  EGFR-targeting stearoyl gemcitabine nanoparticles show enhanced anti-tumor activity. Presenter: Michael Sandoval, University of Texas at Austin. Author(s): M. A. Sandoval, B. R. Sloat, D. Lansakara-P, A. Kumar, Z. Cui. VIEW ABSTRACT

414  Enhanced Targeted Therapy with Polymer-Drug Conjugates Pretargeted with HER2-specific Affibody-Anti-DTPA Fab Bispecific Complexes in HER2/neu Over-expressing Human Breast Carcinoma. Presenter: Keyur Gada, Northeastern University. Author(s): K. Gada, V. Patil, R. Panwar, A. Hetafi, B. Khaw. VIEW ABSTRACT

416  Formulation and Evaluation of pH-Sensitive, Long Circulating Liposomes for Paclitaxel Delivery. Presenter: Smita Bonde, SVKM,s NMIMS, School of Pharmacy and Technology Management. Author(s): B. Prabhakar, S. Bonde. VIEW ABSTRACT

419  Formulation, In vitro Release and Pharmacokinetics of Diethylstilbestrol Nanosuspension in Rats. Presenter: Tanay Samant, College of Pharmacy, University of Houston. Author(s): T. Samant, D. Chow. VIEW ABSTRACT

420  Herceptin-conjugated Temperature Sensitive Immunoliposomes Encapsulating Gemcitabine for Breast Cancer. Presenter: Mihee Choi, Sookmyung Women's University. Author(s): M. Choi, M. Koo, R. Jeon, J. Ryu, J. Kim. VIEW ABSTRACT

423  Hyaluronic acid-modified liposomes: preparation and preliminary biological characterization. Presenter: Luigi Cattel, Università degli Studi di Torino Dipartimento di Scienza e Tecnologia del Farmaco. Author(s): C. Lerda, C. Costanzo, S. Arpicco, M. Palmieri, I. Dando, B. Stella, A. Ferrero, L. Cattel. VIEW ABSTRACT

424  Hydrazone-Ester Dual Linker Micelles for pH-sensitive Release of Dexamethasone. Presenter: Melissa Howard, Department of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky. Author(s): M. D. Howard, A. Ponta, A. Eckman, M. Jay, Y. Bae. VIEW ABSTRACT

425  Hydrogel in liposome (lipogel) - A novel drug delivery system. Presenter: Yan Wang, University of Wisconsin. Author(s): S. Tu, Y. Wang, M. P. Xiong. VIEW ABSTRACT

426  Hydrophobic Polymer Films for Localized Chemotherapy. Presenter: Stefan Yohe, Boston University. Author(s): R. Liu, J. Wolinsky, S. Yohe, M. Grinstaff, Y. Colson. VIEW ABSTRACT

427  Improved Efficacy of Local Radionuclide Therapy of Solid Tumors by Optimization of Intratumoral Depot of Thermally Responsive Polypeptide. Presenter: Wenge Liu, Department of Biomedical Engineering of Duke University. Author(s): W. Liu, J. R. McDaniel, X. Li, D. Asai, M. R. Zalutsky, A. Chilkoti. VIEW ABSTRACT

428  In situ forming implants for bone metastases treatment through combined SPION-induced hyperthermia and chemotherapy. Presenter: Mohamed Mohamed, University of Geneva School of Pharmaceutical Sciences. Author(s): M. Mohamed, V. Bernau, H. Hofmann, G. Thalmann, G. Borchard, O. Jordan. VIEW ABSTRACT

429  In Vitro Cytotoxicity of pH-Sensitive Micelles for Tunable Release of Doxorubicin. Presenter: Andrei Ponta, University of Kentucky. Author(s): A. Ponta, Y. Bae. VIEW ABSTRACT

431  In vivo evaluation of novel PEGylated polyglutamic acid nanocapsules for antitumor drug delivery. Presenter: Giovanna Lollo, University of Santiago de Compostela. Author(s): G. Lollo, M. Garcia-Fuentes, D. Torres, P. Aviles, M. Guillén, P. Calvo, M. Alonso. VIEW ABSTRACT

434  In-vitro serum stability of polymeric micelles. Presenter: Tobias Miller, Merck KGaA Darmstadt, Germany/University of Regensburg, Germany. Author(s): T. Miller. VIEW ABSTRACT

437  Liposomal Drug Delivery system for Receptor Based Hepatic Targeting. Presenter: Shilpa Patere, Bombay College of Pharmacy. Author(s): S. N. Patere, S. M. Shah, P. O. Pathak, M. S. Nagarsenker. VIEW ABSTRACT

439  Liposomal pravastatin inhibits tumor growth in mice. Presenter: Maria Coimbra, Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht, The Netherlands. Author(s): M. Coimbra, M. Banciu, M. Fens, G. Storm, R. M. Schiffelers. VIEW ABSTRACT

440  Mechanically-Optimized Murine Mesenchymal Stem CellsAccumulate in 4T1 Mammary Tumors. Presenter: Deepraj Ghosh, Georgia Institute Of Technology. Author(s): M. Dawson, D. Ghosh, D. McGrail. VIEW ABSTRACT

441  Mitochondrial Preservation via Targeted Nanocarriers for Amelioration of Oxidative Damage to Cardiac Muscle Associated with Adriamycin-Induced Cadiotoxicity. Presenter: Tamer Elbayoumi, Midwestern University - Gelndale. Author(s): T. A. Elbayoumi, A. Faulk, B. Brownlow. VIEW ABSTRACT

442  Multifunctional Nanoassemblies: Selective Interactions with Breast Cancer Cells. Presenter: Srimeenakshi Srinivasan, Department of Nanomedicine, The Methodist Hospital Research Institute, Houston, Texas. Author(s): S. Srinivasan, W. P. Driessen, B. Proneth, J. F. Alexander, Y. Hu, X. Liu, W. Arap, R. Pasqualini, M. Ferrari. VIEW ABSTRACT

443  Nano-formulation of a water soluble drug gemcitabine. Presenter: Deepak Chitkara, National Institute of Pharmaceutical Education & Research. Author(s): D. Chitkara, N. Kumar. VIEW ABSTRACT

444  Novel Oral Local Sirolimus Sustained Release Delivery Systems for the Prevention of Oral Squamous Cell Carcinoma. Presenter: Zakhar Nudelman, The Hebrew University of Jerusalem. Author(s): Z. Nudelman, M. Friedman, R. Czerninski. VIEW ABSTRACT

445  Novel poly-L-asparagine nanocapsules as vehicles for anticancer drug delivery. Presenter: Gustavo Rivera-Rodriguez, University of Santiago de Compostela. Author(s): G. R. Rivera-Rodriguez, M. Alonso, D. Torres. VIEW ABSTRACT

446  Novel Pro-Apopototic Genistein-Loaded Lipidic Nanocarriers as Adjuvants for Anti-Cancer Chemotherapy. Presenter: Tamer Elbayoumi, Midwestern University- Gelndale. Author(s): T. A. Elbayoumi, J. Walters, B. Brownlow. VIEW ABSTRACT

447  Novel strategy for cancer cell specific oligonucleotide therapeutics with intracellular environmental condition responsible Peptide Ribonucleic Acids. Presenter: Takehiko Wada, IMRAM, Tohoku University. Author(s): T. Wada, T. Mizutani, A. Nagami, Y. Araki, S. Sakamoto, S. Futaki, Y. Inoue. VIEW ABSTRACT

448  Optimization and Pharmacokinetics of nanoformulation of CZ48, Lactone-Stabilized Prodrug of camptothecin. Presenter: Dong Dong, University of Houston. Author(s): D. Dong, B. C. Giovanella, D. S. Chow. VIEW ABSTRACT

451  pH-Sensitive PEGylated LiposomesFor Tumour Cell Targeting. Presenter: Stefano Salmaso, Department of Pharmaceutical Sciences, University of Padova, Italy. Author(s): E. Ravazzolo, F. Mastrotto, P. Caliceti, S. Salmaso. VIEW ABSTRACT

454  Redox Nanoparticle Enhances Effect of Anticancer Chemotherapy. Presenter: Yuki Ozaki, Graduate School of Pure and Applied Sciences, Graduate School of Comprehensive Human Sciences and Satellite Laboratory of International Center for Materials Nanoarchitechtonics, National Institute of Materials Science (NIMS), University of Tsukuba. Author(s): Y. Ozaki ,. T. Yoshitomi, Y. Nagasaki. VIEW ABSTRACT

455  Redox Sensitive Microspheres for Controlled Drug Delivery. Presenter: Koorosh Ashrafi, Biocompatibles UK Ltd. Author(s): K. Ashrafi, C. L. Heaysman, A. L. Lewis, A. W. Lloyd, G. J. Phillips. VIEW ABSTRACT

456  Self-assembled peptide-based hydrogel system for local drug delivery in cancer therapy. Presenter: Eliya Yishay-Safranchik, Ben-Gurion university. Author(s): E. Yishay-Safranchik, A. David. VIEW ABSTRACT

459  The Effect of Oxygen Carrier on the Cytotoxicity of Glucose Oxidase Encapsulated Microspheres towards Multidrug Resistant Breast Cancer Cells. Presenter: Xiao Yu Wu, University of Toronto. Author(s): J. Cheng, C. Z. Zhu, P. Prasad, A. M. Rauth, X. Y. Wu. VIEW ABSTRACT

461  The importance of cleavage of PEG chains from pegylated zinc protoporphyrin (PEG-ZnPP) by tumor proteases on intracellular uptake. Presenter: Kenji Tsukigawa, Faculty of Pharmaceutical Sciences and Department of Applied Chemistry, Sojo University. Author(s): K. Tsukigawa, H. Nakamura, J. Fang, H. Maeda. VIEW ABSTRACT

464  Tumor Regression by Treatment with a Novel and Simplified Thermosensitive Liposome. Presenter: Mark Ernsting, Ontario Institute for Cancer Research. Author(s): T. Tagami, M. J. Ernsting, S. Li. VIEW ABSTRACT

 

Ophthalmic: Bioactive Materials     [RETURN TO TOP]

300  A New Approach for Improving Ultrasound-mediated Intrascleral Drug Delivery – Addition of Microbubbles. Presenter: Y. Chau, Department of Chemical and Biomolecular Engineering, The Hong Kong University of Science and Technology. Author(s): H. Wong, Y. Chau. VIEW ABSTRACT

301  Biodegradable Polymeric Dispersions for Trans-scleral Delivery of Antisense Oligonucleotides. Presenter: Raid Alany, Kingston University London. Author(s): R. G. Alany. VIEW ABSTRACT

302  Bovine corneal opacity, permeability and histological effects of non-ionic surfactant vesicles (niosomes. Presenter: Raid Alany, Kingston University London. Author(s): R. G. Alany. VIEW ABSTRACT

305  Design of a new ophthalmic drug delivery system based on soaking contact lenses in nanocapsule suspensions. Presenter: Tatiele Katzer, Post Graduation Program in Pharmaceutical Sciences - UFRGS. Author(s): T. Katzer, P. Chaves, S. S. Guterres, A. R. Pohlmann, R. C. Beck. VIEW ABSTRACT

307  Doxycycline loaded poly(ethylene glycol) hydrogels for healing sulfur mustard induced ocular wounds. Presenter: Manjeet Deshmukh, Department of Pharmaceutics, Rutgers University, NJ and UMDNJ-Rutgers Counteract Research Center of Excellence, Rutgers University. Author(s): M. Deshmukh, A. S. DeSantis, M. C. Babin, M. K. Gordon, P. J. Sinko. VIEW ABSTRACT

308  Drug delivery to the posterior eye segment: a new ex vivo model for ocular iontophoretic studies. Presenter: Tais Gratieri, Univ of Geneva. Author(s): T. Gratieri, D. R. Kalaria, Y. N. Kalia. VIEW ABSTRACT

309  In vitro release, transcorneal permeation and stability studies onthe opioid growth factor antagonist (Naltrexone HCl). Presenter: Raid Alany, Kingston University London. Author(s): R. G. Alany. VIEW ABSTRACT

310  Investigation of Effect of Vesicular Size on Intraocular Pressure Lowering Activity. Presenter: Prabhakara Prabhu, NGSM Institute of Pharmaceutical Sciences, Nitte University. Author(s): P. Prabhu, N. R, M. Koland, N. Charyulu. VIEW ABSTRACT

311  Novel Polysaccharide Based Topical Film for Ophthalmic Delivery of Ofloxacin. Presenter: Ramchandra Patale, Department of Pharmaceutical Sciences and Technology, Institute of Chemical Technology, Matunga, Mumbai-400019, India. Author(s): R. L. Patale, D. B. Patravale. VIEW ABSTRACT

312  Options for Localized Delivery in the Eye: Liposomes for glaucoma therapy. Presenter: Jayaganesh Venkatasubramani, Nanyang Technological University. Author(s): S. S. Venkatraman, C. Wong, J. Venkatasubramani. VIEW ABSTRACT

314  Studies On Ocular Aqua Triggered Water-In-Oil Phase Transition Timolol Microemulsion System. Presenter: Rahul Hegde, Department of Pharmaceutics, Goa College of Pharmacy, Panaji Goa. Author(s): R. R. Hegde. VIEW ABSTRACT

315  Sustained release of L-lactic acid for vasodilation of the retinal vasculature. Presenter: Lutz Asmus, University of Geneva. Author(s): M. Veurink, L. Asmus, B. Kaufmann, M. Moeller, E. Mendrinos, C. J. Pournaras, R. Gurny. VIEW ABSTRACT

 

Oral Controlled Release: Bioactive Materials     [RETURN TO TOP]

642  A formulation approach to improve the in vivo performance of furosemide. Presenter: Gunnar Gloeckl, Institute of Pharmacy, University of Greifswald. Author(s): G. Gloeckl, R. Lukas, G. Garbacz, W. Weitschies. VIEW ABSTRACT

643  A Gastric Retention Modeling Study of Floating Devices. Presenter: Ross Phan, University of Texas at Austin. Author(s): R. Phan, S. Thitinan, J. T. McConville. VIEW ABSTRACT

644  A liquid gas based drug delivery system for controlled oral delivery of liquid and semisolid drug formulations. Presenter: Sandra Klein, Ernst Moritz Arndt University Greifswald. Author(s): D. Haznar-Garbacz, G. Garbacz, F. Eisenächer, S. Klein, W. Weitschies. VIEW ABSTRACT

646  A Multiple-Unit Ileocolonic Delivery System Containing A High Load Of 5-Asa. Presenter: Andrea Gazzaniga, Università degli Studi di Milano. Author(s): G. Di Pretoro, L. Zema, L. Palugan, D. I. Wilson, S. L. Rough, A. Gazzaniga. VIEW ABSTRACT

647  A new approach to screening the segregation risk of hydrophilic matrix systems. Presenter: Richard Elkes, MSD. Author(s): R. Elkes. VIEW ABSTRACT

648  A Novel Approach to Formulation of Controlled Release Orally Disintegrating Tablets using Ion Exchange Resins. Presenter: Blaise Mwanda, CRS member soon. Author(s): R. Thota, R. Kasina, B. Mwanda, P. Sundararajan, A. QU. VIEW ABSTRACT

649  A Solid Polymer-In-Drug Dosage Form. Controlled Release of a High-Dose, Water Soluble API. Presenter: Daniel Bar-Shalom, University of Copenhagen. Author(s): D. Bar-Shalom, K. Naelapaa, A. Huus. VIEW ABSTRACT

650  A Triple-Mechanism Gastroretentive System for Zero-Order Delivery of Levodopa. Presenter: Ndidi Ngwuluka, University of the Witwatersrand. Author(s): N. C. Ngwuluka, V. Pillay, G. Modi, D. Naidoo, Y. E. Choonara, L. C. du Toit. VIEW ABSTRACT

651  Advantage to Properties and Release Profile of Tablet Prepared with a New Globular Special Fine Powder of Hydroxypropyl Cellulose by Direct Compression Method. Presenter: Shinichiro Tsue, Nippon Soda Co., Ltd. Author(s): S. Tsue. VIEW ABSTRACT

652  Application of Cross-linking for Controlled-Release Drug Delivery System. Presenter: Chue Yang, Banner Pharmacaps, Inc.. Author(s): C. H. Yang, T. A. Dyakonov, S. Majuru, M. S. Hariharan. VIEW ABSTRACT

653  Application of Quality by Design (QbD) Principles to the Formulation of Extended Release Theophylline Hydrophilic Matrix Tablets. Presenter: Hua Deng, Colorcon Inc.. Author(s): H. Deng, S. Vass, S. Tiwari, T. Cabelka, A. Faham, T. Farrell, A. Rajabi-Siahboomi. VIEW ABSTRACT

654  Barrier Membrane Coating of Hydrophilic Matrices: A Strategy to Reduce Drug Release Variability and Possible Food Effect. Presenter: Raxit Mehta, Colorcon Inc.. Author(s): R. Y. Mehta, S. B. Tiwari, T. P. Farrell, A. R. Rajabi-Siahboomi. VIEW ABSTRACT

655  Barrier Membrane Coating of Hydrophilic Matrices: Influence of Tablet Shape and Geometry on Drug Release. Presenter: Raxit Mehta, Colorcon Inc.. Author(s): R. Y. Mehta, S. B. Tiwari, T. P. Farrell, A. R. Rajabi-Siahboomi. VIEW ABSTRACT

656  Bile Salt Enhanced the Intestinal Absorption of Candesartan Cilexetil Loaded Lipid Nanocarriers. Presenter: Zhiwen Zhang, Shanghai Institute of Materia Medica, Chinese Academy of Sciences. Author(s): Z. Zhang. VIEW ABSTRACT

657  Bioavailability enhancement of antiretrovirals via melt Extrusion using EUDRAGIT® polymers. Presenter: Firouz Asgarzadeh, Evonik Degussa Corp. Author(s): S. Bodinge, K. Nollenberger, S. Shetty, G. Singh, R. Jeste, S. Gadhinglajkar, R. Hema, F. Asgarzadeh. VIEW ABSTRACT

658  Blends of Hydrophobic and Swelling Agents in Swelling layer to Prepare Delayed Release Pelletsfor Hydrophilic Drug with Low MW: Physicochemical Characterization and in-vivo Evaluation. Presenter: Chang You, Institute of Chinese Medical Sciences, University of Macau. Author(s): C. You, L. Xuedan, S. Jianbei, F. Tianyuan, Z. Ying. VIEW ABSTRACT

659  Cationic Polymeric Nanoparticles as a Rationally Designed Platform for Enhanced Oral Bioavailability and Hepatoprotective Activity of CoQ10. Presenter: Nitin Swarnakar, Centre for Pharmaceutical Nanotechnology, National Institute of Pharmaceutical Education and Research (NIPER), S.A.S. Nagar (Mohali), Punjab. Author(s): N. K. Swarnakar, A. K. Jain, R. P. Singh, C. Godugu, M. Das, S. Jain. VIEW ABSTRACT

660  Compritol® 888ATO a release modifier for sustained release of highly water soluble agent: Formulation, Evaluation and IVIVC study. Presenter: Mangal Nagarsenker, Bombay College of Pharmacy. Author(s): M. S. Nagarsenker, S. N. Patere, N. S. Desai, A. S. Jain, P. P. Kadam, N. J. Gogtay, U. M. Thatte, C. J. Kapadia, N. Farah. VIEW ABSTRACT

662  Controlled Delivery of Verapamil through a Nanofibrous Sheet Barrier. Presenter: Young Bin Choy, Interdisiplinary Program in Bioengineering; Department of Biomedical Engineering, College of Medicine and Institute of Medical & Biological Engineering, Medical Research Center, Seoul National University. Author(s): J. Lee, C. Park, M. Park, S. Lee, Y. Choy. VIEW ABSTRACT

663  Controlled Release Formulation for A Water Soluble Drug with High Dose Using Anionic Methacrylic Polymer. Presenter: Yatish Bansal, Ipca Laboratories Ltd. Author(s): Y. K. Bansal. VIEW ABSTRACT

664  Controlled Release Melt Extruded Drug Delivery Systems. Presenter: Suneela Prodduturi, Aizant Drug Research Solutions Pvt. Ltd.. Author(s): S. Prodduturi, N. Dintakurthi, V. Jatla. VIEW ABSTRACT

665  Controlled Release of High Dose Highly Soluble Drugs: Hot Melt Extrusion using Ethylcellulose. Presenter: Elanor Pinto, Ashland. Author(s): E. Pinto. VIEW ABSTRACT

667  Design of Paliperidone prodrugs with oral delivery system using rat in situ stomach perfusion (ISSP) and rat single pass intestinal perfusion (SPIPï) experiment. Presenter: Lijia Yuan, Jilin University. Author(s): L. Yuan, X. Shi, F. Sun, H. Xia, C. Wang, y. li. VIEW ABSTRACT

668  Development and clinical evaluation of Huperazine A novel ovalbumin based oral controlled release delivery system. Presenter: Gregory Burshtein, Institute for Drug Research, the Hebrew University of Jerusalem. Author(s): G. Burshtein, M. Friedman, A. Hoffman. VIEW ABSTRACT

669  Development And Optimization Of Liquid Type Alginate Raft System For Antireflux. Presenter: Myung Joo Kang, Dong-A Pharmaceutical Co Ltd. Author(s): M. Kang, K. Kang, B. Kim, S. Jin, J. Kim. VIEW ABSTRACT

671  Development of Gastro-retentive Formulation Containing clarithromycin. Presenter: Ha-Seong Kim, Sungkyunkwan University. Author(s): H. Kim, S. Jo, Y. Rhee, J. Kim, J. Seo, N. Tung, E. Park. VIEW ABSTRACT

672  Development of multiparticulate dosage form containing aspirin and simvastatin. Presenter: K.W. Nam, Boryung Central Research Institute, Boryung Pharmaceutical Co. Ltd.. Author(s): K. Nam, H. Lee, J. Kim. VIEW ABSTRACT

673  Development of novel floating mucoadhesive drug delivery system. Presenter: Hoo-Kyun Choi, College of Pharmacy, Chosun University, Seosuk Dong, Gwangju, 501-759. Author(s): P. Bhusal, R. K. Subedi, H. Choi. VIEW ABSTRACT

674  Development of Push Pull Osmotic Pump Tablets for a Slightly Soluble Model Drug. Presenter: Piyush Patel, Colorcon. Author(s): S. Missaghi, P. Patel, S. B. Tiwari, T. P. Farrell, A. R. Rajabi-Siahboomi. VIEW ABSTRACT

675  Dissolution of pioglitazone 45 mg tablets under conditions simulating standard fasting conditions of bioequivalence studies. Presenter: Grzegorz Garbacz, University of Greifswald. Author(s): G. Garbacz, J. Mazgalski, S. Klein, W. Weitschies. VIEW ABSTRACT

676  Effect of Different Processing Conditions on the Performance of Push Pull Osmotic Pump Tablets of a Slightly Soluble Model Drug. Presenter: Piyush Patel, Colorcon. Author(s): S. Missaghi, P. Patel, S. Tiwari, T. Farrell, A. R. Rajabi-Siahboomi. VIEW ABSTRACT

677  Effect of Glycerol on Coalescence of Polymeric Particles from Chitosan Colloidal Dispersion. Presenter: Jarunee Sakwanichol, Department of Manufacturing Pharmacy, Faculty of Pharmacy, Mahidol University, Bangkok. Author(s): J. Sakwanichol, S. Puttipipatkhachorn. VIEW ABSTRACT

678  Effect of Surface Area by Volume Ratio on Drug Release in Simulated Gastric Fluid and Simulated Intestinal Fluid. Presenter: Kishore Kurapati, Suve Life Sciences Limited. Author(s): R. Manthri, K. Kurapati, K. Mudigonda, R. Nirogi. VIEW ABSTRACT

679  Effect of Talc as Antiadherent on the Physical and Mechanical Properties of Ethyl Cellulose Films Casted from Organic Solvents. Presenter: Manuel Vega Zepeda, CIMA LABS. Author(s): M. A. Vega Zepeda, Q. Wang, E. Hamed. VIEW ABSTRACT

680  Effect Of Kollidon Cl And Ac-Di-Sol On Release Behavior Of Rifampicin Dispersible Tablets For Treatment Of Tuberculosis. Presenter: Vikesh Shukla, KLE University. Author(s): V. K. Shukla. VIEW ABSTRACT

681  Effective taste-masking based on a new coating dispersion. Presenter: Karl Kolter, BASF SE, R&D Pharma Ingredients. Author(s): K. Kolter, F. Guth, M. Angel. VIEW ABSTRACT

682  Effects of Food Ingestion and Peristalsis on Bioavailability of Theophylline from Press-Coated Tablets as Chronopharmaceuticals. Presenter: Yoshiteru Watanabe, Showa Pharmaceutical University. Author(s): Y. Watanabe, B. Mukai, T. Ishikawa, M. Kondoh, N. Koizumi, M. Fujii. VIEW ABSTRACT

683  Effects of Lipids on Absorption of Poorly Water-Soluble Drugs. Presenter: Selena Di Maio, Northeastern University. Author(s): S. Di Maio, R. L. Carrier. VIEW ABSTRACT

684  Electrostatically Spun Formulations of Etravirine: Potential Systems for Oral and Non-Oral Administration Routes. Presenter: Marcus Brewster, Janssen Research and Development. Author(s): G. Verreck, I. Van Assche, I. Chun, J. Rosenblatt, K. Swinney, S. Stokbroekx, J. Van Gelder, M. E. Brewster. VIEW ABSTRACT

685  Enhanced dissolution and stability properties of supercritical fluid processed fenofibrate-silica systems. Presenter: Robert Ahern, School of Pharmacy, University College Cork. Author(s): R. J. Ahern, K. Ryan, A. M. Crean. VIEW ABSTRACT

687  Enhancement of Intestinal Absorption of Salmon Calcitonin Using a Novel Liquid Emulsion Drug Delivery System - LEDDS®. Presenter: Tanira Aguirre, University College Dublin. Author(s): T. Aguirre, M. Rosa. VIEW ABSTRACT

688  Environmentally Responsive Polymeric Carrier Systems for Oral Delivery of Hydrophobic Cancer Drugs. Presenter: Mary Caldorera-Moore, The University of Texas at Austin. Author(s): M. E. Caldorera-Moore, N. A. Peppas. VIEW ABSTRACT

689  Establishment of new preparation method for solubiliy enhanced microparticles of poorly soluble drugs. Presenter: KyungHee Kim, Samyang R&D center. Author(s): K. Kim, J. Hwang, S. Hwang, H. Lee, C. Pai. VIEW ABSTRACT

690  Eudragit® EPO/S100 interpolyelectrolyte complex as a matrix carrier for colon-specific delivery. Presenter: Rouslan Moustafine, Professor, Head of the Department of Pharmaceutical Chemistry, Dean of the Faculty of Pharmaceutical Sciences. Author(s): R. I. Moustafine. VIEW ABSTRACT

691  Evaluating the performance of PEO, HEC and HPMC in extended release (ER) erosion-based hydrophilic matrices for low solubility drugs. Presenter: Christian Seiler, MSD. Author(s): S. R. Pygall, D. A. Thompson, A. Djemai, C. Seiler. VIEW ABSTRACT

692  Evaluation of EUDRAGIT® NE 40 D for sustained release matrix granulation processes. Presenter: Abishek Kathuria, Evonik Degussa Corp. Author(s): P. Niepoth, I. Forlizzi, K. Nollenberger, A. Kathuria. VIEW ABSTRACT

693 Evaluation of Plantago Ovata mucilage as a novel superdisintegrant for pulsatile drug delivery system (PDDS). Presenter: Atish Mundada, SSDJ College of Pharmacy, Neminagar, Chandwad, Nashik. VIEW ABSTRACT

694  Evaluation of silicone adhesive matrix for oral controlled release of ionizable drugs. Presenter: Gaurav Tolia, University of Cincinnati. Author(s): G. Tolia, S. Li. VIEW ABSTRACT

695  Evaluation of Water Uptake and Mechanical Properties of Blending Polymer Films for Preparing Gas-Generated Multiple-Unit Floating Dosage Form. Presenter: Ming-Thau Sheu, Taipei Medical University. Author(s): Y. Chen, H. Lin, S. Hung, M. Sheu. VIEW ABSTRACT

698  Formulation and Statistical Optimization of Tamsulosin Modified Release Pellets. Presenter: Alireza Ghaffari, Department of Pharmaceutics, Islamic Azad University, Pharmaceutical Sciences Branch. Author(s): A. Ghaffari, M. Sadat Rezaei, S. Wu. VIEW ABSTRACT

699  Formulation Effects on Drug Release from Sustained Release Compritol® 888 ATO Tablets and Mini-Tablets. Presenter: Shabbir Mostafa, Gattefosse UK. Author(s): S. Mostafa, M. Roberts, D. Vellucci, D. Marchaud, C. Miolane. VIEW ABSTRACT

701  Formulation of Sustained Release Microparticles containing Pramipexole. Presenter: Ji-ho Shin, SungKyunKwan University. Author(s): J. Shin, S. An, J. Ha, J. Han, B. Lee, V. Nho, Y. Rhee, E. Park. VIEW ABSTRACT

704  Gastroretentive Drug Delivery Systems Of 5 Fluorouracil. Presenter: Kavitha Karuppian, Anna University of Technology. Author(s): K. Karuppian, S. G, N. C.N.. VIEW ABSTRACT

709  Influence of Dissolution Media on the Release of Drug from HPMC Matrix Tablets. Presenter: Kishore Kurapati, Suven Life Sciences Limited. Author(s): K. Kurapati, R. Manthri, K. Mudigonda, R. Nirogi.

712  Injection-Molded Capsular Device for Oral Pulsatile Delivery: an In Vivo Evaluation. Presenter: Andrea Gazzaniga, Università degli Studi di Milano, Dipartimento di Scienze Farmaceutiche “P. Pratesiâ. Author(s): A. Gazzaniga, A. Foppoli, A. Maroni, A. Cozzi, E. Macchi, M. Cerea. VIEW ABSTRACT

713  Interpenetrating Networks for the Oral Delivery of Chemotherapeutics. Presenter: Cody Schoener, University of Texas at Austin. Author(s): C. A. Schoener, N. A. Peppas. VIEW ABSTRACT

714  Interrogating drug liberation phenomena from hydrophilic matrices using near infrared (NIR) spectroscopy. Presenter: Christian Seiler, MSD. Author(s): P. Avalle, S. R. Pygall, J. Pritchard, A. Jastrzemska, R. Saklatvala, C. Seiler. VIEW ABSTRACT

715  Investigation of a Polymeric System to Reduce Alcohol Dose-dumping of Marketed Drug Products. Presenter: Hardik Shah, Elan Drug Technologies. Author(s): H. K. Shah, W. McCormack, D. S. Manser, P. Glynn, G. Liversidge, G. S. Rekhi. VIEW ABSTRACT

716  Investigation of Stability of Sustained Release Matrices Containing Polyethylene Oxides. Presenter: Ali Nokhodchi, 2nd supervisor. Author(s): S. Shojaee, K. Asare-Addo, A. Nokhodchi, I. K. Cumming. VIEW ABSTRACT

717  In-Vitro Release Evaluation of Gastro-Retentive Amoxicillin Preparations for Treatment of Helicobacter Pylori. Presenter: Ahmed El-Ashmawy, National Research Centre. Author(s): L. H. Emara, A. R. Abdou, A. A. El-Ashmawy, N. M. Mursi. VIEW ABSTRACT

718  Invulnerability of Cellulosic Controlled Release Technologies to Alcohol Dose Dumping: Morphological and Rheological Evidence. Presenter: Elanor Pinto, Ashland. Author(s): E. Pinto. VIEW ABSTRACT

719  Kollidon® Va 64: A Vital Polymer For Fast Dissolving Hot-Melt Extruded Dosage Forms. Presenter: Michael Repka, The University of Mississippi. Author(s): M. A. Repka, S. Maddineni, J. Lu, S. Shah, S. Majumdar, K. Kolter, N. Langley. VIEW ABSTRACT

722  Milling-Induced Changes in Surface Energy and Aspect Ratio for Mannitol. Presenter: Daniel Burnett, Surface Measurement Systems. Author(s): D. J. Burnett, R. Ho, M. Naderi, G. Thiel, A. Keith. VIEW ABSTRACT

723  Minimize the Influence of Drug-Polymer Interaction on Drug Release from Enteric Coated Extended Release Matrix Tablet. Presenter: Xiaodi Guo, Prinston Pharmaceutical LLC. Author(s): F. Cai, S. Yang, J. Cai, H. Chen, K. Zhang, R. Luo, M. Wang, X. Guo. VIEW ABSTRACT

724  Modified Release Bicalutamide Formulation with Improved Bioavailability. Presenter: Sarabjit Singh, Panacea Biotec Ltd., Mumbai. Author(s): S. Singh, S. Puthli, A. Singh, R. Shegokar, R. Mueller. VIEW ABSTRACT

725  Modified Release Once a Day Formulation of Ramipril. Presenter: Sarabjit Singh, Panacea Biotec Ltd., Mumbai. Author(s): S. Singh, S. Puthli, R. Jain, R. Shegokar, R. Mueller. VIEW ABSTRACT

727  Nanosized Particles of Simvastatin for Enhanced Hypolipidemic Activity. Presenter: Heena Soni, Maharaja Sayajirao University of Baroda. Author(s): S. S. Chavhan, K. C. Petkar, K. K. Sawant, H. Soni. VIEW ABSTRACT

728  Natural Products Targeting for Colon Drug Delivery. Presenter: Hyunjo Kim, Sahmyook University. Author(s): H. Kim. VIEW ABSTRACT

729  New carriers on the base of Carbopol®/Eudragit® EPO interpolyelectrolyte complexes for colon-specific delivery. Presenter: Rouslan Moustafine, Professor, Head of the Department of Pharmaceutical Chemistry, Dean of the Faculty of Pharmaceutical Sciences. Author(s): R. I. Moustafine. VIEW ABSTRACT

730  New LC-MS/MS method for simultaneous determination of Tenofovir and Lamivudine in human plasma and its application to bio equivalence study. Presenter: Gowri Dannana, University College of Pharmaceutical Sciences,Andhra University, Vishakhapatnam. Andhra Pradesh.. Author(s): G. S. Dannana, R. H. Babu.Ch, S. I. Deta. VIEW ABSTRACT

731  Nifedipine-HPMCAS Solid Dispersions Prepared by Hot-Melt Extrusion: Effect of Substitution. Presenter: Fumie Tanno, Shin-Etsu Chemical Co., Ltd.. Author(s): F. K. Tanno, Y. Ikeda, S. Obara. VIEW ABSTRACT

732  Novel Drug Delivery Approach to Achieve Zero-order Release Kinetics: Coated Matrix Based Formulation for Freely Soluble Drugs Using Controlled Release Polymers. Presenter: Yogesh Chachare, AAPS Member, Not a CRS member. Author(s): R. Thota, R. Kasina, S. Manickam, Y. Chachare, A. Qu. VIEW ABSTRACT

733  Optimization of Levodopa-loaded PLGA nanoparticles using factorial design. Presenter: Jingyuan Wen, University of Auckland. Author(s): Y. Zhou, R. G. Alany, J. Wen. VIEW ABSTRACT

734  Optimization of Oral Paclitaxel Formulations to Improve Patient Compliance and Manufacturing Process. Presenter: Min Kyung Ko, Korea Institute of Science and Technology. Author(s): M. Ko. VIEW ABSTRACT

735  Optimization of prescription of Tolterodine Tartrate sustained release tablets using Box-Behnken experimental design method. Presenter: Lijia Yuan, Jilin University. Author(s): L. Yuan, L. Wang, F. Sun, H. Xia, X. Shi, W. Huang, Y. Li. VIEW ABSTRACT

736  Oral Redox Nanotherapy for Ulcerative Colitis Treatment. Presenter: Long Vong Binh, Graduate School of Pure and Applied Sciences, Satellite Laboratory of International Center for Materials Nanoarchitechtonics, National Institute of Materials Science (NIMS), University of Tsukuba. Author(s): L. Vong Binh, T. Yoshitomi, H. Matsui, Y. Nagasaki. VIEW ABSTRACT

737  Orally Disintegrating Films (ODF) as Vectors for Micro/Nanoparticle Delivery Using Benzocaine as a Model Drug. Presenter: Carmen Popescu, Roquette America Inc.. Author(s): C. Popescu, M. Moore, L. Zhou, R. Zhu, H. Almoasen, P. Wildfong, D. Damour, X. Parissaux. VIEW ABSTRACT

738  Performance of a Compritol® 888 ATO Lipid Matrix Tablet to Deliver Sustained Release of Diclofenac Sodium . Presenter: Delphine Marchaud, Gattefossé SAS. Author(s): D. Marchaud, E. Dauphin-Chanard, J. Girard, C. Miolane. VIEW ABSTRACT

739  pH Responsive Raft-forming Formulation of Risedronate for Reduced Gastrointestinal Mucosal Irritation. Presenter: Myung Joo Kang, Pharmaceutical Product Research Laboratories, Dong-A Pharmaceutical Co. LTD.. Author(s): M. Kang. VIEW ABSTRACT

740  Pharmacokinetic Study of NAL8238 Sildenafil Citrate Orally Dissolving Film (ODF) Administered via Two Different Routes in Comparison to Sildenafil Citrate Tablet. Presenter: Zheng Wang, NAL Pharmaceuticals Ltd.. Author(s): Z. Wang, O. Chu, G. Lu, K. Lo. VIEW ABSTRACT

741  Physical Characteristics and Pharmacokinetics of Oral Tamoxifen Formulations. Presenter: Jeong-Wook Kang, Korea Institute of Science and Technology. Author(s): J. Kang. VIEW ABSTRACT

742  Polyphenol Floating Drug Delivery Systems for Eradication of Helicobacter Pylori. Presenter: Ohad Rosenzweig, Institute of Drug Research, The Hebrew University of Jerusalem. Author(s): O. Rosenzweig, R. Kohen, M. Friedman. VIEW ABSTRACT

743  Preparation and Characterization of Ketoprofen Solid Dispersions With Poloxamer. Presenter: Mine özyazici, Assoct. Prof.. Author(s): S. Rençber, M. özyazici, G. Ertan. VIEW ABSTRACT

744  Preparation and Evaluation of a Swellable/Erodible Multiple-Unit Formulation for Oral Pulsatile Release and Time-Based Colon Delivery. Presenter: Andrea Gazzaniga, Università degli Studi di Milano. Author(s): M. D. Del Curto, A. Maroni, L. Zema, G. Loreti, A. Gazzaniga, M. E. Sangalli. VIEW ABSTRACT

745  Preparation and Evaluation of Starch-Urea Cross-linked with Calcium for Oral Controlled Release of Aceclofenac. Presenter: Nalamolu Koteswara Rao, Senior Lecturer. Author(s): N. Koteswara Rao, U. Vivek Kumar. VIEW ABSTRACT

746  Preparation of Low-Dose Oral Fast-Dissolving Films Using Thermal Ink-Jet Printing. Presenter: Mark Saunders, Kuecept Ltd. Author(s): M. Saunders. VIEW ABSTRACT

747  Preparation of Sustained Release Microparticles for Early Assessment in Preclinical Models. Presenter: Mark Saunders, Kuecept Ltd. Author(s): M. H. Saunders. VIEW ABSTRACT

748  Release of Paclitaxel Nanoparticles from pH Sensitive and Biodegradable Dextran Based Hydrogels. Presenter: Xiao Yu, Texas A&M University. Author(s): X. Yu, M. V. Pishko. VIEW ABSTRACT

749  Rheological Characterization of (Meth)acrylic Copolymers Suitable for Melt Extrusion Applications. Presenter: Firouz Asgarzadeh, Evonik Industries, Pharma Polymers, Piscataway, USA. Author(s): F. Asgarzadeh, R. Edgar, J. Li, J. Moß, K. Nollenberger. VIEW ABSTRACT

750  Rheological Properties and Processing Characteristics of Soluplus, Kollidon VA-64 & HPMC-AS. Presenter: Shaukat Ali, BASF Corporation. Author(s): A. E. Listro, S. Ali, N. Langley. VIEW ABSTRACT

751  Serratiopeptidase /chitosan nanoparticle carriers prepared by polyelectrolyte complexation. Presenter: Nitin Mali, Research Fellow. Author(s): N. D. Mali. VIEW ABSTRACT

752  Solid dispersion of cilostazol with enhanced solubility and dissolution. Presenter: Jun-Hyung Park, BK21 Project Team, College of Pharmacy, Chosun University. Author(s): J. Park, R. K. Subedi, H. Choi. VIEW ABSTRACT

754  Solubilization Of A Lipophilic Bioactive In Hydroxypropylcellulose (Klucel® Hpc) Solid Matrix Dispersions Via Hot Melt Extrusion. Presenter: Michael Repka, The University of Mississippi. Author(s): M. A. Repka, A. Singh, W. Deng, N. Mohammed, S. Shah, S. Majumdar, E. Pinto, D. Tiwari, T. Durig. VIEW ABSTRACT

758  Targeting to ICAM-1 Induces Transport of Polymer Carriers Across Gastrointestinal Epithelial Cells. Presenter: Rasa Ghaffarian, Fischell Dept. of Bioengineering of the University of Maryland, College Park. Author(s): R. Ghaffarian, O. Ayyub, P. Kofinas, S. G. Muro. VIEW ABSTRACT

759  Tetradecylmaltoside is a permeability enhancer: Isolated rat colonic mucosae in Ussing chambers. Presenter: Signe Petersen, UCD. Author(s): S. B. Petersen, G. Nolan, S. Maher, U. L. Rahbek, M. Guldbrandt, D. J. Brayden. VIEW ABSTRACT

760  The Influence Dissolution Media pH on Drug Release from Ethylcellulose Coated Multi-particulates. Presenter: Charles Vesey, Colorcon, Hareysville, . Author(s): V. D. Dias, V. Ambudkar, C. F. Vesey, T. Farrell, A. R. Rajabi-Siahboomi. VIEW ABSTRACT

761  The Influence of Drug Solubility on Release from Ethylcellulose Barrier Membrane Coated Multi-particulates. Presenter: Charles Vesey, Colorcon, Harleysville, PA. Author(s): V. D. Dias, V. Ambudkar, C. F. Vesey, T. Farrell, A. R. Rajabi-Siahboomi. VIEW ABSTRACT

762  The Influence of Film Coating and Storage on Propranolol Hydrochloride Release from Polyethylene Oxide Extended Release Matrices. Presenter: Dasha Palmer, Colorcon Limited, Flagship House, Victory Way, Crossways, Dartford . Author(s): D. Palmer, M. Levina, T. Farrell, A. R. Rajabi-Siahboomi. VIEW ABSTRACT

763  The Influence of Sodium Carboxymethyl Cellulose on Drug Release from Polyethylene Oxide Extended Release Matrices. Presenter: Dasha Palmer, Colorcon Limited, Flagship House, Victory Way, Crossways, Dartford . Author(s): D. Palmer, M. Levina, A. Nokhodchi, T. Farrell, A. R. Rajabi-Siahboomi. VIEW ABSTRACT

764  The Investigation of the Influence of Aqueous Ethylcellulose Coating on the Performance of Hydrophilic Polyethylene Oxide Mini-Matrices Containing a Freely Water Soluble Drug. Presenter: Ali Rajabi-Siahboomi, Colorcon, Inc., Harleysville, PA. Author(s): H. Vuong, M. Levina, T. Farrell, A. R. Rajabi-Siahboomi. VIEW ABSTRACT

765  Use of Starch 1500® to Minimize Variability on Drug Release from Hypromellose Matrices. Presenter: Hua Deng, Colorcon Inc.. Author(s): H. Deng, S. Vass, S. Tiwari, T. Farrell, A. Rajabi-Siahboomi. VIEW ABSTRACT

766  Use of USP Apparatus III (Simulated Fed and Fasted Conditions) to Study the Effects of Ionic Strength of Dissolution Media on Theophylline Release from Hypromellose Matrix Tablets. Presenter: Kofi Asare-Addo, Medway School of Pharmacy, Universities of Kent and Greenwich, Chatham, Kent, ME4 4TB. Author(s): K. Asare-Addo, M. Levina, A. Rajabi-Siahboomi, A. Nokhodchi. VIEW ABSTRACT

767  Water permeability of ethyl cellulose - hydroxypropyl cellulose controlled release films in presence of ethanol. Presenter: Mikael Larsson, Department of Chemical and Biological Engineering, Chalmers University of Technology. Author(s): M. Larsson, J. Hjärtstam, J. Berndtsson, M. Stading, A. Larsson. VIEW ABSTRACT

768  Zero-order drug release obtained with gradient matrix systems based on hydrophilic polymers. Presenter: Andrea Gazzaniga, Università degli Studi di Milano. Author(s): M. Cerea, L. Palugan, A. Foppoli, M. Del Curto, G. Loreti, A. Gazzaniga. VIEW ABSTRACT

 

Pharmaceutical Manufacturing: Bioactive Materials     [RETURN TO TOP]

769  A High Throughput Robot for Solubiliser Screening. Presenter: Karl Kolter, BASF SE. Author(s): K. Kolter, D. Djuric, A. Marguerre, U. Troppmann, C. Holtze, E. Wagner, M. G. Herting. VIEW ABSTRACT

770  A Preliminary Attempt to Prepare a Liquid Formulation for Pantoprazole Sodium Injection. Presenter: Farid Dorkoosh, Department of pharmaceutics, Faculty of Pharmacy, Tehran University of Medical Sciences. Author(s): S. Maleki, N. Jafary Omid, F. Dorkoosh. VIEW ABSTRACT

771  A Study on the Robustness of the Wet-Granulation Process to Prepare Metformin HCl Extended-Release Matrix Tablets using METOLOSE® 90SH-15000SR. Presenter: Sakae Obara, Shin-Etsu Chemical Co., Ltd.. Author(s): S. Obara, H. Akin, L. Chen. VIEW ABSTRACT

774  Continuous Wet Granulation using linked twin-screw granulator and continuous fluid bed dryer -- a pilot scale prove-of-concept study. Presenter: Andreas Gryczke, Thermo Fisher Scientific. Author(s): A. Gryczke, T. Geissler, D. Hauch, S. Henschke, M. Jakob, M. Guttzeit, A. Winkler. VIEW ABSTRACT

776  Develop and validate an isocratic HPLC method for separation of five primary catechin derivatives. Presenter: Jingyuan Wen, School of Pharmacy, Faculty of Medical and Health Sciences, The University of Auckland. Author(s): J. Wen, D. LI, Z. Wu, N. Martini. VIEW ABSTRACT

778  Effect of Different Lubricants and Screen Size to Flowing Characteristics Of Granules. Presenter: Buket Aksu, Standard Member. Author(s): B. Aksu. VIEW ABSTRACT

779  Effect of punch tip coating and geometry on the sticking tendency of an ibuprofen tablet formulation. Presenter: Ines Saniocki, University of Hamburg, Institute of Pharmacy. Author(s): I. Saniocki, A. Sakmann, C. S. Leopold. VIEW ABSTRACT

781  Formulation Transfer & Modification of the ENCODEPhloralTM Colonic Delivery Coating System. Presenter: Sarah Eccleston, Encap Drug Delivery. Author(s): S. J. Eccleston. VIEW ABSTRACT

782  GMS as Effective Anti-Agglomeration Agent in Drug Layering of MCC Spheres. Presenter: Stephen Levine, Emerson Resources, Inc.. Author(s): S. P. Levine, N. D. Kirkland, D. E. Moseson. VIEW ABSTRACT

783  Increasing the Solubility of Poorly Soluble API by Using Hot-Melt Extrusion (HME). Presenter: Dennis Douroumis, University of Greenwich, School of Science. Author(s): D. Douroumis, M. Maniruzzaman, J. S. Boateng. VIEW ABSTRACT

784  Influence Of Gelucire Grade Binder On The Properties Of Acetaminophen High Dose Tablets. Preliminary Study For The Preparation Of Orally Disintegrating Tablets. Presenter: Gratiela Popa, University Of Medicine And Pharmacy Iasi, Faculty Of Pharmacy. Author(s): G. Popa, L. Ochiuz, I. Stoleriu, I. Cojocaru, A. Bosinceanu, I. Popovici. VIEW ABSTRACT

785  Influence of the Lyophilization Process on the Characterization of Xylan-based Microparticles Produced by Interfacial Cross-linking Polymerization. Presenter: Acarilia Silva, Laboratório de Sistemas Dispersos (LASID), Universidade Federal do Rio Grande do Norte (UFRN). Author(s): H. R. Marcelino, M. C. Gomes, A. E. Silva, E. S. Egito. VIEW ABSTRACT

786  Isobutyl carbonate-paliperidone hydrochlorate oil suspension : in vitro and in vivo evaluation. Presenter: Yanan Shi, Jilin University. Author(s): Y. Shi, C. Sui, D. Wang, W. Liu, Y. Li. VIEW ABSTRACT

787  Laboratory and Pilot Scale Manufacture of a Multi-Source Interchangeable Clobetasol 17-Propionate Cream. Presenter: Roderick Walker, Rhodes University. Author(s): R. B. Walker. VIEW ABSTRACT

788  Manufacturing, Process Development andOptimizationUsing Quality By Design. Presenter: Sridhar Gumudavelli, Manager. Author(s): S. Gumudavelli. VIEW ABSTRACT

789  Miscibility study of itraconazole and the polymers poly(lactic-co-glycolic acid) and polyvinylpyrrolidone as a first step in the development of an injectable controlled release formulation. Presenter: Joke Meeus, Catholic University of Leuven. Author(s): J. Meeus, G. Van den Mooter. VIEW ABSTRACT

790  Optimization of the Process for Manufacturing Docetaxel Injection. Presenter: H.S. Lee, Boryung Central Research Institute, Boryung Pharmaceutical Co. Ltd. Author(s): H. Lee, K. Nam, J. Kim. VIEW ABSTRACT

791  Scale up of LBLplus nanocrystal production. Presenter: Christoph Dunmann, R&D Scientist. Author(s): C. Dunmann, M. Grabo, R. Müller. VIEW ABSTRACT

793  Sustained-Release Formulations of Tramadol Hydrochloride Tablets Using Hydrophilic Matrix System. Presenter: Nersi Jafary Omid, Department of pharmaceutics, Faculty of Pharmacy, Tehran University of Medical Sciences. Author(s): N. Jafary Omid, S. Maleki, F. Dorkoosh. VIEW ABSTRACT

794  Taste Masking of Paracetamol by Hot Melt Extrusion (HME): An Electronic Tongue Evaluation. Presenter: Dennis Douroumis, University of Greenwich, School of Science. Author(s): D. Douroumis, M. Maniruzzaman, J. S. Boateng, M. Bonnefille, A. Aranyos. VIEW ABSTRACT

795  The use of the most flowable MCC Ceolus™ UF-702 in high shear granulation method. Presenter: Masayuki Kakizawa, Asahikasei Chemicals Corporation. Author(s): H. Yoshida, M. Kakizawa, K. Obae. VIEW ABSTRACT

 

Poorly Soluble Drugs: Bioactive Materials     [RETURN TO TOP]

796  De-risking early stage formulation of poorly water soluble drugs. Presenter: Andrew Parker, Molecular Profiles. Author(s): P. Whiteside, J. James, J. Ledru, S. Rutherford, J. Sloth, M. Walhberg, N. Patel, A. Parker. VIEW ABSTRACT

797  Effect of Coprecipitation and Particle Size Reduction by Nanomilling on the Intrinsic Dissolution Rate of Aripiprazole. Presenter: Aly Abdelrahman, Thomas J long School of Pharmacy & Health Sciences, University of the Pacific. Author(s): A. A. Abdelrahman, A. I. Elassasy, M. A. El-Nabarawi, X. Li, B. Jasti. VIEW ABSTRACT

798  Electrospinning for Solid Dispersions of Poorly Soluble Drugs. Presenter: Shaukat Ali, BASF Corporation. Author(s): S. Ali, N. Langley, D. Djuric, K. Kolter, S. Mirza. VIEW ABSTRACT

799  Facile preparation of water-insoluble photosensitizer-loaded polylactide nanoparticles for photodynamic therapy. Presenter: Takaichi Watanabe, Okayama University. Author(s): T. Watanabe, T. Ono, Y. Kimura, K. Ogawara, K. Higaki, I. Sakata. VIEW ABSTRACT

801  LBLplus: Capsulutionâ-™s multilayer nanocrystals for the delivery of poorly soluble drugs. Presenter: Christoph Dunmann, Scientist R&D. Author(s): C. Dunmann, M. Grabo, R. Müller. VIEW ABSTRACT

803  Novel technology for the targeted delivery of poorly solouble drugs. Presenter: Nirupama Sabnis, UNTHSC. Author(s): N. Sabnis, S. Pratap, M. Israel, A. G. Lacko. VIEW ABSTRACT

804  Oral Bioavailability Enhancement of the Poorly Soluble CompoundAlbendazole Using the Novel Solumer® Technology. Presenter: Mark Saunders, Kuecept Ltd. Author(s): M. Saunders. VIEW ABSTRACT

805  Solutions as Solutions - A Liquid Polymer as Solvent for Lipophilic Drugs and Sustained-Release Excipient. Presenter: Lutz Asmus, University of Geneva. Author(s): L. R. Asmus, R. Gurny, M. Möller. VIEW ABSTRACT

 

Protein Delivery: Bioactive Materials     [RETURN TO TOP]

806  Accomplishing pH controlled release of metals using a novel tripeptide. Presenter: Jennifer Laurence, Department of Pharmaceutical Chemistry, University of Kansas. Author(s): J. S. Laurence, M. E. Krause, A. M. Glass, T. A. Jackson, B. Ridl, S. Cai, Q. Yang, M. L. Forrest. VIEW ABSTRACT

807  Affinity Based Delivery of PSC-RANTES to Prevent HIV Transmission. Presenter: Nick Wang, Case Western Reserve University. Author(s): N. X. Wang, H. A. von Recum. VIEW ABSTRACT

808  CapsInjectTM: LBL Coating Technology for Controlled Delivery of Biologicals. Presenter: Omar Shoukry, Capsulution Pharma AG, D-12489 Berlin, Germany. Author(s): O. Shoukry, G. Borchard. VIEW ABSTRACT

809  Control of ocular drug bioavailability using thermo-responsive polypeptides. Presenter: Wan Wang, University of Southern California, Department of Pharmacology and Pharmaceutical Sciences. Author(s): W. Wang, M. Shah, A. Jashnani, F. Yarber, S. Hamm-Alvarez, J. MacKay. VIEW ABSTRACT

811  Controlling Microparticle Size and Porosity from a Novel scCO2 Technology using a Design of Experiment (DoE) approach. Presenter: Marie Warren, Nottingham University. Author(s): M. G. Warren. VIEW ABSTRACT

813  Development of a Gas Empowered Drug Delivery System for Peptide Delivery in the SmallIntestine. Presenter: Assal M.M.Sadeghi, Leiden University. Author(s): A. M.M.Sadeghi, M. Avadi, F. Dorkoosh, M. Rafiee Tehrani, H. E. Junginger. VIEW ABSTRACT

814  Development of a novel HA-activated derivative for protein delivery. Presenter: Gianfranco Pasut, University of Padua. Author(s): M. Pasqualin, A. Mero, M. Campisi, M. D'Este, I. Montagner, D. Boldrin, A. Rosato, G. Pasut. VIEW ABSTRACT

815  Enzyme loaded Hollow gold nanoparticles have potential application in Cancer Nanotechnology. Presenter: Anju Shrivastava, Department of Zoology, University of Delhi. Author(s): A. Shrivastava, N. Gupta, R. K. Sharma, A. Maitra. VIEW ABSTRACT

816  Evaluation of absorption enhancer effect of dextran sulfate/chitosan nanoparticles as oral insulin delivery system involving triple co-culture in vitro cell models. Presenter: Bruno Sarmento, Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Porto, Portugal. Author(s): F. Antunes, F. Andrade, D. Ferreira, B. Sarmento. VIEW ABSTRACT

817 Formulation optimization of cetyl alcohol lipospheres of serratiopeptidase using selected variables. Presenter: Manju Singh, University Institute of Pharmacy, Pt. Ravishankar Shukla University, Raipur, Chhattisgarh, India. VIEW ABSTRACT

818  Gelatin-Based Nanoparticles as Novel Carriers for Oral Delivery of Human Insulin. Presenter: Kenneth Ofokansi, Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, University of Nigeria. Author(s): K. C. Ofokansi, G. Winter, G. Fricker, M. N. Ofokansi, R. I. Echezona, C. Coester. VIEW ABSTRACT

819  Heparin-triggered release of tissue plasminogen activator for targeted thrombolysis. Presenter: Mohammad Absar, School of Pharmacy, Texas Tech University Health Sciences Center. Author(s): M. S. Absar, S. Choi, V. C. Yang, Y. M. Kwon. VIEW ABSTRACT

821  High-content analysis (HCA) for determination of potential cytotoxicity effects of sodium caprate (C10) on Caco-2 cells. Presenter: Edwin Walsh, UCD School of Veterinary Medicine and Conway Institute, University College Dublin. Author(s): E. G. Walsh, T. W. Leonard, D. J. Brayden. VIEW ABSTRACT

822  Highly Porous Bioresorbable Scaffolds with Protein Controlled Release for Tissue Regeneration Applications. Presenter: Meital Zilberman, Tel-Aviv University. Author(s): O. Grinberg, I. Binderman, M. Zilberman. VIEW ABSTRACT

823  Hyaluronic acid nanogel systems for sustained-release of protein. Presenter: Takashi Nakai, Chugai Pharmaceutical Co Ltd. Author(s): T. Nakai, T. Hirakura, Y. Sakurai, T. Shimoboji, M. Ishigai, K. Akiyoshi. VIEW ABSTRACT

825  Low Melting Point, Amphiphilic Microspheres For Delivery of Bone Morphogenic Protein-6 and Transforming Growth Factor ß-3 in a Hydrogel Matrix. Presenter: Oladunni Babasola, Queen's University. Author(s): B. G. Amsden, A. Sukarto, O. Babasola. VIEW ABSTRACT

826  New solubilizing agent for poorly soluble parenteral or oraldrugs. Presenter: Stéphane Ascarateil, SEPPIC. Author(s): S. Ascarateil, C. Nawrocki. VIEW ABSTRACT

827  Non-covalent stabilization of salmon calcitonin by tryptophan-mPEGs. Presenter: Gerrit Borchard, University of Geneva. Author(s): G. Borchard, C. Muller, T. Arvinte, M. Capelle, E. Seyrek. VIEW ABSTRACT

829  PLGA Based Nanoparticles formulation: Role of large poly vinyl alcohol (PVA) in prevention of aggregation and denaturation of bovine insulin. Presenter: Sanjay Rawat, sanjay rawat. Author(s): S. Rawat, D. K. Sahoo, C. R. Suri. VIEW ABSTRACT

830  Protein Release Behavior of Injectable Implants Prepared from PLGA-PEG Block Copolymers and PLGA/PLGA-PEG Blends. Presenter: Vesna Milacic, University of Michigan. Author(s): V. Milacic, S. P. Schwendeman. VIEW ABSTRACT

831  Recombinant Albumin: A multipurpose excipient for Formulation and Stabilisation of Biotherapeutics. Presenter: Khadija Schwach-Abdellaoui, Novozymes Biopharma DK A/S. Author(s): K. Schwach-Abdellaoui. VIEW ABSTRACT

832  Stability of Salmon Calcitonin-Sugar Nanoporous Microparticles. Presenter: Fatma Farag, School of Pharmacy, University College Cork, Ireland. Author(s): F. F. Farag, M. I. Amaro, C. M. O'Driscoll, A. M. Healy, A. M. Crean. VIEW ABSTRACT

833  Stabilization of Proteins at High Temperatures and its Implications in the Development of Polymer Implants via Hot-Melt Extrusion for Sustained Release Applications. Presenter: Karthikan Rajagopal, Genentech Inc.. Author(s): K. Rajagopal, J. Wood, T. W. Patapoff, T. Nivaggioli. VIEW ABSTRACT

834  Sublingual Administration of Ultra-rapid Acting Insulin: Proof of Concept. Presenter: Bryan Wilson, Biodel Inc.. Author(s): B. R. Wilson, R. Seibert, S. Steiner, R. Hauser, R. Pohl. VIEW ABSTRACT

835  Understanding the adsorption mechanism of four model antigens onto chitosan-based particles. Presenter: Gerrit Borchard, University of Geneva. Author(s): O. Borges, S. Jesus, D. Bento, F. Lebre, G. Borchard. VIEW ABSTRACT

836  Use of MFI for Sub-Visible and Visible Particle Characterization. Presenter: David Thomas, Brightwell Technologies Inc.. Author(s): D. Thomas. VIEW ABSTRACT

 

Pulmonary Delivery: Bioactive Materials     [RETURN TO TOP]

316  Advanced Spray Dried Microparticles/Nanoparticles of Antibiotics and a Mucolytic in the Solid-state for Cystic Fibrosis Treatment by Targeted Pulmonary Delivery. Presenter: Xiaojian Li, University of Kentucky. Author(s): X. Li, D. H. Jr., H. M. Mansour. VIEW ABSTRACT

317  Advanced Spray Dried Particles For Targeted Pulmonary Delivery In Lung Cancer. Presenter: Jiayue Ma, Department of Pharmaceutical Sciences, University of Kentucky. Author(s): J. Ma, H. M. Mansour, T. D. Dziubla. VIEW ABSTRACT

318  Advanced Spray-dried Vancomycin hydrochloride and Clarithromycin Particles for Targeted Pulmonary Inhalation Delivery as Dry Powders. Presenter: Chun-Woong Park, University of Kentucky College of Pharmacy. Author(s): C. Park, D. Hayes, H. M. Mansour. VIEW ABSTRACT

319  Anthocyanin-Encapsulated Porous Poly(lactic-co-glycolide) Microparticles for Pulmonary Delivery. Presenter: Na Young Yoo, Division of Biotechnology, The Catholic University of Korea. Author(s): N. Yoo, S. Park, E. Lee. VIEW ABSTRACT

320  Development of Itraconazole-loaded NLC for pulmonary application. Presenter: Sabrina Weber, Institute of Pharmaceutical Sciences, Department of Pharmaceutical Technology, Karl-Franzens Universität Graz. Author(s): S. Weber, H. P. Zarfl, A. Zimmer, J. Pardeike. VIEW ABSTRACT

321  Development of Mannosylated Liposomes for Targeted Delivery of siRNA to Alveolar Macrophages. Presenter: James Barlow, Royal College of Surgeons in Ireland. Author(s): C. Kelly, C. Lawlor, J. Barlow, N. G. McElvaney, C. Jefferies, S. Cryan. VIEW ABSTRACT

322  Non-Invasive Delivery of Polymeric Nanocarriers Using Propellant-Driven Formulations to Target Chlamydial Respiratory Infections. Presenter: Sandro da Rocha, Department of Chemical Engineering and Materials Science, Wayne State University. Author(s): B. S. Bharatwaj, L. Wu, J. A. Whittum-Hudson, S. da Rocha. VIEW ABSTRACT

323  Potent antituberculosis activity by pulmonary delivery of PLGA microspheres loaded with the antituberculosis agent rifampicin. Presenter: Keiji Hirota, Tokyo University of Science. Author(s): K. Hirota, T. Nakajima, K. Makino, H. Terada. VIEW ABSTRACT

324  Surface properties do not affect the in vitro toxicity of biodegradable nanoparticles towards bronchial cells. Presenter: Simona Mura, . Author(s): S. Mura, H. Hillaireau, J. Nicolas, B. Le Droumaguet, S. Kerdine-Rômer, M. Pallardy, N. Tsapis, E. Fattal. VIEW ABSTRACT

325  The influence of using carriers with increasing elongation ratios on uniformity, adhesion and in vitro aerosolozation performance of salbutamol sulphate from dry powder inhalers. Presenter: Ali Nokhodchi, Medway School of Pharmacy, University of Kent. Author(s): A. Nokhodchi, W. Kaialy, M. D. TIcehurst. VIEW ABSTRACT

 

Regenerative Medicine Technologies: Bioactive Materials     [RETURN TO TOP]

80  Liver anti-fibrosis therapy with mesenchymal stem cells secreting hepatocyte growth factor. Presenter: Yasuhiko Tabata, Department of Biomaterials, Institute for Frontier Medical Sciences, Kyoto University. Author(s): H. Ishikawa, J. Jo, Y. Tabata. VIEW ABSTRACT

468  In vitro Three Dimensional Tumor Model as a Tool for Drug Activity Studies. Presenter: Kalpna Garkhal, National Institute of Pharmaceutical Education and Research (NIPER). Author(s): K. Garkhal. VIEW ABSTRACT

 

Transdermal delivery: Bioactive Materials     [RETURN TO TOP]

470  A Topical Microemulsion Based Formulation for Tacrolimus. Presenter: Dhaval Kalaria, University of Geneva. Author(s): D. R. Kalaria, T. Gratieri, Y. N. Kalia. VIEW ABSTRACT

472  Application of statistical experimental design methodology to microemulsion formulations optimization. Presenter: Yi-Hung Tsai, Professor. Author(s): Y. Tsai, H. Tsou, C. Huang. VIEW ABSTRACT

473  Calcipotriol Entrapped Cyclodextrin Carrier Systems for Improving the Solubility. Presenter: Nilufer Tarimci, Ankara University Faculty Of Pharmacy. Author(s): U. Badilli, T. Sen, N. -. Tarimci. VIEW ABSTRACT

475  Comparison of gravimetric and spectroscopic approaches for quantification of mass of stratum corneum removed by tape-stripping. Presenter: Diar Mohammed, The School of Pharmacy, University of London. Author(s): D. Mohammed, Q. Yang, R. H. Guy, P. J. Matts, J. Hadgraft, M. E. Lane. VIEW ABSTRACT

476  Design of Dissolvable Microneedles for Drug Delivery. Presenter: Marie McGrath, School of Pharmacy, University College Cork, Ireland. Author(s): M. G. McGrath, C. O'Mahony, A. Vrdoljak, A. C. Moore, A. M. Crean. VIEW ABSTRACT

477  Development of a Fentanyl 3-Day Matrix Patch (NAL1237) for Treatment of Chronic Pain. Presenter: Je Phil Ryoo, NAL Pharmaceuticals Ltd.. Author(s): H. Yamauchi, N. Nakajima, C. Moon, J. Ryoo. VIEW ABSTRACT

478  Development of an Immunocompetent Human Skin Tissue Model Using Three Dimensional (3D) Freeform Fabrication. Presenter: Gurtej Singh, Chemical and Biological Engineering, Rensselaer Polytechnic Institute. Author(s): G. Singh, V. Lee, J. P. Trasatti, S. Yoo, G. Dai, P. Karande. VIEW ABSTRACT

479  Development of ImmuPatch Microneedle Arrays Coated with Live Vaccine. Presenter: Abina Crean, School of Pharmacy, University College Cork, Ireland. Author(s): A. Vrdoljak, M. G. McGrath, J. B. Carey, C. O'Mahony, A. M. Crean, A. C. Moore. VIEW ABSTRACT

480  Development of lidocaine coated microneedle product for rapid local analgesic action. Presenter: Kris Hansen, 3M Drug Delivery Systems Division. Author(s): Y. Zhang, K. Brown, K. Siebenaler, A. Determan, D. Dohmeier, K. Hansen. VIEW ABSTRACT

481  Different Colloidal Carriers for Transungual Delivery of Terbinafine HCl: Liposome & Ethosomes. Presenter: Ozgen Ozer, Prof. Dr.. Author(s): S. Tuncay, I. Vejnovic, G. Betz, O. Ozer. VIEW ABSTRACT

482  Drop-on demand inkjet printing for prepartion of transdermal patches. Presenter: Ajay Banga, Transdermal Delivery Laboratory, College of Pharmacy and Health Sciences, Mercer University. Author(s): S. Saluja, V. Kumar, A. Badkar, A. Banga. VIEW ABSTRACT

483  Effect of Microneedles and Iontophoresis on Depot Kinetics of Imiquimod. Presenter: Ajay Banga, Mercer University. Author(s): H. Kalluri, P. Friden, A. K. Banga. VIEW ABSTRACT

484  Effect of pressure sensitive adhesives on transdermal delivery of same class compounds. Presenter: Hoo-Kyun Choi, College of Pharmacy, Chosun University, Seosuk Dong, Gwangju, 501-759. Author(s): E. Lee, R. K. Subedi, H. Choi. VIEW ABSTRACT

485  Enhancement of a water-dissolving-microneedle system using the versatility of liposomal formulation. Presenter: Meeree Han, College of Pharmacy, Sookmyung Womenâ University. Author(s): M. Han, S. Oh, J. Park. VIEW ABSTRACT

486  Facilitated Dendrimer Penetration into Skin by Low-Intensity Ultrasound. Presenter: Yang Yang, University of Illinois at Chicago. Author(s): Y. Yang, K. L. Watkin, S. Hong. VIEW ABSTRACT

487  Immunization using ImmuPatch Silicon Microneedle Arrays results in Enhanced T cell and antibody responses compared to traditional immunization routes. Presenter: Abina Crean, School of Pharmacy. Author(s): J. B. Carey, F. E. Pearson, A. M. Crean, A. Vrdoljak, C. O'Mahony, A. V. Hill, A. C. Moore. VIEW ABSTRACT

489  In Vitro Permeation Enhancement of a Model Drug-loaded Nanocarrier System Using Microneedles. Presenter: Iván Calderón-Lojero, División de Estudios de Posgrado (Tecnología Farmacéutica), Facultad de Estudios Superiores Cuautitlán, Universidad Nacional Autónoma de México. Author(s): I. O. Calderón-Lojero, C. L. Domínguez-Delgado, G. Nava-Arzaluz, I. M. Rodríguez-Cruz1, D. Quintanar-Guerrero, A. Ganem-Rondero. VIEW ABSTRACT

490  In Vivo Permeation Study of Triclosan Included in Polymeric Nanoparticles and in an Emulsion (o/w) Intended to be Used for the Treatment of Acne. Presenter: Clara Domínguez-Delgado, Facultad de Estudios Superiores Cuautitlán, UNAM.. Author(s): C. L. Domínguez-Delgado, I. O. Calderón-Lojero, I. M. Rodríguez-Cruz, M. G. Nava-Arzaluz, G. Vidal-Romero, D. Quintanar-Guerrero, A. Ganem-Rondero. VIEW ABSTRACT

491  Influence of Aqueous Cream on corneocyte size, maturity, skin protease activity, protein content and Trans-Epidermal Water Loss. Presenter: Diar Mohammed, The School of Pharmacy, University of London. Author(s): D. Mohammed, P. J. Matts, J. Hadgraft, M. E. Lane. VIEW ABSTRACT

492  Iontophoretic delivery of ketorolac tromethamine across porcine and human skin in vitro. Presenter: Tais Gratieri, Univ of Geneva. Author(s): T. Gratieri, E. P. Bello, S. Dubey, Y. N. Kalia. VIEW ABSTRACT

493  Iontophoretic Delivery of Ondansetron Hydrochloride In vitro: Contribution of Electromigration and Electroosmosis. Presenter: Sevgi Gungor, Post-doc. Author(s): D. Ozdin, S. Gungor. VIEW ABSTRACT

494  Lengthening drug delivery time of degradable microneedle by mixing Maltose and Pullulan. Presenter: Yoshikazu Tobinaga, Elegaphy, Inc.. Author(s): Y. Tobinaga. VIEW ABSTRACT

495  Lutein-loaded Lipid Nanoparticles for Dermal application. Presenter: Rainer Müller, Freie Universität Berlin, Institute of Pharmacy, Kelchstr. 31, 12169 Berlin. Author(s): K. Mitri, R. Shegokar, C. Anselmi, S. Gohla, R. H. Müller. VIEW ABSTRACT

496  Mechanism of Transdermal Penetration of Cationic Liposomes by Iontophoresis. Presenter: Kentaro Kogure, Kyoto Pharmaceutical University. Author(s): K. Kogure, Y. Kimura, S. Hama, A. Mikami, K. Kigasawa, K. Kanamura, A. Tamura, Y. Nagasaki, K. Kajimoto. VIEW ABSTRACT

497  Microneedle-enhanced naltrexone delivery in Yucatan minipig. Presenter: Audra Stinchcomb, University of Kentucky/AllTranz. Author(s): M. Milewski, S. L. Banks, N. K. Brogden, P. Ghosh, K. S. Paudel, D. C. Hammell, A. L. Stinchcomb. VIEW ABSTRACT

498  MRI Induced RF Heating of Transdermal Patches. Presenter: Ryan Gordon, 3M Drug Delivery Systems. Author(s): R. D. Gordon, R. Visaria, D. Shrivastava, J. T. Vaughan. VIEW ABSTRACT

499  Nicotine Release from Transdermal Patch Samples Studied by UV Imaging. Presenter: Jesper ? stergaard, Department of Pharmaceutics and Analytical Chemistry, Faculty of Pharmaceutical Sciences, University of Copenhagen. Author(s): J. ? stergaard, E. Meng-Lund, S. W. Larsen, C. Larsen, K. Petersson, J. Lenke, H. Jensen. VIEW ABSTRACT

500  Noninvasive and efficient transdermal delivery of CpG-oligodeoxynucleotide for cancer immunotherapy. Presenter: Kaoru Kigasawa, Hokkaido Univercity. Author(s): K. Kigasawa, K. Kajimoto, T. Nakamura, S. Hama, K. Kanamura, H. Harashima. VIEW ABSTRACT

503  The Use Of Triclosan Nanospheres To Increase Drug Deposition Into Human Skin. Presenter: Clara Domínguez-Delgado, Facultad de Estudios Superiores Cuautitlán, Universidad Nacional Autónoma de México. Author(s): I. M. Rodríguez -Cruz, C. L. Domínguez-Delgado, I. O. Calderón-Lojero, V. Merino, A. Ganem-Rondero, D. Quintanar-Guerrero. VIEW ABSTRACT

504  Transdermal delivery of donepezil: a feasibility study. Presenter: Hoo-Kyun Choi, BK21 Project Team, College of Pharmacy, Chosun University. Author(s): R. K. Subedi, J. Ryoo, H. Choi. VIEW ABSTRACT

505  Transdermal Delivery of Local Anesthetics. Presenter: Jeanetta Du Plessis, Drug Research and Development, North-West University, Private Bag X6001, Potchefstroom, North-West Province, 2531. Author(s): J. Du Plessis, L. Kruger, A. M. Grobler, M. Gerber, M. M. Malan, J. L. Du Preez. VIEW ABSTRACT

506  Transdermal Delivery of Selected 5-Fluorouracil Formulations. Presenter: Minja Gerber, Drug Research and Development, North-West University, Private Bag X6001, Potchefstroom, North-West Province, 2531. Author(s): M. Gerber, M. Vermaas, J. M. Viljoen, J. Du Plessis. VIEW ABSTRACT

 

Vaccines: Bioactive Materials     [RETURN TO TOP]

507  A model vaccine containing the contrast agent Resovist® for tracking of aluminum hydroxide adjuvant using magnetic resonance imaging. Presenter: Kathleen Thom, Institute of Pharmacy EMA University of Greifswald. Author(s): K. Thom, K. Aurich, J. Suendermann, G. Gloeckl, J. Kuehn, W. Weitschies. VIEW ABSTRACT

508  A novel strategy for mucosal vaccination using a claudin binder. Presenter: Masuo Kondoh, Osaka University. Author(s): S. Yamane, H. Suzuki, H. Kakutani, A. Watari, M. Kondoh, K. Yagi. VIEW ABSTRACT

509  An injectable, immunepriming center for cancer vaccines: Simultaneous, single-carrier delivery oftumor-antigens and immune-modulatory IL-10 siRNA to dendritic cells. Presenter: Eileen Dawson, Department of Biomedical Engineering, The University of Texas At Austin. Author(s): E. R. Dawson, N. A. Peppas, K. Roy. VIEW ABSTRACT

510  Characterisation of Bilayer Vesicles using Differential Scanning Calorimetry (DSC). Presenter: Jitinder Wilkhu, Aston University. Author(s): J. S. Wilkhu, D. Anderson, Y. Perrie. VIEW ABSTRACT

511  Characterisation of cationic liposomal adjuvants for the delivery of a promising sub-unit tuberculosis vaccine. Presenter: Yvonne Perrie, Aston University. Author(s): M. J. Hussain, V. W. Bramwell, D. Christensen, Y. Perrie. VIEW ABSTRACT

513  Design of a Therapeutic Melanoma Vaccine Candidate: Coencapsulation of a Melanoma Peptide Antigen and a CpG Oligonucleotide as an Adjuvant into Polymeric Nanoparticles. Presenter: Joana Silva, Research Institute for Medicines and Pharmaceutical Sciences (iMed.UL), Faculty of Pharmacy, University of Lisbon, Portugal; Louvain Drug Research Institute, Unit of Pharmaceutics, Université Catholique de Louvain, Brussels, Belgium.. Author(s): J. M. Silva. VIEW ABSTRACT

514  Developing an In Vitro Tool Kit to Screen Particulate Vaccine Adjuvants. Presenter: Yvonne Perrie, Aston University. Author(s): S. E. McNeil, J. Wilkhu, Y. Perrie. VIEW ABSTRACT

516  Dexamethasone and Peptide Loaded Acetalated Dextran Nanoparticle for Multiple Sclerosis Treatment. Presenter: Naveen Kanthamneni, The Ohio State University. Author(s): N. Kanthamneni, M. Guerau, D. Huss, A. Smith, A. Lovett-Racke, E. Bachelder, K. Ainslie. VIEW ABSTRACT

518  Effect of the topological control of adjuvant in antigen carrier to immunological responses. Presenter: Takashi Nakamura, Faculty of Pharmaceutical Sciences, Hokkaido University. Author(s): T. Nakamura, R. Moriguchi, K. Kogure, H. Harashima. VIEW ABSTRACT

523  New method to produce equine antirabies immunoglobulin F(ab')2 fragments from crude plasma in high quality and yield. Presenter: Sukanda Kittipongwarakarn, Department of Manufacturing Pharmacy, Faculty of Pharmacy, Mahidol University. Author(s): S. Kittipongwarakarn, S. Puttipipatkhachorn, W. Jiskoot, A. Hawe, S. Khomvilai, R. Tantipolphan, K. Limsuwun. VIEW ABSTRACT

524  Uptake of glucan particles via dectin-1 receptor mediated endocytosis in Peyer's patches?. Presenter: Tauseef Ahmad, School of Agriculture, Food Science and Veterinary Medicine and Conway Institute, University College Dublin, Belfield, Dublin 4, Ireland. Author(s): T. Ahmad, J. C. Simpson, D. J. Brayden. VIEW ABSTRACT

© Copyright Controlled Release Society  | Contact Us - Report a Bad Link